{
 "metadata": {
  "name": "",
  "signature": "sha256:fc333fab516b4f4c722f7889e533682fbff215ffb968f33ede8f9315ae2fccca"
 },
 "nbformat": 3,
 "nbformat_minor": 0,
 "worksheets": [
  {
   "cells": [
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "\n"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "import os\n",
      "execfile('./setup_python_env.py')"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stderr",
       "text": [
        "/Users/localadmin/Library/Enthought/Canopy_64bit/User/lib/python2.7/site-packages/pandas/io/excel.py:626: UserWarning: Installed openpyxl is not supported at this time. Use >=1.6.1 and <2.0.0.\n",
        "  .format(openpyxl_compat.start_ver, openpyxl_compat.stop_ver))\n"
       ]
      }
     ],
     "prompt_number": 1
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "R = 50\n",
      "alpha = 1\n",
      "gammaForTF = [0.001, 0.05, 0.05]\n",
      "save_folder = './pickle_folder_20140814/'\n",
      "\n",
      "\n",
      "#create output folder if it does not exist\n",
      "if not os.path.exists(save_folder):\n",
      "\tos.makedirs(save_folder)\n",
      "    \n",
      "startTime = time.time()#start time -- to time it\n",
      "##factorization\n",
      "print \"running factorization\"\n",
      "spntf_htn_subset_analyzed_withGamma = SP_NTF.SP_NTF(loaded_X_subset_to_analyze, R=R, alpha=alpha)\n",
      "Yinfo_htn_subset_analyzed_withGamma = spntf_htn_subset_analyzed_withGamma.computeDecomp(gamma=gammaForTF)\n",
      "marbleElapse = time.time() - startTime #elapsed time\n",
      "\n",
      "#tensor decomposition factors (\"phenotypes\"):\n",
      "pheno_htn_subset_analyzed_withGamma_REG = spntf_htn_subset_analyzed_withGamma.M[0]\n",
      "pheno_htn_subset_analyzed_withGamma_AUG = spntf_htn_subset_analyzed_withGamma.M[1]\n",
      "pheno_htn_subset_analyzed_withGamma = (pheno_htn_subset_analyzed_withGamma_REG, pheno_htn_subset_analyzed_withGamma_AUG) \n",
      "\n",
      "\n",
      "#string for saving the file based upon gamma\n",
      "gamma_str = '_gamma'\n",
      "for num in gammaForTF:\n",
      "    gamma_str = gamma_str + '-' + str(num)\n",
      "gamma_str = gamma_str + '.pickle'\n",
      "\n",
      "#save factorization in pickle\n",
      "outfile_str = save_folder + \"pheno_htn_subset_analyzed_REG\" + gamma_str\n",
      "with open(outfile_str, \"wb\") as output_file: ##IMPT! phenotype stored in this pickle\n",
      "    pickle.dump(pheno_htn_subset_analyzed_withGamma, output_file)\n",
      "output_file.close()\n",
      "outfile_str = save_folder + \"pheno_htn_subset_analyzed_AUG\" + gamma_str\n",
      "with open(outfile_str, \"wb\") as output_file: ##IMPT! phenotype stored in this pickle\n",
      "    pickle.dump(pheno_htn_subset_analyzed_withGamma, output_file)\n",
      "output_file.close()\n",
      "outfile_str = save_folder + \"Yinfo_htn_subset_analyzed\" + gamma_str\n",
      "with open(outfile_str, \"wb\") as output_file:\n",
      "    pickle.dump(Yinfo_htn_subset_analyzed_withGamma, output_file)\n",
      "output_file.close()\n"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "running factorization\n",
        "Iteration 0: Xi = 0.499999999912, dll = 0.000720625277609, time = 159.96833992"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 1: Xi = 0.499999999912, dll = 6912606.77242, time = 156.588908911"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 2: Xi = 0.739269072281, dll = 235865.798878, time = 157.628616095"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 3: Xi = 0.865136608479, dll = 97620.8217963, time = 156.888142824"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 4: Xi = 0.925535051966, dll = 154824.100923, time = 155.021204948"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 5: Xi = 0.960880406914, dll = 41698.8335434, time = 152.639779091"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 6: Xi = 0.978763972651, dll = 37163.5183282, time = 152.387804031"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 7: Xi = 0.987413454168, dll = 43816.6064356, time = 152.824157953"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 8: Xi = 0.993271999412, dll = 9684.81377982, time = 152.685360909"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 9: Xi = 0.996462983195, dll = 3855.7764322, time = 152.77131319"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 10: Xi = 0.998223154243, dll = 185.806040516, time = 152.837651014"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 11: Xi = 0.998977624869, dll = 2986.05582064, time = 152.909878016"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 12: Xi = 0.999185294783, dll = 6770.10753342, time = 152.907948971"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 13: Xi = 0.999577085012, dll = 347.137174539, time = 153.09487915"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 14: Xi = 0.999788417035, dll = 2.79877583683, time = 153.077599049"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 15: Xi = 0.999894203348, dll = 0.115315448493, time = 153.264214993"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 16: Xi = 0.999947101113, dll = 0.0125105027109, time = 158.807796001"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 17: Xi = 0.999969651441, dll = 86.9750082064, time = 158.768397093"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 18: Xi = 0.99998474783, dll = 1.73745364323, time = 159.469112873"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 19: Xi = 0.999992373482, dll = 0.00965772755444, time = 162.305660963"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n"
       ]
      }
     ],
     "prompt_number": 28
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "startTime = time.time()#start time -- to time it\n",
      "##factorization\n",
      "print \"running factorization\"\n",
      "spntf_htn_subset_analyzed_withGamma = SP_NTF.SP_NTF(loaded_X_subset_to_analyze, R=R, alpha=alpha)\n",
      "Yinfo_htn_subset_analyzed_withGamma = spntf_htn_subset_analyzed_withGamma.computeDecomp(gamma=gammaForTF)\n",
      "marbleElapse = time.time() - startTime #elapsed time"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "running factorization\n",
        "Iteration 0: Xi = 0.0921068258687, dll = 13865570.9052, time = 158.917155027"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 1: Xi = 0.521415014142, dll = 154285.677004, time = 158.502012968"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 2: Xi = 0.612102837462, dll = 1258849.17045, time = 156.898342848"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 3: Xi = 0.737762612506, dll = 578483.215185, time = 155.707965851"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 4: Xi = 0.855880225843, dll = 97630.6088607, time = 165.873701096"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 5: Xi = 0.909279404532, dll = 145563.794967, time = 158.095938921"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 6: Xi = 0.949292546536, dll = 42161.6471746, time = 155.45082593"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 7: Xi = 0.969614610876, dll = 40077.333292, time = 155.295474052"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 8: Xi = 0.981381531023, dll = 27474.6339246, time = 157.003990889"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 9: Xi = 0.988913940689, dll = 14300.9156481, time = 155.39209795"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 10: Xi = 0.992911211306, dll = 12479.745698, time = 155.871671915"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 11: Xi = 0.994772643388, dll = 13633.3501064, time = 155.767528057"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 12: Xi = 0.996631638185, dll = 6122.78591403, time = 161.140794992"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 13: Xi = 0.997759416654, dll = 4519.15037641, time = 157.670635939"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 14: Xi = 0.998165594999, dll = 5808.38802324, time = 159.448128939"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 15: Xi = 0.998628892495, dll = 3695.28457911, time = 159.411009073"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 16: Xi = 0.99901830689, dll = 2412.3279444, time = 162.872064829"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 17: Xi = 0.99923181, dll = 2260.47176973, time = 157.634582043"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 18: Xi = 0.999378192538, dll = 1938.3832904, time = 161.527398109"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 19: Xi = 0.999670781625, dll = 149.348922804, time = 164.027773857"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 20: Xi = 0.999829038028, dll = 51.8051899578, time = 158.216000795"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 21: Xi = 0.999913224552, dll = 10.5559747978, time = 15051.968436"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 22: Xi = 0.999956533781, dll = 0.640106991865, time = 156.346779823"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 23: Xi = 0.999974341496, dll = 32.0106729474, time = 160.896203041"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 24: Xi = 0.99998582457, dll = 10.9777929201, time = 158.018313885"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 25: Xi = 0.999992877057, dll = 0.287278907374, time = 158.186841965"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 26: Xi = 0.99999642856, dll = 0.0812909887172, time = 157.841801882"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 27: Xi = 0.999998211763, dll = 0.0205285861157, time = 160.700264931"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 28: Xi = 0.999999105233, dll = 0.00528622139245, time = 158.416303873"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n"
       ]
      }
     ],
     "prompt_number": 9
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 28
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "\n"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 28
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 26
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "gamma_str = '_gamma-0.001-0.01-0.01.pickle'\n",
      "\n",
      "def calculateValues(TM, M):\n",
      "    fms = TM.greedy_fms(M)\n",
      "    fos = TM.greedy_fos(M)\n",
      "    nnz = tensorTools.countTensorNNZ(M)\n",
      "    return fms, fos, nnz\n",
      "\n",
      "## load the tensor #######\n",
      "loaded_X, loaded_axisDict, loaded_classDict = tensorIO.loadSingleTensor(\"htn-tensor-subsetforanalysis-20140811-{0}.dat\")\n",
      "\n",
      "\n",
      "##read in the pickles:\n",
      "pickle_folder = \"./pickle_folder_20140814/\"\n",
      "\n",
      "outfile_str = pickle_folder + \"pheno_htn_subset_analyzed_REG\" + gamma_str\n",
      "matrix_pkl = open(outfile_str, \"rb\")\n",
      "pheno_htn_subset_analyzed_REG_withGamma = pickle.load(matrix_pkl)\n",
      "matrix_pkl.close()\n",
      "\n",
      "outfile_str = pickle_folder + \"Yinfo_htn_subset_analyzed\" + gamma_str  \n",
      "matrix_pkl = open(outfile_str, \"rb\")\n",
      "Yinfo_htn_subset_analyzed_withGamma = pickle.load(matrix_pkl)\n",
      "matrix_pkl.close()\n",
      "\n",
      "#write output file\n",
      "pheno_outstream = open(pickle_folder + \"phenotypes\"+gamma_str+\".out\", 'w+')\n",
      "\n",
      "#read in the pheWAS dictionary\n",
      "execfile('./read_pheWAS_dictionary_xls.py')\n",
      "\n",
      "#tensor with all phenotypes (factorization)\n",
      "ktensor_phenotypes = pheno_htn_subset_analyzed_REG_withGamma[0]\n",
      "l_pts = loaded_axisDict[0].keys()\n",
      "l_jdrange = loaded_axisDict[1].keys()\n",
      "l_meds= loaded_axisDict[2].keys()\n",
      "\n",
      "#will store all the data\n",
      "d_pheno_nonzero_labels = OrderedDict()\n",
      "\n",
      "\n",
      "#sort phenotypes by lambda values:\n",
      "d_lambda_phenoNumber = OrderedDict(zip(list(ktensor_phenotypes.lmbda),\n",
      "                                        list(range(R) )\n",
      "                                        ))\n",
      "l_phenoNumbers_sorted_by_lambda = [  d_lambda_phenoNumber[x] for x in sorted(d_lambda_phenoNumber.keys(), reverse=True)]                                  \n",
      "\n",
      "#print phenotype feature names #################\n",
      "#for i in range(10):\n",
      "for i in l_phenoNumbers_sorted_by_lambda:\n",
      "    print \"===== phenotype \" + str(i) + \"=================================================================\"\n",
      "    pheno_outstream.write(\"===== phenotype \" + str(i) + \"=================================================================\" + '\\n')\n",
      "    this_lmbda = ktensor_phenotypes.lmbda[i]\n",
      "    this_pheno_pt_factor = ktensor_phenotypes.U[0][:,i]\n",
      "    this_pheno_jdrange_factor = ktensor_phenotypes.U[1][:,i]\n",
      "    this_pheno_med_factor = ktensor_phenotypes.U[2][:,i]\n",
      "    \n",
      "    this_pheno_pt_nnz = np.nonzero(this_pheno_pt_factor)[0]\n",
      "    this_pheno_jdrange_nnz = np.nonzero(this_pheno_jdrange_factor)[0]\n",
      "    this_pheno_med_nnz = np.nonzero(this_pheno_med_factor)[0]\n",
      "    \n",
      "    l_nonzero_pt_thisPheno = []\n",
      "    l_nonzero_meds_thisPheno = []\n",
      "    l_nonzero_jdrange_thisPheno = []\n",
      "    l_nonzero_jdrange_names_thisPheno = []\n",
      "    \n",
      "    for j in this_pheno_pt_nnz:\n",
      "        l_nonzero_pt_thisPheno.append(l_pts[j])\n",
      "    for j in this_pheno_jdrange_nnz:\n",
      "        l_nonzero_jdrange_thisPheno.append(l_jdrange[j])\n",
      "        l_nonzero_jdrange_names_thisPheno.append(d_jdrange_lookup[l_jdrange[j]])\n",
      "    for j in this_pheno_med_nnz:\n",
      "        l_nonzero_meds_thisPheno.append(l_meds[j])\n",
      "    \n",
      "    #data\n",
      "    d_pheno_nonzero_labels[i] = dict() #for phenotype i\n",
      "    d_pheno_nonzero_labels[i]['LAMBDA'] = this_lmbda #lambda value\n",
      "    d_pheno_nonzero_labels[i]['PERCENT_PTS'] = len(l_nonzero_pt_thisPheno) / float(len(this_pheno_pt_factor))\n",
      "    d_pheno_nonzero_labels[i]['MEDS_NZ'] = l_nonzero_meds_thisPheno #for phenotype i\n",
      "    d_pheno_nonzero_labels[i]['JDRANGE_NZ'] = l_nonzero_jdrange_thisPheno #for phenotype i   \n",
      "    d_pheno_nonzero_labels[i]['JDRANGE_NAMES_NZ'] = l_nonzero_jdrange_names_thisPheno #for phenotype i \n",
      "    \n",
      "    print \"proportion of pts: \" + str(d_pheno_nonzero_labels[i]['PERCENT_PTS'])\n",
      "    pheno_outstream.write(\"proportion of pts: \" + str(d_pheno_nonzero_labels[i]['PERCENT_PTS']) + '\\n')\n",
      "    print \"lambda: \" + str(this_lmbda)\n",
      "    pheno_outstream.write(\"lambda: \" + str(this_lmbda) + '\\n')\n",
      "    print \"----------------------------------------\" #divider\n",
      "    pheno_outstream.write(\"----------------------------------------\" + '\\n')\n",
      "    #print \"\\tnumber jdrange: \" + str(len(d_pheno_nonzero_labels[i]['JDRANGE_NZ']))\n",
      "    #print \"\\tjdrange: \" + str(d_pheno_nonzero_labels[i]['JDRANGE_NZ'])\n",
      "    for jdrange in d_pheno_nonzero_labels[i]['JDRANGE_NZ']:\n",
      "        print d_jdrange_lookup[jdrange]\n",
      "        pheno_outstream.write(str(d_jdrange_lookup[jdrange]) + '\\n')\n",
      "    #print \"\\tnumber meds: \" + str(len(d_pheno_nonzero_labels[i]['MEDS_NZ']))\n",
      "    #print \"\\tmeds: \" + str(d_pheno_nonzero_labels[i]['MEDS_NZ'])\n",
      "    print \"----------------------------------------\" #divider between diagnostic codes and meds\n",
      "    pheno_outstream.write(\"----------------------------------------\" + '\\n')\n",
      "    for med in d_pheno_nonzero_labels[i]['MEDS_NZ']:\n",
      "        print med   \n",
      "        pheno_outstream.write(med + '\\n')\n",
      "pheno_outstream.close()"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "===== phenotype 26=================================================================\n",
        "proportion of pts: 0.0975803252678\n",
        "lambda: 29076.7869051\n",
        "----------------------------------------\n",
        "Malignant neoplasm of digestive organs and peritoneum\n",
        "Operations on the nose, mouth, and pharynx\n",
        "Disorders of thyroid gland\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Na\n",
        "Hereditary and degenerative diseases of the central nervous system\n",
        "Other disorders of the central nervous system\n",
        "Operations on the cardiovascular system\n",
        "Disorders of the peripheral nervous system\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Cerebrovascular disease\n",
        "Diseases of arteries, arterioles, and capillaries\n",
        "Other diseases of respiratory system\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Operations on the musculoskeletal system\n",
        "General symptoms\n",
        "Symptoms involving nervous and musculoskeletal systems\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Symptoms involving urinary system\n",
        "Nonspecific abnormal findings on radiological and other examination of body structure\n",
        "Ill-defined and unknown causes of morbidity and mortality\n",
        "Complications of surgical and medical care, not elsewhere classified\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-2 Receptor Agonists\n",
        "Adrenergic beta-Antagonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Local\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents, Local\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticoagulants\n",
        "Anticonvulsants\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antidepressive Agents, Tricyclic\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antimanic Agents\n",
        "Antiparkinson Agents\n",
        "Antipruritics\n",
        "Antipsychotic Agents\n",
        "Antipyretics\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cathartics\n",
        "Cholinergic Antagonists\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Drug Carriers\n",
        "Excitatory Amino Acid Antagonists\n",
        "Explosive Agents\n",
        "Fibrinolytic Agents\n",
        "GABA Modulators\n",
        "Gastrointestinal Agents\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists\n",
        "Histamine H2 Antagonists\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypolipidemic Agents\n",
        "Nitric Oxide Donors\n",
        "Parasympatholytics\n",
        "Phosphodiesterase Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Protein Synthesis Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Purinergic P2Y Receptor Antagonists\n",
        "Serotonin Antagonists\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Solvents\n",
        "Surface-Active Agents\n",
        "Sympatholytics\n",
        "Tocolytic Agents\n",
        "Vasodilator Agents\n",
        "===== phenotype 10=================================================================\n",
        "proportion of pts: 0.0864736215787\n",
        "lambda: 26684.0835748\n",
        "----------------------------------------\n",
        "Other bacterial diseases\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Coagulation or hemorrhagic diseases\n",
        "Other diseases of the blood\n",
        "Na\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Organic sleep disorders\n",
        "Hereditary and degenerative diseases of the central nervous system\n",
        "Pain\n",
        "Other disorders of the central nervous system\n",
        "Disorders of the peripheral nervous system\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Pneumonia and influenza\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Other diseases of respiratory system\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Hernia of abdominal cavity\n",
        "Other diseases of intestines and peritoneum\n",
        "Nephritis, nephrotic syndrome, and nephrosis\n",
        "Infections of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "Congenital anomalies\n",
        "Operations on the musculoskeletal system\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Ill-defined and unknown causes of morbidity and mortality\n",
        "Fractures\n",
        "Operations on the integumentary system\n",
        "Other and unspecified effects of external causes\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic Uptake Inhibitors\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-2 Receptor Agonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Intravenous\n",
        "Anesthetics, Local\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents\n",
        "Anti-Infective Agents, Local\n",
        "Anti-Infective Agents, Urinary\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Ulcer Agents\n",
        "Anticoagulants\n",
        "Anticonvulsants\n",
        "Antidepressive Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antidepressive Agents, Tricyclic\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antimanic Agents\n",
        "Antineoplastic Agents, Alkylating\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antiparkinson Agents\n",
        "Antipruritics\n",
        "Antipsychotic Agents\n",
        "Antipyretics\n",
        "Antitussive Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiovascular Agents\n",
        "Cathartics\n",
        "Cholinergic Antagonists\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Excitatory Amino Acid Antagonists\n",
        "GABA Modulators\n",
        "GABA-A Receptor Agonists\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists\n",
        "Hypnotics and Sedatives\n",
        "Leprostatic Agents\n",
        "Muscle Relaxants, Central\n",
        "Myeloablative Agonists\n",
        "Narcotics\n",
        "Protein Synthesis Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Rodenticides\n",
        "Serotonin Antagonists\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sweetening Agents\n",
        "Sympatholytics\n",
        "Sympathomimetics\n",
        "Tocolytic Agents\n",
        "Topoisomerase II Inhibitors\n",
        "Vasoconstrictor Agents\n",
        "Voltage-Gated Sodium Channel Blockers\n",
        "===== phenotype 41=================================================================\n",
        "proportion of pts: 0.10749702499\n",
        "lambda: 26481.1469323\n",
        "----------------------------------------\n",
        "Intestinal infectious diseases\n",
        "Mycoses\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Coagulation or hemorrhagic diseases\n",
        "Other diseases of the blood\n",
        "Drug dependence\n",
        "Hypertensive disease\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Other diseases of the upper respiratory tract\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Other diseases of respiratory system\n",
        "Other diseases of intestines and peritoneum\n",
        "Liver\n",
        "Other diseases of digestive system\n",
        "Nephritis, nephrotic syndrome, and nephrosis\n",
        "Other diseases of urinary system\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms concerning nutrition, metabolism, and development\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Symptoms involving urinary system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Abnormal results of function studies\n",
        "Miscellaneous diagnostic and therapeutic procedures\n",
        "----------------------------------------\n",
        "Adjuvants, Anesthesia\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Adrenergic beta-2 Receptor Agonists\n",
        "Adrenergic beta-Antagonists\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Intravenous\n",
        "Anesthetics, Local\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents\n",
        "Anti-Infective Agents, Urinary\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antiemetics\n",
        "Antifungal Agents\n",
        "Antihypertensive Agents\n",
        "Antimalarials\n",
        "Antimetabolites\n",
        "Antineoplastic Agents, Alkylating\n",
        "Antineoplastic Agents, Phytogenic\n",
        "Antiprotozoal Agents\n",
        "Antipruritics\n",
        "Antipsychotic Agents\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cathartics\n",
        "Cholinergic Antagonists\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Dopamine Antagonists\n",
        "Drug Carriers\n",
        "Fibrinolytic Agents\n",
        "Gastrointestinal Agents\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists\n",
        "Hypoglycemic Agents\n",
        "Ionophores\n",
        "Mineralocorticoid Receptor Antagonists\n",
        "Narcotics\n",
        "Platelet Aggregation Inhibitors\n",
        "Protein Synthesis Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Radiation-Sensitizing Agents\n",
        "Serotonin Antagonists\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Solvents\n",
        "Surface-Active Agents\n",
        "Sweetening Agents\n",
        "Tocolytic Agents\n",
        "Topoisomerase II Inhibitors\n",
        "Trace Elements\n",
        "Tubulin Modulators\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "===== phenotype 34=================================================================\n",
        "proportion of pts: 0.124157080524\n",
        "lambda: 26411.3540232\n",
        "----------------------------------------\n",
        "Mycoses\n",
        "Disorders of thyroid gland\n",
        "Diabetes\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Disorders of the peripheral nervous system\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Cerebrovascular disease\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Nephritis, nephrotic syndrome, and nephrosis\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Symptoms involving urinary system\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic alpha-2 Receptor Agonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-Antagonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Local\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents, Local\n",
        "Anti-Infective Agents, Urinary\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticoagulants\n",
        "Anticonvulsants\n",
        "Antidepressive Agents, Tricyclic\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antimanic Agents\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antiparkinson Agents\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cardiovascular Agents\n",
        "Diuretics\n",
        "Excitatory Amino Acid Antagonists\n",
        "Glucocorticoids\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Mineralocorticoid Receptor Antagonists\n",
        "Muscarinic Antagonists\n",
        "Muscle Relaxants, Central\n",
        "Narcotics\n",
        "Proton Pump Inhibitors\n",
        "Rodenticides\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Tranquilizing Agents\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "Voltage-Gated Sodium Channel Blockers\n",
        "===== phenotype 38=================================================================\n",
        "proportion of pts: 0.12177707259\n",
        "lambda: 26138.6576726\n",
        "----------------------------------------\n",
        "Mycoses\n",
        "Disorders of thyroid gland\n",
        "Diabetes\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Gout\n",
        "Other immune disorders\n",
        "Anemias\n",
        "Hereditary and degenerative diseases of the central nervous system\n",
        "Disorders of the peripheral nervous system\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Cerebrovascular disease\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Nephritis, nephrotic syndrome, and nephrosis\n",
        "Other diseases of urinary system\n",
        "Infections of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving nervous and musculoskeletal systems\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Nonspecific findings on examination of urine\n",
        "Open wound\n",
        "Na\n",
        "Certain traumatic complications and unspecified injuries\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic Uptake Inhibitors\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-Antagonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents, Tricyclic\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antimanic Agents\n",
        "Antimetabolites\n",
        "Antioxidants\n",
        "Antiparkinson Agents\n",
        "Antipruritics\n",
        "Antipyretics\n",
        "Antitussive Agents\n",
        "Bone Density Conservation Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cathartics\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Excitatory Amino Acid Antagonists\n",
        "Explosive Agents\n",
        "Fibrinolytic Agents\n",
        "Free Radical Scavengers\n",
        "GABA Modulators\n",
        "Gastrointestinal Agents\n",
        "Gout Suppressants\n",
        "Histamine H1 Antagonists\n",
        "Histamine H2 Antagonists\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Protein Synthesis Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Purinergic P2Y Receptor Antagonists\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Topoisomerase II Inhibitors\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 21=================================================================\n",
        "proportion of pts: 0.115033716779\n",
        "lambda: 26046.8088837\n",
        "----------------------------------------\n",
        "Neoplasms of unspecified nature\n",
        "Disorders of thyroid gland\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of mineral metabolism\n",
        "Anemias\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Disorders of the peripheral nervous system\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Other diseases of respiratory system\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of urinary system\n",
        "Infections of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "Congenital anomalies\n",
        "General symptoms\n",
        "Symptoms involving nervous and musculoskeletal systems\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving urinary system\n",
        "Nonspecific findings on examination of blood\n",
        "Fractures\n",
        "Superficial, contusion, crushing injuries\n",
        "Na\n",
        "Certain traumatic complications and unspecified injuries\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic Uptake Inhibitors\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Local\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Antacids\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antimanic Agents\n",
        "Antioxidants\n",
        "Antiparkinson Agents\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Calcium Channel Blockers\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Dopamine Uptake Inhibitors\n",
        "Estrogens\n",
        "Excitatory Amino Acid Antagonists\n",
        "Fibrinolytic Agents\n",
        "GABA Modulators\n",
        "Histamine H1 Antagonists\n",
        "Histamine H2 Antagonists\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Narcotics\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Surface-Active Agents\n",
        "Sympatholytics\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "Voltage-Gated Sodium Channel Blockers\n",
        "===== phenotype 5=================================================================\n",
        "proportion of pts: 0.132090440301\n",
        "lambda: 24825.8081682\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Other disorders of pancreatic internal secretion\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Other diseases of the blood\n",
        "Disorders of the eye and adnexa\n",
        "Chronic rheumatic heart disease\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Cerebrovascular disease\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Other diseases of respiratory system\n",
        "Nephritis, nephrotic syndrome, and nephrosis\n",
        "Congenital anomalies\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Nonspecific findings on examination of blood\n",
        "Abnormal results of function studies\n",
        "Other and unspecified effects of external causes\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-Antagonists\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticoagulants\n",
        "Antihypertensive Agents\n",
        "Antineoplastic Agents\n",
        "Antioxidants\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Explosive Agents\n",
        "Fibrinolytic Agents\n",
        "Hematinics\n",
        "Hemostatics\n",
        "Histamine H2 Antagonists\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Narcotics\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Purinergic P2Y Receptor Antagonists\n",
        "Rodenticides\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Tissue Adhesives\n",
        "Topoisomerase II Inhibitors\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 16=================================================================\n",
        "proportion of pts: 0.113843712812\n",
        "lambda: 24818.0931693\n",
        "----------------------------------------\n",
        "Malignant neoplasm of respiratory and intrathoracic organs\n",
        "Diabetes\n",
        "Diseases of other endocrine glands\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Anemias\n",
        "Operations on the respiratory system\n",
        "Drug dependence\n",
        "Organic sleep disorders\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Diseases of pulmonary circulation\n",
        "Other forms of heart disease\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Other diseases of the upper respiratory tract\n",
        "Pneumonia and influenza\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Other diseases of respiratory system\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Nephritis, nephrotic syndrome, and nephrosis\n",
        "Other diseases of urinary system\n",
        "Diseases of male genital organs\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Nonspecific findings on examination of blood\n",
        "Ill-defined and unknown causes of morbidity and mortality\n",
        "Range name na\n",
        "----------------------------------------\n",
        "5-alpha Reductase Inhibitors\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Adrenergic alpha-2 Receptor Agonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-2 Receptor Agonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Androgens\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Asthmatic Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antihypertensive Agents\n",
        "Antimanic Agents\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antioxidants\n",
        "Antiparkinson Agents\n",
        "Antipyretics\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cholinergic Antagonists\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Excitatory Amino Acid Antagonists\n",
        "Expectorants\n",
        "Explosive Agents\n",
        "Fibrinolytic Agents\n",
        "Glucocorticoids\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Nitric Oxide Donors\n",
        "Parasympatholytics\n",
        "Phosphodiesterase 5 Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Purinergic P2Y Receptor Antagonists\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Sympathomimetics\n",
        "Tocolytic Agents\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 47=================================================================\n",
        "proportion of pts: 0.152717175724\n",
        "lambda: 24102.7460795\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other disorders of female genital tract\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Nonspecific findings on examination of blood\n",
        "Sprains and strains of joints and adjacent muscles\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Abortifacient Agents, Nonsteroidal\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Analgesics, Non-Narcotic\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antimetabolites, Antineoplastic\n",
        "Antioxidants\n",
        "Antipyretics\n",
        "Antirheumatic Agents\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cardiovascular Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Folic Acid Antagonists\n",
        "Gout Suppressants\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Immunosuppressive Agents\n",
        "Nucleic Acid Synthesis Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Tocolytic Agents\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "===== phenotype 13=================================================================\n",
        "proportion of pts: 0.157080523602\n",
        "lambda: 23815.2838211\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Anemias\n",
        "Na\n",
        "Organic sleep disorders\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Diseases of arteries, arterioles, and capillaries\n",
        "Acute respiratory infections\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Nonspecific findings on examination of blood\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-Antagonists\n",
        "Analgesics, Non-Narcotic\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antidepressive Agents, Tricyclic\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antineoplastic Agents, Phytogenic\n",
        "Antioxidants\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Dipeptidyl-Peptidase IV Inhibitors\n",
        "Diuretics\n",
        "Fibrinolytic Agents\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Immunosuppressive Agents\n",
        "Incretins\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Purinergic P2Y Receptor Antagonists\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Tubulin Modulators\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 25=================================================================\n",
        "proportion of pts: 0.123760412535\n",
        "lambda: 23731.4204789\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Anemias\n",
        "Na\n",
        "Organic sleep disorders\n",
        "Disorders of the peripheral nervous system\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Other diseases of the upper respiratory tract\n",
        "Other diseases of intestines and peritoneum\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving head and neck\n",
        "Sprains and strains of joints and adjacent muscles\n",
        "Open wound\n",
        "Certain traumatic complications and unspecified injuries\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Abortifacient Agents, Nonsteroidal\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Local\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents, Tricyclic\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antimanic Agents\n",
        "Antimetabolites, Antineoplastic\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antiparkinson Agents\n",
        "Antipruritics\n",
        "Antipyretics\n",
        "Antirheumatic Agents\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cyclooxygenase 2 Inhibitors\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Excitatory Amino Acid Antagonists\n",
        "Fibrinolytic Agents\n",
        "Folic Acid Antagonists\n",
        "GABA-A Receptor Agonists\n",
        "Glucocorticoids\n",
        "Gout Suppressants\n",
        "Hematinics\n",
        "Histamine H1 Antagonists\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Immunosuppressive Agents\n",
        "Muscle Relaxants, Central\n",
        "Narcotics\n",
        "Nucleic Acid Synthesis Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Tranquilizing Agents\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "Voltage-Gated Sodium Channel Blockers\n",
        "===== phenotype 23=================================================================\n",
        "proportion of pts: 0.0844902816343\n",
        "lambda: 23495.7164083\n",
        "----------------------------------------\n",
        "Operations on the nervous system\n",
        "Other bacterial diseases\n",
        "Operations on the nose, mouth, and pharynx\n",
        "Diabetes\n",
        "Overweight, obesity and other hyperalimentation\n",
        "Organic psychotic conditions\n",
        "Na\n",
        "Organic sleep disorders\n",
        "Hereditary and degenerative diseases of the central nervous system\n",
        "Pain\n",
        "Other disorders of the central nervous system\n",
        "Operations on the cardiovascular system\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Other diseases of respiratory system\n",
        "Other diseases of urinary system\n",
        "Infections of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Congenital anomalies\n",
        "Operations on the musculoskeletal system\n",
        "General symptoms\n",
        "Symptoms involving nervous and musculoskeletal systems\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving urinary system\n",
        "Nonspecific findings on examination of blood\n",
        "Nonspecific abnormal findings on radiological and other examination of body structure\n",
        "Ill-defined and unknown causes of morbidity and mortality\n",
        "Miscellaneous diagnostic and therapeutic procedures\n",
        "Complications of surgical and medical care, not elsewhere classified\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adjuvants, Anesthesia\n",
        "Adrenergic alpha-Antagonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Intravenous\n",
        "Anesthetics, Local\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents, Local\n",
        "Anti-Infective Agents, Urinary\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticoagulants\n",
        "Anticonvulsants\n",
        "Antidepressive Agents, Tricyclic\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antimanic Agents\n",
        "Antineoplastic Agents\n",
        "Antineoplastic Agents, Alkylating\n",
        "Antiparkinson Agents\n",
        "Antipruritics\n",
        "Antipsychotic Agents\n",
        "Antipyretics\n",
        "Antitussive Agents\n",
        "Bone Density Conservation Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cathartics\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Dopamine Antagonists\n",
        "Excitatory Amino Acid Antagonists\n",
        "Fibrinolytic Agents\n",
        "Gastrointestinal Agents\n",
        "Histamine H1 Antagonists\n",
        "Histamine H2 Antagonists\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Immunosuppressive Agents\n",
        "Muscle Relaxants, Central\n",
        "Narcotics\n",
        "Platelet Aggregation Inhibitors\n",
        "Protein Synthesis Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Rodenticides\n",
        "Serotonin Antagonists\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Surface-Active Agents\n",
        "Sweetening Agents\n",
        "Sympatholytics\n",
        "Topoisomerase II Inhibitors\n",
        "Tranquilizing Agents\n",
        "Vitamins\n",
        "Voltage-Gated Sodium Channel Blockers\n",
        "===== phenotype 42=================================================================\n",
        "proportion of pts: 0.112257040857\n",
        "lambda: 23435.116458\n",
        "----------------------------------------\n",
        "Disorders of thyroid gland\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Na\n",
        "Organic sleep disorders\n",
        "Hereditary and degenerative diseases of the central nervous system\n",
        "Other disorders of the central nervous system\n",
        "Disorders of the peripheral nervous system\n",
        "Disorders of the eye and adnexa\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of intestines and peritoneum\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Symptoms involving urinary system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Nonspecific findings on examination of blood\n",
        "Abnormal results of function studies\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adjuvants, Anesthesia\n",
        "Adrenergic Uptake Inhibitors\n",
        "Adrenergic alpha-2 Receptor Agonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Intravenous\n",
        "Anesthetics, Local\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Asthmatic Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antidepressive Agents, Tricyclic\n",
        "Antiemetics\n",
        "Antifungal Agents\n",
        "Antihypertensive Agents\n",
        "Antimalarials\n",
        "Antimanic Agents\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antiparkinson Agents\n",
        "Antipruritics\n",
        "Antipsychotic Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Dopamine Uptake Inhibitors\n",
        "Estrogens\n",
        "Excitatory Amino Acid Antagonists\n",
        "GABA Modulators\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hypnotics and Sedatives\n",
        "Muscarinic Antagonists\n",
        "Muscle Relaxants, Central\n",
        "Narcotics\n",
        "Neuroprotective Agents\n",
        "Proton Pump Inhibitors\n",
        "Serotonin Uptake Inhibitors\n",
        "Sympatholytics\n",
        "Voltage-Gated Sodium Channel Blockers\n",
        "===== phenotype 37=================================================================\n",
        "proportion of pts: 0.123760412535\n",
        "lambda: 23166.5754272\n",
        "----------------------------------------\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Organic psychotic conditions\n",
        "Na\n",
        "Other psychoses\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Drug dependence\n",
        "Organic sleep disorders\n",
        "Pain\n",
        "Disorders of the peripheral nervous system\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Pneumonia and influenza\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Diseases of oral cavity, salivary glands, and jaws\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Nonspecific findings on examination of blood\n",
        "Sprains and strains of joints and adjacent muscles\n",
        "Certain traumatic complications and unspecified injuries\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic Uptake Inhibitors\n",
        "Adrenergic alpha-Antagonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-2 Receptor Agonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antidepressive Agents, Tricyclic\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antimanic Agents\n",
        "Antioxidants\n",
        "Antiparkinson Agents\n",
        "Antipruritics\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase 2 Inhibitors\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Dopamine Uptake Inhibitors\n",
        "Excitatory Amino Acid Antagonists\n",
        "Fibrinolytic Agents\n",
        "GABA Modulators\n",
        "GABA-A Receptor Agonists\n",
        "Histamine H1 Antagonists\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypolipidemic Agents\n",
        "Muscle Relaxants, Central\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Tocolytic Agents\n",
        "Tranquilizing Agents\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "Voltage-Gated Sodium Channel Blockers\n",
        "===== phenotype 9=================================================================\n",
        "proportion of pts: 0.134867116224\n",
        "lambda: 22501.6343898\n",
        "----------------------------------------\n",
        "Mycoses\n",
        "Diabetes\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Other and unspecified disorders of metabolism\n",
        "Organic sleep disorders\n",
        "Disorders of the peripheral nervous system\n",
        "Disorders of the eye and adnexa\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Other diseases of the upper respiratory tract\n",
        "Other diseases of urinary system\n",
        "Infections of skin and subcutaneous tissue\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving urinary system\n",
        "Sprains and strains of joints and adjacent muscles\n",
        "Superficial, contusion, crushing injuries\n",
        "Certain traumatic complications and unspecified injuries\n",
        "Range name na\n",
        "----------------------------------------\n",
        "14-alpha Demethylase Inhibitors\n",
        "Analgesics, Non-Narcotic\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Asthmatic Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents, Local\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antifungal Agents\n",
        "Antihypertensive Agents\n",
        "Antimalarials\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Fibrinolytic Agents\n",
        "GABA-A Receptor Agonists\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Immunosuppressive Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Topoisomerase II Inhibitors\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 0=================================================================\n",
        "proportion of pts: 0.134470448235\n",
        "lambda: 22133.7434116\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Organic psychotic conditions\n",
        "Organic sleep disorders\n",
        "Hereditary and degenerative diseases of the central nervous system\n",
        "Other disorders of the central nervous system\n",
        "Disorders of the eye and adnexa\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Cerebrovascular disease\n",
        "Other diseases of urinary system\n",
        "Diseases of male genital organs\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "Operations on the musculoskeletal system\n",
        "General symptoms\n",
        "Na\n",
        "Symptoms involving nervous and musculoskeletal systems\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Symptoms involving urinary system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Nonspecific findings on examination of blood\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Analgesics, Non-Narcotic\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents, Urinary\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antihypertensive Agents\n",
        "Antioxidants\n",
        "Antiparkinson Agents\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cholinesterase Inhibitors\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Dopamine Agonists\n",
        "Explosive Agents\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Muscarinic Antagonists\n",
        "Nootropic Agents\n",
        "Phosphodiesterase 5 Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Purinergic P2Y Receptor Antagonists\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Topoisomerase II Inhibitors\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 40=================================================================\n",
        "proportion of pts: 0.0702102340341\n",
        "lambda: 21697.7685111\n",
        "----------------------------------------\n",
        "nan\n",
        "Diabetes\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Coagulation or hemorrhagic diseases\n",
        "Drug dependence\n",
        "Operations on the cardiovascular system\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Diseases of pulmonary circulation\n",
        "Other forms of heart disease\n",
        "Diseases of arteries, arterioles, and capillaries\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Other diseases of respiratory system\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of urinary system\n",
        "Operations on the musculoskeletal system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Nonspecific findings on examination of blood\n",
        "Ill-defined and unknown causes of morbidity and mortality\n",
        "Miscellaneous diagnostic and therapeutic procedures\n",
        "Complications of surgical and medical care, not elsewhere classified\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adjuvants, Anesthesia\n",
        "Adrenergic alpha-2 Receptor Agonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Intravenous\n",
        "Anesthetics, Local\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antimalarials\n",
        "Antioxidants\n",
        "Antipruritics\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Explosive Agents\n",
        "Fibrinolytic Agents\n",
        "Folic Acid Antagonists\n",
        "GABA Modulators\n",
        "Hemostatics\n",
        "Histamine H1 Antagonists\n",
        "Histamine H2 Antagonists\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Leprostatic Agents\n",
        "Muscarinic Antagonists\n",
        "Muscle Relaxants, Central\n",
        "Narcotics\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Purinergic P2Y Receptor Antagonists\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Surface-Active Agents\n",
        "Sweetening Agents\n",
        "Sympatholytics\n",
        "Sympathomimetics\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "Voltage-Gated Sodium Channel Blockers\n",
        "===== phenotype 20=================================================================\n",
        "proportion of pts: 0.122173740579\n",
        "lambda: 21211.5164613\n",
        "----------------------------------------\n",
        "Mycoses\n",
        "Malignant neoplasm of skin\n",
        "Benign neoplasm of skin\n",
        "Neoplasm of uncertain behavior of other sites & tissues\n",
        "Nutritional deficiencies\n",
        "Disorders of the eye and adnexa\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Diseases of arteries, arterioles, and capillaries\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Other diseases of urinary system\n",
        "Infections of skin and subcutaneous tissue\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving urinary system\n",
        "Fractures\n",
        "Sprains and strains of joints and adjacent muscles\n",
        "Open wound\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Local\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Antacids\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents\n",
        "Anti-Infective Agents, Local\n",
        "Anti-Infective Agents, Urinary\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticoagulants\n",
        "Antifungal Agents\n",
        "Antihypertensive Agents\n",
        "Antimalarials\n",
        "Antimetabolites\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antioxidants\n",
        "Antipyretics\n",
        "Antirheumatic Agents\n",
        "Bone Density Conservation Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Glucocorticoids\n",
        "Gout Suppressants\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypolipidemic Agents\n",
        "Immunosuppressive Agents\n",
        "Narcotics\n",
        "Platelet Aggregation Inhibitors\n",
        "Protein Synthesis Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Surface-Active Agents\n",
        "Sympatholytics\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "Voltage-Gated Sodium Channel Blockers\n",
        "===== phenotype 2=================================================================\n",
        "proportion of pts: 0.133677112257\n",
        "lambda: 20781.5362378\n",
        "----------------------------------------\n",
        "Diseases of other endocrine glands\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Acute respiratory infections\n",
        "Pneumonia and influenza\n",
        "Disorders of breast\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "Operations on the musculoskeletal system\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Nonspecific findings on examination of blood\n",
        "Nonspecific abnormal findings on radiological and other examination of body structure\n",
        "Abnormal results of function studies\n",
        "Certain traumatic complications and unspecified injuries\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-Antagonists\n",
        "Analgesics, Non-Narcotic\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticoagulants\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cardiovascular Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Glucocorticoids\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypolipidemic Agents\n",
        "Mineralocorticoid Receptor Antagonists\n",
        "Phosphodiesterase 5 Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Rodenticides\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "===== phenotype 8=================================================================\n",
        "proportion of pts: 0.104720349068\n",
        "lambda: 20714.6223921\n",
        "----------------------------------------\n",
        "Other bacterial diseases\n",
        "Operations on the nose, mouth, and pharynx\n",
        "Diabetes\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Operations on the digestive system\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Other diseases of respiratory system\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Hernia of abdominal cavity\n",
        "Other diseases of intestines and peritoneum\n",
        "Other diseases of digestive system\n",
        "Dorsopathies\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "Congenital anomalies\n",
        "Operations on the musculoskeletal system\n",
        "General symptoms\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Nonspecific abnormal findings on radiological and other examination of body structure\n",
        "Abnormal results of function studies\n",
        "Certain traumatic complications and unspecified injuries\n",
        "Other and unspecified effects of external causes\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adjuvants, Anesthesia\n",
        "Adrenergic alpha-2 Receptor Agonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Intravenous\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antidepressive Agents, Tricyclic\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antioxidants\n",
        "Antipruritics\n",
        "Antipsychotic Agents\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cathartics\n",
        "Cyclooxygenase Inhibitors\n",
        "Explosive Agents\n",
        "Fibrinolytic Agents\n",
        "GABA Modulators\n",
        "GABA-A Receptor Agonists\n",
        "Histamine H1 Antagonists\n",
        "Histamine H2 Antagonists\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Indicators and Reagents\n",
        "Muscarinic Antagonists\n",
        "Muscle Relaxants, Central\n",
        "Mydriatics\n",
        "Narcotics\n",
        "Parasympatholytics\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Serotonin Antagonists\n",
        "Serotonin Uptake Inhibitors\n",
        "Trace Elements\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 17=================================================================\n",
        "proportion of pts: 0.110273700912\n",
        "lambda: 20600.278738\n",
        "----------------------------------------\n",
        "Viral diseases accompanied by exanthem\n",
        "Malignant neoplasm of skin\n",
        "Malignant neoplasm of male and female genital organs\n",
        "Malignant neoplasm of badder, kidney and other urinary organs\n",
        "Benign neoplasm of other parts of digestive system\n",
        "Disorders of thyroid gland\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Gout\n",
        "Anemias\n",
        "Organic sleep disorders\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Operations on the digestive system\n",
        "Other forms of heart disease\n",
        "Hernia of abdominal cavity\n",
        "Other diseases of intestines and peritoneum\n",
        "Other diseases of digestive system\n",
        "Other diseases of urinary system\n",
        "Diseases of male genital organs\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Nonspecific findings on examination of blood\n",
        "Range name na\n",
        "----------------------------------------\n",
        "5-alpha Reductase Inhibitors\n",
        "Adjuvants, Anesthesia\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Adrenergic alpha-2 Receptor Agonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-Antagonists\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Intravenous\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticoagulants\n",
        "Anticonvulsants\n",
        "Antihypertensive Agents\n",
        "Antimetabolites\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antipyretics\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cardiovascular Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Free Radical Scavengers\n",
        "GABA Modulators\n",
        "Glucocorticoids\n",
        "Gout Suppressants\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Narcotics\n",
        "Phosphodiesterase 5 Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Rodenticides\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Surface-Active Agents\n",
        "Sympatholytics\n",
        "Tocolytic Agents\n",
        "Tubulin Modulators\n",
        "Urological Agents\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "===== phenotype 33=================================================================\n",
        "proportion of pts: 0.10749702499\n",
        "lambda: 20203.5793631\n",
        "----------------------------------------\n",
        "Other bacterial diseases\n",
        "Mycoses\n",
        "Disorders of thyroid gland\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Hereditary and degenerative diseases of the central nervous system\n",
        "Other disorders of the central nervous system\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Cerebrovascular disease\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Pneumonia and influenza\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Other diseases of respiratory system\n",
        "Other diseases of urinary system\n",
        "Other disorders of female genital tract\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Dorsopathies\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving nervous and musculoskeletal systems\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Symptoms involving urinary system\n",
        "Ill-defined and unknown causes of morbidity and mortality\n",
        "Late effects of injuries, poisonings, toxic effects, and other external causes\n",
        "Certain traumatic complications and unspecified injuries\n",
        "----------------------------------------\n",
        "14-alpha Demethylase Inhibitors\n",
        "Adrenergic beta-2 Receptor Agonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Asthmatic Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents\n",
        "Anti-Infective Agents, Urinary\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antiemetics\n",
        "Antifungal Agents\n",
        "Antihypertensive Agents\n",
        "Antimalarials\n",
        "Antimanic Agents\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antiparkinson Agents\n",
        "Antipruritics\n",
        "Antipyretics\n",
        "Antirheumatic Agents\n",
        "Antiviral Agents\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Excitatory Amino Acid Antagonists\n",
        "Expectorants\n",
        "Fibrinolytic Agents\n",
        "GABA Modulators\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Immunosuppressive Agents\n",
        "Ionophores\n",
        "Muscle Relaxants, Central\n",
        "Narcotics\n",
        "Neuroprotective Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Tocolytic Agents\n",
        "Topoisomerase II Inhibitors\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "===== phenotype 49=================================================================\n",
        "proportion of pts: 0.117810392701\n",
        "lambda: 20119.4486123\n",
        "----------------------------------------\n",
        "Viral diseases accompanied by exanthem\n",
        "Disorders of thyroid gland\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Coagulation or hemorrhagic diseases\n",
        "Organic sleep disorders\n",
        "Disorders of the eye and adnexa\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Other diseases of intestines and peritoneum\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "General symptoms\n",
        "Na\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Complications of surgical and medical care, not elsewhere classified\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic alpha-2 Receptor Agonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-2 Receptor Agonists\n",
        "Adrenergic beta-Antagonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Asthmatic Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticoagulants\n",
        "Anticonvulsants\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antimanic Agents\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antioxidants\n",
        "Antiparkinson Agents\n",
        "Antipruritics\n",
        "Antipyretics\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Excitatory Amino Acid Antagonists\n",
        "Expectorants\n",
        "GABA Modulators\n",
        "GABA-A Receptor Agonists\n",
        "Gastrointestinal Agents\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Histamine H2 Antagonists\n",
        "Hypnotics and Sedatives\n",
        "Leukotriene Antagonists\n",
        "Lipoxygenase Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Rodenticides\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Sympathomimetics\n",
        "Tocolytic Agents\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Voltage-Gated Sodium Channel Blockers\n",
        "===== phenotype 4=================================================================\n",
        "proportion of pts: 0.105910353035\n",
        "lambda: 20071.2946979\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Diseases of other endocrine glands\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Overweight, obesity and other hyperalimentation\n",
        "Anemias\n",
        "Other diseases of the blood\n",
        "Na\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Organic sleep disorders\n",
        "Other disorders of the central nervous system\n",
        "Hypertensive disease\n",
        "Diseases of arteries, arterioles, and capillaries\n",
        "Acute respiratory infections\n",
        "Pneumonia and influenza\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Noninfectious enteritis and colitis\n",
        "Other diseases of digestive system\n",
        "Nephritis, nephrotic syndrome, and nephrosis\n",
        "Disorders of breast\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other and unspecified effects of external causes\n",
        "----------------------------------------\n",
        "Adrenergic Uptake Inhibitors\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Anesthetics, Local\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antidepressive Agents, Tricyclic\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antimanic Agents\n",
        "Antineoplastic Agents, Phytogenic\n",
        "Antioxidants\n",
        "Antiparkinson Agents\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Central Nervous System Stimulants\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Dopamine Uptake Inhibitors\n",
        "Excitatory Amino Acid Antagonists\n",
        "Fibrinolytic Agents\n",
        "GABA Modulators\n",
        "GABA-A Receptor Agonists\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Immunosuppressive Agents\n",
        "Muscle Relaxants, Central\n",
        "Neuroprotective Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Tocolytic Agents\n",
        "Trace Elements\n",
        "Tranquilizing Agents\n",
        "Tubulin Modulators\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 18=================================================================\n",
        "proportion of pts: 0.109480364935\n",
        "lambda: 19889.2748581\n",
        "----------------------------------------\n",
        "Viral diseases accompanied by exanthem\n",
        "Mycoses\n",
        "Malignant neoplasm of skin\n",
        "Operations on the nose, mouth, and pharynx\n",
        "Benign neoplasm of skin\n",
        "Neoplasm of uncertain behavior of other sites & tissues\n",
        "Disorders of thyroid gland\n",
        "Diabetes\n",
        "Diseases of other endocrine glands\n",
        "Disorders of lipoid metabolism\n",
        "Organic psychotic conditions\n",
        "Na\n",
        "Other psychoses\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Hereditary and degenerative diseases of the central nervous system\n",
        "Disorders of the peripheral nervous system\n",
        "Disorders of the eye and adnexa\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Cerebrovascular disease\n",
        "Diseases of arteries, arterioles, and capillaries\n",
        "Acute respiratory infections\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Other disorders of female genital tract\n",
        "Infections of skin and subcutaneous tissue\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Na\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Abortifacient Agents, Nonsteroidal\n",
        "Adrenergic Uptake Inhibitors\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antidepressive Agents, Tricyclic\n",
        "Antiemetics\n",
        "Antifungal Agents\n",
        "Antihypertensive Agents\n",
        "Antimanic Agents\n",
        "Antimetabolites, Antineoplastic\n",
        "Antiparkinson Agents\n",
        "Antipsychotic Agents\n",
        "Antipyretics\n",
        "Antirheumatic Agents\n",
        "Bone Density Conservation Agents\n",
        "Calcium Channel Blockers\n",
        "Cholinesterase Inhibitors\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Dopamine Agents\n",
        "Dopamine Antagonists\n",
        "Dopamine Uptake Inhibitors\n",
        "Enzyme Inhibitors\n",
        "Excitatory Amino Acid Antagonists\n",
        "Fibrinolytic Agents\n",
        "Folic Acid Antagonists\n",
        "GABA Modulators\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Immunosuppressive Agents\n",
        "Nootropic Agents\n",
        "Nucleic Acid Synthesis Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "===== phenotype 46=================================================================\n",
        "proportion of pts: 0.13248710829\n",
        "lambda: 19801.945809\n",
        "----------------------------------------\n",
        "Disorders of thyroid gland\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Gout\n",
        "Overweight, obesity and other hyperalimentation\n",
        "Organic sleep disorders\n",
        "Disorders of the peripheral nervous system\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of intestines and peritoneum\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Nonspecific abnormal findings on radiological and other examination of body structure\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic Uptake Inhibitors\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Antidepressive Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antihypertensive Agents\n",
        "Antioxidants\n",
        "Antipruritics\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Dopamine Uptake Inhibitors\n",
        "Drug Carriers\n",
        "Enzyme Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Gout Suppressants\n",
        "Histamine H1 Antagonists\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Histamine H2 Antagonists\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Immunosuppressive Agents\n",
        "Mineralocorticoid Receptor Antagonists\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Solvents\n",
        "Surface-Active Agents\n",
        "Sympatholytics\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "===== phenotype 22=================================================================\n",
        "proportion of pts: 0.121380404601\n",
        "lambda: 19797.9202161\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Overweight, obesity and other hyperalimentation\n",
        "Na\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Organic sleep disorders\n",
        "Disorders of the eye and adnexa\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of urinary system\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms concerning nutrition, metabolism, and development\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving urinary system\n",
        "----------------------------------------\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-2 Receptor Agonists\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Asthmatic Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents, Urinary\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antihypertensive Agents\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Central Nervous System Stimulants\n",
        "Cholinergic Antagonists\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Food Additives\n",
        "GABA-A Receptor Agonists\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypolipidemic Agents\n",
        "Leukotriene Antagonists\n",
        "Lipoxygenase Inhibitors\n",
        "Phosphodiesterase Inhibitors\n",
        "Protein Synthesis Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Purinergic P1 Receptor Antagonists\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Sympathomimetics\n",
        "Tocolytic Agents\n",
        "Topoisomerase II Inhibitors\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "===== phenotype 11=================================================================\n",
        "proportion of pts: 0.133280444268\n",
        "lambda: 19755.9799559\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Anemias\n",
        "Organic sleep disorders\n",
        "Pain\n",
        "Disorders of the peripheral nervous system\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Diseases of oral cavity, salivary glands, and jaws\n",
        "Other diseases of intestines and peritoneum\n",
        "Other diseases of urinary system\n",
        "Disorders of breast\n",
        "Other disorders of female genital tract\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving urinary system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Nonspecific findings on examination of blood\n",
        "Nonspecific abnormal findings on radiological and other examination of body structure\n",
        "Range name na\n",
        "----------------------------------------\n",
        "14-alpha Demethylase Inhibitors\n",
        "Abortifacient Agents, Nonsteroidal\n",
        "Adrenergic alpha-2 Receptor Agonists\n",
        "Analgesics\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Local\n",
        "Antacids\n",
        "Anti-Anxiety Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents\n",
        "Anti-Infective Agents, Local\n",
        "Anti-Infective Agents, Urinary\n",
        "Antifungal Agents\n",
        "Antimalarials\n",
        "Antimetabolites, Antineoplastic\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antipruritics\n",
        "Antipsychotic Agents\n",
        "Antirheumatic Agents\n",
        "Antitussive Agents\n",
        "Bone Density Conservation Agents\n",
        "Central Nervous System Stimulants\n",
        "Dermatologic Agents\n",
        "Detergents\n",
        "Drug Carriers\n",
        "Enzyme Inhibitors\n",
        "Excitatory Amino Acid Antagonists\n",
        "Folic Acid Antagonists\n",
        "Gastrointestinal Agents\n",
        "Immunosuppressive Agents\n",
        "Muscarinic Antagonists\n",
        "Muscle Relaxants, Central\n",
        "Mutagens\n",
        "Myeloablative Agonists\n",
        "Narcotics\n",
        "Nucleic Acid Synthesis Inhibitors\n",
        "Parasympatholytics\n",
        "Phosphodiesterase Inhibitors\n",
        "Preservatives, Pharmaceutical\n",
        "Protein Synthesis Inhibitors\n",
        "Purinergic P1 Receptor Antagonists\n",
        "Solvents\n",
        "Surface-Active Agents\n",
        "Topoisomerase II Inhibitors\n",
        "Trace Elements\n",
        "Tubulin Modulators\n",
        "Voltage-Gated Sodium Channel Blockers\n",
        "===== phenotype 1=================================================================\n",
        "proportion of pts: 0.113050376835\n",
        "lambda: 19748.7733744\n",
        "----------------------------------------\n",
        "Viral diseases accompanied by exanthem\n",
        "Benign neoplasm of other parts of digestive system\n",
        "Diabetes\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Gout\n",
        "Overweight, obesity and other hyperalimentation\n",
        "Na\n",
        "Drug dependence\n",
        "Organic sleep disorders\n",
        "Hereditary and degenerative diseases of the central nervous system\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Liver\n",
        "Nephritis, nephrotic syndrome, and nephrosis\n",
        "Infections of skin and subcutaneous tissue\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Nonspecific findings on examination of blood\n",
        "Abnormal results of function studies\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic Uptake Inhibitors\n",
        "Adrenergic alpha-2 Receptor Agonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents\n",
        "Anti-Infective Agents, Urinary\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antihypertensive Agents\n",
        "Antimalarials\n",
        "Antimanic Agents\n",
        "Antimetabolites\n",
        "Antineoplastic Agents, Phytogenic\n",
        "Antioxidants\n",
        "Antiparkinson Agents\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Dopamine Agonists\n",
        "Dopamine Uptake Inhibitors\n",
        "Enzyme Inhibitors\n",
        "Excitatory Amino Acid Antagonists\n",
        "Fibrinolytic Agents\n",
        "Free Radical Scavengers\n",
        "GABA-A Receptor Agonists\n",
        "Gout Suppressants\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypoglycemic Agents\n",
        "Mineralocorticoid Receptor Antagonists\n",
        "Muscle Relaxants, Central\n",
        "Narcotics\n",
        "Phosphodiesterase 5 Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Tocolytic Agents\n",
        "Tubulin Modulators\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "Voltage-Gated Sodium Channel Blockers\n",
        "===== phenotype 15=================================================================\n",
        "proportion of pts: 0.106307021023\n",
        "lambda: 19747.1729169\n",
        "----------------------------------------\n",
        "Malignant neoplasm of badder, kidney and other urinary organs\n",
        "Disorders of thyroid gland\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Organic sleep disorders\n",
        "Hereditary and degenerative diseases of the central nervous system\n",
        "Pain\n",
        "Disorders of the peripheral nervous system\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Cerebrovascular disease\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Other diseases of the upper respiratory tract\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Other diseases of respiratory system\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of urinary system\n",
        "Diseases of male genital organs\n",
        "Infections of skin and subcutaneous tissue\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving urinary system\n",
        "Nonspecific findings on examination of blood\n",
        "Certain traumatic complications and unspecified injuries\n",
        "Range name na\n",
        "----------------------------------------\n",
        "5-alpha Reductase Inhibitors\n",
        "Adrenergic Uptake Inhibitors\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Adrenergic alpha-Agonists\n",
        "Adrenergic beta-2 Receptor Agonists\n",
        "Adrenergic beta-Agonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Local\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Asthmatic Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents, Urinary\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents\n",
        "Antidepressive Agents, Tricyclic\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antimanic Agents\n",
        "Antiparkinson Agents\n",
        "Antipruritics\n",
        "Antipyretics\n",
        "Antiviral Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cholinergic Antagonists\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Excitatory Amino Acid Antagonists\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Histamine H2 Antagonists\n",
        "Leukotriene Antagonists\n",
        "Lipoxygenase Inhibitors\n",
        "Muscarinic Antagonists\n",
        "Muscle Relaxants, Central\n",
        "Mydriatics\n",
        "Narcotics\n",
        "Nasal Decongestants\n",
        "Parasympatholytics\n",
        "Phosphodiesterase Inhibitors\n",
        "Protein Synthesis Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Serotonin Uptake Inhibitors\n",
        "Surface-Active Agents\n",
        "Sympathomimetics\n",
        "Tocolytic Agents\n",
        "Topoisomerase II Inhibitors\n",
        "Tranquilizing Agents\n",
        "Urological Agents\n",
        "Vasoconstrictor Agents\n",
        "Vasodilator Agents\n",
        "Voltage-Gated Sodium Channel Blockers\n",
        "===== phenotype 27=================================================================\n",
        "proportion of pts: 0.128123760413\n",
        "lambda: 19509.1609439\n",
        "----------------------------------------\n",
        "Other bacterial diseases\n",
        "Operations on the nose, mouth, and pharynx\n",
        "Benign neoplasm of other parts of digestive system\n",
        "Disorders of thyroid gland\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Anemias\n",
        "Other diseases of the blood\n",
        "Disorders of the eye and adnexa\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Cerebrovascular disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Other diseases of intestines and peritoneum\n",
        "Other diseases of urinary system\n",
        "Other disorders of female genital tract\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving urinary system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Nonspecific findings on examination of urine\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Adrenergic beta-2 Receptor Agonists\n",
        "Analgesics, Non-Narcotic\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Antacids\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents, Local\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antioxidants\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cathartics\n",
        "Cyclooxygenase Inhibitors\n",
        "Detergents\n",
        "Diuretics\n",
        "Fibrinolytic Agents\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypolipidemic Agents\n",
        "Parasympatholytics\n",
        "Platelet Aggregation Inhibitors\n",
        "Preservatives, Pharmaceutical\n",
        "Proton Pump Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Solvents\n",
        "Surface-Active Agents\n",
        "Sympatholytics\n",
        "Tocolytic Agents\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 48=================================================================\n",
        "proportion of pts: 0.120983736612\n",
        "lambda: 19438.8869538\n",
        "----------------------------------------\n",
        "Other diseases due to viruses and chlamydiae\n",
        "Hemangioma and lymphangioma any site\n",
        "Disorders of thyroid gland\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Anemias\n",
        "Organic sleep disorders\n",
        "Hypertensive disease\n",
        "Cerebrovascular disease\n",
        "Diseases of arteries, arterioles, and capillaries\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Disorders of breast\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Nonspecific findings on examination of blood\n",
        "Abnormal results of function studies\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Abortifacient Agents, Nonsteroidal\n",
        "Analgesics, Non-Narcotic\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Asthmatic Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antimetabolites, Antineoplastic\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antioxidants\n",
        "Antipyretics\n",
        "Antirheumatic Agents\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiovascular Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Folic Acid Antagonists\n",
        "Glucocorticoids\n",
        "Gout Suppressants\n",
        "Hematinics\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypolipidemic Agents\n",
        "Immunosuppressive Agents\n",
        "Lipoxygenase Inhibitors\n",
        "Nucleic Acid Synthesis Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 6=================================================================\n",
        "proportion of pts: 0.0979769932566\n",
        "lambda: 19302.5709819\n",
        "----------------------------------------\n",
        "Other diseases due to viruses and chlamydiae\n",
        "Benign neoplasm of breast, ovary, uterus, and other genitourinary organs\n",
        "Disorders of thyroid gland\n",
        "Diseases of other endocrine glands\n",
        "Nutritional deficiencies\n",
        "Overweight, obesity and other hyperalimentation\n",
        "Na\n",
        "Other psychoses\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Drug dependence\n",
        "Organic sleep disorders\n",
        "Hypertensive disease\n",
        "Operations on the digestive system\n",
        "Acute respiratory infections\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Operations on the urinary system\n",
        "Other diseases of intestines and peritoneum\n",
        "Liver\n",
        "Gallbladder\n",
        "Other diseases of urinary system\n",
        "Other disorders of female genital tract\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Miscellaneous diagnostic and therapeutic procedures\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antioxidants\n",
        "Antipruritics\n",
        "Antipsychotic Agents\n",
        "Antipyretics\n",
        "Antirheumatic Agents\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Dopamine Antagonists\n",
        "Dopamine Uptake Inhibitors\n",
        "Enzyme Inhibitors\n",
        "Fibrinolytic Agents\n",
        "GABA Modulators\n",
        "GABA-A Receptor Agonists\n",
        "Gastrointestinal Agents\n",
        "Histamine H1 Antagonists\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Histamine H2 Antagonists\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Immunosuppressive Agents\n",
        "Muscarinic Antagonists\n",
        "Mydriatics\n",
        "Narcotics\n",
        "Parasympatholytics\n",
        "Platelet Aggregation Inhibitors\n",
        "Protein Synthesis Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Serotonin Antagonists\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Surface-Active Agents\n",
        "Sympatholytics\n",
        "Vasoconstrictor Agents\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "Voltage-Gated Sodium Channel Blockers\n",
        "===== phenotype 14=================================================================\n",
        "proportion of pts: 0.11106703689\n",
        "lambda: 19191.3077998\n",
        "----------------------------------------\n",
        "Other bacterial diseases\n",
        "Malignant neoplasm of digestive organs and peritoneum\n",
        "Malignant neoplasm of badder, kidney and other urinary organs\n",
        "Disorders of thyroid gland\n",
        "Disorders of lipoid metabolism\n",
        "Gout\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Diseases of arteries, arterioles, and capillaries\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Pneumonia and influenza\n",
        "Diseases of oral cavity, salivary glands, and jaws\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of intestines and peritoneum\n",
        "Nephritis, nephrotic syndrome, and nephrosis\n",
        "Other diseases of urinary system\n",
        "Operations on the musculoskeletal system\n",
        "General symptoms\n",
        "Symptoms involving cardiovascular system\n"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Symptoms involving urinary system\n",
        "Nonspecific findings on examination of blood\n",
        "Nonspecific findings on examination of urine\n",
        "Abnormal results of function studies\n",
        "Operations on the integumentary system\n",
        "Complications of surgical and medical care, not elsewhere classified\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Abortifacient Agents, Nonsteroidal\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-Antagonists\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents\n",
        "Anti-Infective Agents, Urinary\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticoagulants\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antihypertensive Agents\n",
        "Antimalarials\n",
        "Antimetabolites\n",
        "Antimetabolites, Antineoplastic\n",
        "Antineoplastic Agents\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antioxidants\n",
        "Antipyretics\n",
        "Antirheumatic Agents\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Folic Acid Antagonists\n",
        "Free Radical Scavengers\n",
        "Glucocorticoids\n",
        "Gout Suppressants\n",
        "Hematinics\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypolipidemic Agents\n",
        "Immunosuppressive Agents\n",
        "Nucleic Acid Synthesis Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Rodenticides\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Surface-Active Agents\n",
        "Sympatholytics\n",
        "Topoisomerase II Inhibitors\n",
        "Tubulin Modulators\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 35=================================================================\n",
        "proportion of pts: 0.104720349068\n",
        "lambda: 19137.1464962\n",
        "----------------------------------------\n",
        "Operations on the nose, mouth, and pharynx\n",
        "Benign neoplasm of other parts of digestive system\n",
        "Disorders of thyroid gland\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Organic sleep disorders\n",
        "Other disorders of the central nervous system\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of urinary system\n",
        "Disorders of breast\n",
        "Other disorders of female genital tract\n",
        "Infections of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Symptoms involving urinary system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Dislocation\n",
        "Sprains and strains of joints and adjacent muscles\n",
        "Effects of foreign body entering through orifice\n",
        "Certain traumatic complications and unspecified injuries\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adjuvants, Anesthesia\n",
        "Adrenergic beta-2 Receptor Agonists\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Intravenous\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Asthmatic Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents, Urinary\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antimalarials\n",
        "Antineoplastic Agents\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antioxidants\n",
        "Antipruritics\n",
        "Antipyretics\n",
        "Antirheumatic Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase 2 Inhibitors\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Estrogens\n",
        "GABA Modulators\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hypnotics and Sedatives\n",
        "Hypoglycemic Agents\n",
        "Immunosuppressive Agents\n",
        "Leukotriene Antagonists\n",
        "Muscarinic Antagonists\n",
        "Muscle Relaxants, Central\n",
        "Mydriatics\n",
        "Narcotics\n",
        "Neuroprotective Agents\n",
        "Parasympatholytics\n",
        "Proton Pump Inhibitors\n",
        "Serotonin 5-HT1 Receptor Agonists\n",
        "Serotonin Uptake Inhibitors\n",
        "Sympathomimetics\n",
        "Tocolytic Agents\n",
        "Topoisomerase II Inhibitors\n",
        "Vasoconstrictor Agents\n",
        "===== phenotype 12=================================================================\n",
        "proportion of pts: 0.112257040857\n",
        "lambda: 18982.6475635\n",
        "----------------------------------------\n",
        "Malignant neoplasm of skin\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Overweight, obesity and other hyperalimentation\n",
        "Other diseases of the blood\n",
        "Organic sleep disorders\n",
        "Disorders of the peripheral nervous system\n",
        "Disorders of the eye and adnexa\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Gallbladder\n",
        "Other diseases of urinary system\n",
        "Infections of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Fractures\n",
        "Miscellaneous diagnostic and therapeutic procedures\n",
        "Superficial, contusion, crushing injuries\n",
        "Na\n",
        "Complications of surgical and medical care, not elsewhere classified\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-Antagonists\n",
        "Analgesics, Non-Narcotic\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents, Urinary\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticoagulants\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antioxidants\n",
        "Antipruritics\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Explosive Agents\n",
        "Fibrinolytic Agents\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypolipidemic Agents\n",
        "Lipoxygenase Inhibitors\n",
        "Mineralocorticoid Receptor Antagonists\n",
        "Platelet Aggregation Inhibitors\n",
        "Protein Synthesis Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Rodenticides\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Surface-Active Agents\n",
        "Sympatholytics\n",
        "Topoisomerase II Inhibitors\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 36=================================================================\n",
        "proportion of pts: 0.103133677112\n",
        "lambda: 18875.9719169\n",
        "----------------------------------------\n",
        "Mycoses\n",
        "Lipoma and other benign neoplasm of connective and other soft tissue\n",
        "Disorders of lipoid metabolism\n",
        "Other immune disorders\n",
        "Anemias\n",
        "Pain\n",
        "Other disorders of the central nervous system\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of intestines and peritoneum\n",
        "Other diseases of urinary system\n",
        "Inflammatory disease of female pelvic organs\n",
        "Other disorders of female genital tract\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms concerning nutrition, metabolism, and development\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving digestive system\n",
        "Symptoms involving urinary system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Nonspecific findings on examination of urine\n",
        "Other nonspecific abnormal findings\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adjuvants, Anesthesia\n",
        "Adrenergic Uptake Inhibitors\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Local\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Antacids\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antidepressive Agents, Tricyclic\n",
        "Antiemetics\n",
        "Antifungal Agents\n",
        "Antihypertensive Agents\n",
        "Antineoplastic Agents\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antioxidants\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase 2 Inhibitors\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Dopamine Uptake Inhibitors\n",
        "Drug Carriers\n",
        "Estrogens\n",
        "Fibrinolytic Agents\n",
        "GABA Modulators\n",
        "Glucocorticoids\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypolipidemic Agents\n",
        "Muscarinic Antagonists\n",
        "Muscle Relaxants, Central\n",
        "Narcotics\n",
        "Neuroprotective Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Solvents\n",
        "Surface-Active Agents\n",
        "Topoisomerase II Inhibitors\n",
        "Tranquilizing Agents\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "Voltage-Gated Sodium Channel Blockers\n",
        "===== phenotype 3=================================================================\n",
        "proportion of pts: 0.11106703689\n",
        "lambda: 18622.9439061\n",
        "----------------------------------------\n",
        "Secondary malignant neoplasm of lymph nodes, digestive system and other specified sites\n",
        "Benign neoplasm of other parts of digestive system\n",
        "Disorders of thyroid gland\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Hypertensive disease\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Other diseases of respiratory system\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Hernia of abdominal cavity\n",
        "Noninfectious enteritis and colitis\n",
        "Other diseases of intestines and peritoneum\n",
        "Other diseases of digestive system\n",
        "Other diseases of urinary system\n",
        "Rheumatism, excluding the back\n",
        "Congenital anomalies\n",
        "General symptoms\n",
        "Symptoms concerning nutrition, metabolism, and development\n",
        "Symptoms involving digestive system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Nonspecific abnormal findings in other body substances\n",
        "Fractures\n",
        "Open wound\n",
        "Injury to nerves and spinal cord\n",
        "Certain traumatic complications and unspecified injuries\n",
        "Complications of surgical and medical care, not elsewhere classified\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adjuvants, Anesthesia\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Intravenous\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticoagulants\n",
        "Anticonvulsants\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antiprotozoal Agents\n",
        "Antipruritics\n",
        "Antipsychotic Agents\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cathartics\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Drug Carriers\n",
        "Fibrinolytic Agents\n",
        "GABA Modulators\n",
        "GABA-A Receptor Agonists\n",
        "Gastrointestinal Agents\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypolipidemic Agents\n",
        "Muscle Relaxants, Central\n",
        "Narcotics\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Radiation-Sensitizing Agents\n",
        "Serotonin Antagonists\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Solvents\n",
        "Surface-Active Agents\n",
        "Sympatholytics\n",
        "Topoisomerase II Inhibitors\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "===== phenotype 30=================================================================\n",
        "proportion of pts: 0.122570408568\n",
        "lambda: 18440.6977868\n",
        "----------------------------------------\n",
        "Disorders of thyroid gland\n",
        "Disorders of lipoid metabolism\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Diseases of arteries, arterioles, and capillaries\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Other diseases of respiratory system\n",
        "Nephritis, nephrotic syndrome, and nephrosis\n",
        "Diseases of male genital organs\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Na\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving urinary system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Ill-defined and unknown causes of morbidity and mortality\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Abortifacient Agents, Nonsteroidal\n",
        "Adjuvants, Anesthesia\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-Antagonists\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Antacids\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Anticoagulants\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antimetabolites, Antineoplastic\n",
        "Antineoplastic Agents\n",
        "Antineoplastic Agents, Alkylating\n",
        "Antineoplastic Agents, Phytogenic\n",
        "Antipruritics\n",
        "Antipsychotic Agents\n",
        "Antipyretics\n",
        "Antirheumatic Agents\n",
        "Antitussive Agents\n",
        "Bronchodilator Agents\n",
        "Cardiotonic Agents\n",
        "Central Nervous System Stimulants\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Dopamine Uptake Inhibitors\n",
        "Enzyme Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Folic Acid Antagonists\n",
        "GABA-A Receptor Agonists\n",
        "Gastrointestinal Agents\n",
        "Hematinics\n",
        "Histamine H1 Antagonists\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Immunosuppressive Agents\n",
        "Muscarinic Antagonists\n",
        "Mutagens\n",
        "Nucleic Acid Synthesis Inhibitors\n",
        "Parasympatholytics\n",
        "Platelet Aggregation Inhibitors\n",
        "Rodenticides\n",
        "Serotonin Antagonists\n",
        "Serotonin Uptake Inhibitors\n",
        "Sympatholytics\n",
        "Topoisomerase II Inhibitors\n",
        "Tubulin Modulators\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "===== phenotype 39=================================================================\n",
        "proportion of pts: 0.130107100357\n",
        "lambda: 17823.2845019\n",
        "----------------------------------------\n",
        "Malignant neoplasm of male and female genital organs\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Anemias\n",
        "Na\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Hereditary and degenerative diseases of the central nervous system\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Other diseases of urinary system\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving urinary system\n",
        "Nonspecific findings on examination of blood\n",
        "Fractures\n",
        "Certain traumatic complications and unspecified injuries\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Abortifacient Agents, Nonsteroidal\n",
        "Adjuvants, Immunologic\n",
        "Analgesics, Non-Narcotic\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Antidepressive Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antifungal Agents\n",
        "Antihypertensive Agents\n",
        "Antimetabolites, Antineoplastic\n",
        "Antineoplastic Agents\n",
        "Antioxidants\n",
        "Antipruritics\n",
        "Antipyretics\n",
        "Antirheumatic Agents\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase 2 Inhibitors\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Estrogens\n",
        "Fibrinolytic Agents\n",
        "Folic Acid Antagonists\n",
        "GABA-A Receptor Agonists\n",
        "Glucocorticoids\n",
        "Hematinics\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypolipidemic Agents\n",
        "Immunosuppressive Agents\n",
        "Nucleic Acid Synthesis Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Trace Elements\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 24=================================================================\n",
        "proportion of pts: 0.103133677112\n",
        "lambda: 17709.050207\n",
        "----------------------------------------\n",
        "Other bacterial diseases\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Gout\n",
        "Disorders of mineral metabolism\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Overweight, obesity and other hyperalimentation\n",
        "Other diseases of the blood\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Drug dependence\n",
        "Organic sleep disorders\n",
        "Hereditary and degenerative diseases of the central nervous system\n",
        "Disorders of the eye and adnexa\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Cerebrovascular disease\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Acute respiratory infections\n",
        "Other diseases of respiratory system\n",
        "Diseases of oral cavity, salivary glands, and jaws\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Infections of skin and subcutaneous tissue\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "Operations on the musculoskeletal system\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Fractures\n",
        "Miscellaneous diagnostic and therapeutic procedures\n",
        "Open wound\n",
        "Certain traumatic complications and unspecified injuries\n",
        "Range name na\n",
        "----------------------------------------\n",
        "14-alpha Demethylase Inhibitors\n",
        "Abortifacient Agents, Nonsteroidal\n",
        "Adjuvants, Anesthesia\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Analgesics, Non-Narcotic\n",
        "Anesthetics, Intravenous\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents, Urinary\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Antiemetics\n",
        "Antifungal Agents\n",
        "Antihypertensive Agents\n",
        "Antimalarials\n",
        "Antimetabolites\n",
        "Antimetabolites, Antineoplastic\n",
        "Antineoplastic Agents\n",
        "Antipyretics\n",
        "Antirheumatic Agents\n",
        "Bone Density Conservation Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Enzyme Inhibitors\n",
        "Estrogens\n",
        "Explosive Agents\n",
        "Fibrinolytic Agents\n",
        "Folic Acid Antagonists\n",
        "Free Radical Scavengers\n",
        "GABA Modulators\n",
        "Glucocorticoids\n",
        "Gout Suppressants\n",
        "Hematinics\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypolipidemic Agents\n",
        "Immunosuppressive Agents\n",
        "Ionophores\n",
        "Muscle Relaxants, Central\n",
        "Nucleic Acid Synthesis Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Protein Synthesis Inhibitors\n",
        "Purinergic P2Y Receptor Antagonists\n",
        "Sympatholytics\n",
        "Tubulin Modulators\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 44=================================================================\n",
        "proportion of pts: 0.118603728679\n",
        "lambda: 17379.2852273\n",
        "----------------------------------------\n",
        "Mycoses\n",
        "Benign neoplasm of other parts of digestive system\n",
        "Disorders of thyroid gland\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Anemias\n",
        "Coagulation or hemorrhagic diseases\n",
        "Organic sleep disorders\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of intestines and peritoneum\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "Congenital anomalies\n",
        "Symptoms concerning nutrition, metabolism, and development\n",
        "Nonspecific findings on examination of blood\n",
        "Range name na\n",
        "----------------------------------------\n",
        "14-alpha Demethylase Inhibitors\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Analgesics, Non-Narcotic\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Antifungal Agents\n",
        "Antihypertensive Agents\n",
        "Antioxidants\n",
        "Antipyretics\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Explosive Agents\n",
        "Fibrinolytic Agents\n",
        "GABA Modulators\n",
        "Glucocorticoids\n",
        "Hematinics\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Immunosuppressive Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Purinergic P2Y Receptor Antagonists\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 29=================================================================\n",
        "proportion of pts: 0.0999603332011\n",
        "lambda: 17125.9176919\n",
        "----------------------------------------\n",
        "Malignant neoplasm of skin\n",
        "Malignant neoplasm of lymphatic and hematopoietic tissue\n",
        "Neoplasm of uncertain behavior of other sites & tissues\n",
        "Disorders of thyroid gland\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of plasma protein metabolism\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Other immune disorders\n",
        "Anemias\n",
        "Other diseases of the blood\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Liver\n",
        "Other diseases of urinary system\n",
        "Other disorders of female genital tract\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms concerning nutrition, metabolism, and development\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Symptoms involving urinary system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Nonspecific findings on examination of blood\n",
        "Poisoning by drugs, medicinal and biological substances\n",
        "----------------------------------------\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Antacids\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents, Tricyclic\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antimetabolites, Antineoplastic\n",
        "Antioxidants\n",
        "Antiparkinson Agents\n",
        "Antipruritics\n",
        "Antipsychotic Agents\n",
        "Antipyretics\n",
        "Antirheumatic Agents\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Dopamine Antagonists\n",
        "Enzyme Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Folic Acid Antagonists\n",
        "GABA-A Receptor Agonists\n",
        "Gastrointestinal Agents\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Histamine H2 Antagonists\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Immunosuppressive Agents\n",
        "Muscarinic Antagonists\n",
        "Parasympatholytics\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Serotonin Antagonists\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Tocolytic Agents\n",
        "Topoisomerase II Inhibitors\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 45=================================================================\n",
        "proportion of pts: 0.105117017057\n",
        "lambda: 16862.8969141\n",
        "----------------------------------------\n",
        "Mycoses\n",
        "Malignant neoplasm of skin\n",
        "Malignant neoplasm of lymphatic and hematopoietic tissue\n",
        "Benign neoplasm of skin\n",
        "Neoplasm of uncertain behavior of other sites & tissues\n",
        "Disorders of thyroid gland\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Other diseases of the blood\n",
        "Na\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of intestines and peritoneum\n",
        "Disorders of breast\n",
        "Other disorders of female genital tract\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Nonspecific findings on examination of blood\n",
        "Range name na\n",
        "----------------------------------------\n",
        "14-alpha Demethylase Inhibitors\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Analgesics\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antiemetics\n",
        "Antifungal Agents\n",
        "Antihypertensive Agents\n",
        "Antimetabolites\n",
        "Antioxidants\n",
        "Antipruritics\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Estrogens\n",
        "Fibrinolytic Agents\n",
        "Free Radical Scavengers\n",
        "GABA Modulators\n",
        "Glucocorticoids\n",
        "Gout Suppressants\n",
        "Histamine H1 Antagonists\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Histamine H2 Antagonists\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Lipoxygenase Inhibitors\n",
        "Parasympatholytics\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Serotonin Receptor Agonists\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "===== phenotype 28=================================================================\n",
        "proportion of pts: 0.10749702499\n",
        "lambda: 16631.5689977\n",
        "----------------------------------------\n",
        "Malignant neoplasm of skin\n",
        "Neoplasm of uncertain behavior of other sites & tissues\n",
        "Disorders of lipoid metabolism\n",
        "Gout\n",
        "Na\n",
        "Organic sleep disorders\n",
        "Pain\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Cerebrovascular disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Other diseases of intestines and peritoneum\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Fractures\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adjuvants, Anesthesia\n",
        "Adrenergic Uptake Inhibitors\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-Antagonists\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Asthmatic Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antidepressive Agents, Tricyclic\n",
        "Antihypertensive Agents\n",
        "Antimetabolites\n",
        "Antipyretics\n",
        "Antitussive Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Explosive Agents\n",
        "Fibrinolytic Agents\n",
        "Free Radical Scavengers\n",
        "GABA Modulators\n",
        "GABA-A Receptor Agonists\n",
        "Glucocorticoids\n",
        "Gout Suppressants\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypolipidemic Agents\n",
        "Muscle Relaxants, Central\n",
        "Narcotics\n",
        "Nitric Oxide Donors\n",
        "Phosphodiesterase 5 Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Purinergic P2Y Receptor Antagonists\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Sympathomimetics\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "===== phenotype 31=================================================================\n",
        "proportion of pts: 0.112653708846\n",
        "lambda: 16176.7235546\n",
        "----------------------------------------\n",
        "Other bacterial diseases\n",
        "Malignant neoplasm of male and female genital organs\n",
        "Benign neoplasm of other parts of digestive system\n",
        "Benign neoplasm of skin\n",
        "Disorders of lipoid metabolism\n",
        "Overweight, obesity and other hyperalimentation\n",
        "Other diseases of the blood\n",
        "Drug dependence\n",
        "Operations on the hemic and lymphatic system\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Diseases of arteries, arterioles, and capillaries\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Other diseases of the upper respiratory tract\n",
        "Other diseases of respiratory system\n",
        "Other diseases of intestines and peritoneum\n",
        "Other diseases of urinary system\n",
        "Diseases of male genital organs\n",
        "Infections of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Congenital anomalies\n",
        "Operations on the musculoskeletal system\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Other and unspecified effects of external causes\n",
        "----------------------------------------\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-Antagonists\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Local\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents\n",
        "Anti-Infective Agents, Urinary\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antimalarials\n",
        "Antioxidants\n",
        "Antiprotozoal Agents\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cardiovascular Agents\n",
        "Cathartics\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Fibrinolytic Agents\n",
        "Histamine H1 Antagonists\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Narcotics\n",
        "Phosphodiesterase 5 Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Radiation-Sensitizing Agents\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Topoisomerase II Inhibitors\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 32=================================================================\n",
        "proportion of pts: 0.10392701309\n",
        "lambda: 15998.0180509\n",
        "----------------------------------------\n",
        "Other diseases due to viruses and chlamydiae\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Overweight, obesity and other hyperalimentation\n",
        "Pain\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other diseases of the upper respiratory tract\n",
        "Diseases of oral cavity, salivary glands, and jaws\n",
        "Other diseases of urinary system\n",
        "Disorders of breast\n",
        "Other disorders of female genital tract\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Nonspecific abnormal findings on radiological and other examination of body structure\n",
        "Abnormal results of function studies\n",
        "Sprains and strains of joints and adjacent muscles\n",
        "Certain traumatic complications and unspecified injuries\n",
        "Other and unspecified effects of external causes\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adjuvants, Anesthesia\n",
        "Adrenergic alpha-Agonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-Agonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Local\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antioxidants\n",
        "Antipyretics\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Explosive Agents\n",
        "Fibrinolytic Agents\n",
        "GABA Modulators\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Muscle Relaxants, Central\n",
        "Mydriatics\n",
        "Narcotics\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Serotonin 5-HT1 Receptor Agonists\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Sympathomimetics\n",
        "Vasoconstrictor Agents\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "Voltage-Gated Sodium Channel Blockers\n",
        "===== phenotype 19=================================================================\n",
        "proportion of pts: 0.0995636652122\n",
        "lambda: 15711.8196832\n",
        "----------------------------------------\n",
        "Intestinal infectious diseases\n",
        "Mycoses\n",
        "Malignant neoplasm of breast\n",
        "Neoplasm of uncertain behavior of endocrine glands & nervous system\n",
        "Disorders of thyroid gland\n",
        "Diabetes\n",
        "Diseases of other endocrine glands\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of mineral metabolism\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Disorders of the peripheral nervous system\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Hernia of abdominal cavity\n",
        "Noninfectious enteritis and colitis\n",
        "Other diseases of intestines and peritoneum\n",
        "Other diseases of digestive system\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Nonspecific abnormal findings on radiological and other examination of body structure\n",
        "Other and nonspecific abnormal cytological, histological, immunological and dna test findings\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Abortifacient Agents, Nonsteroidal\n",
        "Adrenergic beta-Antagonists\n",
        "Analgesics, Non-Narcotic\n",
        "Angiotensin II Type 1 Receptor Blockers\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Antacids\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antihypertensive Agents\n",
        "Antimetabolites, Antineoplastic\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antioxidants\n",
        "Antipruritics\n",
        "Antipyretics\n",
        "Antirheumatic Agents\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Folic Acid Antagonists\n",
        "Glucocorticoids\n",
        "Hematinics\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Immunosuppressive Agents\n",
        "Lipoxygenase Inhibitors\n",
        "Mydriatics\n",
        "Nucleic Acid Synthesis Inhibitors\n",
        "Parasympatholytics\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sympathomimetics\n",
        "Tocolytic Agents\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 7=================================================================\n",
        "proportion of pts: 0.0987703292344\n",
        "lambda: 15305.6119985\n",
        "----------------------------------------\n",
        "Malignant neoplasm of breast\n",
        "Malignant neoplasm of other and ill-defined sites\n",
        "Secondary malignant neoplasm of lymph nodes, digestive system and other specified sites\n",
        "Malignant neoplasm of lymphatic and hematopoietic tissue\n",
        "Hemangioma and lymphangioma any site\n",
        "Disorders of thyroid gland\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Anemias\n",
        "Other diseases of the blood\n",
        "Na\n",
        "Organic sleep disorders\n",
        "Hypertensive disease\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Noninfectious enteritis and colitis\n",
        "Diseases of male genital organs\n",
        "Disorders of breast\n",
        "Other disorders of female genital tract\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "Congenital anomalies\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Nonspecific findings on examination of blood\n",
        "Nonspecific abnormal findings on radiological and other examination of body structure\n",
        "Operations on the integumentary system\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Analgesics, Non-Narcotic\n",
        "Analgesics, Opioid\n",
        "Anesthetics, Local\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Antacids\n",
        "Anti-Allergic Agents\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antiemetics\n",
        "Antihypertensive Agents\n",
        "Antineoplastic Agents\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antineoplastic Agents, Phytogenic\n",
        "Antioxidants\n",
        "Antipyretics\n",
        "Aromatase Inhibitors\n",
        "Bone Density Conservation Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Central Nervous System Stimulants\n",
        "Cyclooxygenase Inhibitors\n",
        "Enzyme Inhibitors\n",
        "Estrogen Antagonists\n",
        "Fibrinolytic Agents\n",
        "Food Additives\n",
        "GABA Modulators\n",
        "GABA-A Receptor Agonists\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypolipidemic Agents\n",
        "Immunosuppressive Agents\n",
        "Narcotics\n",
        "Phosphodiesterase Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Purinergic P1 Receptor Antagonists\n",
        "Selective Estrogen Receptor Modulators\n",
        "Serotonin Uptake Inhibitors\n",
        "Surface-Active Agents\n",
        "Sympatholytics\n",
        "Tubulin Modulators\n",
        "Vasodilator Agents\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 43=================================================================\n",
        "proportion of pts: 0.107893692979\n",
        "lambda: 15224.8843342\n",
        "----------------------------------------\n",
        "Other diseases due to viruses and chlamydiae\n",
        "Operations on the eye\n",
        "Malignant neoplasm of badder, kidney and other urinary organs\n",
        "Benign neoplasm of other parts of digestive system\n",
        "Disorders of thyroid gland\n",
        "Diseases of other endocrine glands\n",
        "Disorders of lipoid metabolism\n",
        "Anemias\n",
        "Coagulation or hemorrhagic diseases\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Other diseases of respiratory system\n",
        "Diseases of oral cavity, salivary glands, and jaws\n",
        "Hernia of abdominal cavity\n",
        "Other diseases of intestines and peritoneum\n",
        "Diseases of male genital organs\n",
        "Infections of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "General symptoms\n",
        "Symptoms concerning nutrition, metabolism, and development\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Adrenergic beta-Antagonists\n",
        "Analgesics\n",
        "Analgesics, Non-Narcotic\n",
        "Androgens\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Infective Agents\n",
        "Anti-Infective Agents, Urinary\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antihypertensive Agents\n",
        "Antimalarials\n",
        "Antimetabolites, Antineoplastic\n",
        "Antineoplastic Agents\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antioxidants\n",
        "Antipyretics\n",
        "Antirheumatic Agents\n",
        "Bone Density Conservation Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Enzyme Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Folic Acid Antagonists\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypnotics and Sedatives\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Immunosuppressive Agents\n",
        "Nucleic Acid Synthesis Inhibitors\n",
        "Phosphodiesterase 5 Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Protein Synthesis Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Serotonin Uptake Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Topoisomerase II Inhibitors\n",
        "Vasodilator Agents\n",
        "Vitamins\n"
       ]
      }
     ],
     "prompt_number": 27
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "gamma_str = '_gamma-0.001-0.05-0.05.pickle'\n",
      "\n",
      "def calculateValues(TM, M):\n",
      "    fms = TM.greedy_fms(M)\n",
      "    fos = TM.greedy_fos(M)\n",
      "    nnz = tensorTools.countTensorNNZ(M)\n",
      "    return fms, fos, nnz\n",
      "\n",
      "## load the tensor #######\n",
      "loaded_X, loaded_axisDict, loaded_classDict = tensorIO.loadSingleTensor(\"htn-tensor-subsetforanalysis-20140811-{0}.dat\")\n",
      "\n",
      "\n",
      "##read in the pickles:\n",
      "pickle_folder = \"./pickle_folder_20140814/\"\n",
      "\n",
      "outfile_str = pickle_folder + \"pheno_htn_subset_analyzed_REG\" + gamma_str\n",
      "matrix_pkl = open(outfile_str, \"rb\")\n",
      "pheno_htn_subset_analyzed_REG_withGamma = pickle.load(matrix_pkl)\n",
      "matrix_pkl.close()\n",
      "\n",
      "outfile_str = pickle_folder + \"Yinfo_htn_subset_analyzed\" + gamma_str  \n",
      "matrix_pkl = open(outfile_str, \"rb\")\n",
      "Yinfo_htn_subset_analyzed_withGamma = pickle.load(matrix_pkl)\n",
      "matrix_pkl.close()\n",
      "\n",
      "#write output file\n",
      "pheno_outstream = open(pickle_folder + \"phenotypes\"+gamma_str+\".out\", 'w+')\n",
      "\n",
      "#read in the pheWAS dictionary\n",
      "execfile('./read_pheWAS_dictionary_xls.py')\n",
      "\n",
      "#tensor with all phenotypes (factorization)\n",
      "ktensor_phenotypes = pheno_htn_subset_analyzed_REG_withGamma[0]\n",
      "l_pts = loaded_axisDict[0].keys()\n",
      "l_jdrange = loaded_axisDict[1].keys()\n",
      "l_meds= loaded_axisDict[2].keys()\n",
      "\n",
      "#will store all the data\n",
      "d_pheno_nonzero_labels = OrderedDict()\n",
      "\n",
      "\n",
      "#sort phenotypes by lambda values:\n",
      "d_lambda_phenoNumber = OrderedDict(zip(list(ktensor_phenotypes.lmbda),\n",
      "                                        list(range(R) )\n",
      "                                        ))\n",
      "l_phenoNumbers_sorted_by_lambda = [  d_lambda_phenoNumber[x] for x in sorted(d_lambda_phenoNumber.keys(), reverse=True)]                                  \n",
      "\n",
      "#print phenotype feature names #################\n",
      "#for i in range(10):\n",
      "for i in l_phenoNumbers_sorted_by_lambda:\n",
      "    print \"===== phenotype \" + str(i) + \"=================================================================\"\n",
      "    pheno_outstream.write(\"===== phenotype \" + str(i) + \"=================================================================\" + '\\n')\n",
      "    this_lmbda = ktensor_phenotypes.lmbda[i]\n",
      "    this_pheno_pt_factor = ktensor_phenotypes.U[0][:,i]\n",
      "    this_pheno_jdrange_factor = ktensor_phenotypes.U[1][:,i]\n",
      "    this_pheno_med_factor = ktensor_phenotypes.U[2][:,i]\n",
      "    \n",
      "    this_pheno_pt_nnz = np.nonzero(this_pheno_pt_factor)[0]\n",
      "    this_pheno_jdrange_nnz = np.nonzero(this_pheno_jdrange_factor)[0]\n",
      "    this_pheno_med_nnz = np.nonzero(this_pheno_med_factor)[0]\n",
      "    \n",
      "    l_nonzero_pt_thisPheno = []\n",
      "    l_nonzero_meds_thisPheno = []\n",
      "    l_nonzero_jdrange_thisPheno = []\n",
      "    l_nonzero_jdrange_names_thisPheno = []\n",
      "    \n",
      "    for j in this_pheno_pt_nnz:\n",
      "        l_nonzero_pt_thisPheno.append(l_pts[j])\n",
      "    for j in this_pheno_jdrange_nnz:\n",
      "        l_nonzero_jdrange_thisPheno.append(l_jdrange[j])\n",
      "        l_nonzero_jdrange_names_thisPheno.append(d_jdrange_lookup[l_jdrange[j]])\n",
      "    for j in this_pheno_med_nnz:\n",
      "        l_nonzero_meds_thisPheno.append(l_meds[j])\n",
      "    \n",
      "    #data\n",
      "    d_pheno_nonzero_labels[i] = dict() #for phenotype i\n",
      "    d_pheno_nonzero_labels[i]['LAMBDA'] = this_lmbda #lambda value\n",
      "    d_pheno_nonzero_labels[i]['PERCENT_PTS'] = len(l_nonzero_pt_thisPheno) / float(len(this_pheno_pt_factor))\n",
      "    d_pheno_nonzero_labels[i]['MEDS_NZ'] = l_nonzero_meds_thisPheno #for phenotype i\n",
      "    d_pheno_nonzero_labels[i]['JDRANGE_NZ'] = l_nonzero_jdrange_thisPheno #for phenotype i   \n",
      "    d_pheno_nonzero_labels[i]['JDRANGE_NAMES_NZ'] = l_nonzero_jdrange_names_thisPheno #for phenotype i \n",
      "    \n",
      "    print \"proportion of pts: \" + str(d_pheno_nonzero_labels[i]['PERCENT_PTS'])\n",
      "    pheno_outstream.write(\"proportion of pts: \" + str(d_pheno_nonzero_labels[i]['PERCENT_PTS']) + '\\n')\n",
      "    print \"lambda: \" + str(this_lmbda)\n",
      "    pheno_outstream.write(\"lambda: \" + str(this_lmbda) + '\\n')\n",
      "    print \"----------------------------------------\" #divider\n",
      "    pheno_outstream.write(\"----------------------------------------\" + '\\n')\n",
      "    #print \"\\tnumber jdrange: \" + str(len(d_pheno_nonzero_labels[i]['JDRANGE_NZ']))\n",
      "    #print \"\\tjdrange: \" + str(d_pheno_nonzero_labels[i]['JDRANGE_NZ'])\n",
      "    for jdrange in d_pheno_nonzero_labels[i]['JDRANGE_NZ']:\n",
      "        print d_jdrange_lookup[jdrange]\n",
      "        pheno_outstream.write(str(d_jdrange_lookup[jdrange]) + '\\n')\n",
      "    #print \"\\tnumber meds: \" + str(len(d_pheno_nonzero_labels[i]['MEDS_NZ']))\n",
      "    #print \"\\tmeds: \" + str(d_pheno_nonzero_labels[i]['MEDS_NZ'])\n",
      "    print \"----------------------------------------\" #divider between diagnostic codes and meds\n",
      "    pheno_outstream.write(\"----------------------------------------\" + '\\n')\n",
      "    for med in d_pheno_nonzero_labels[i]['MEDS_NZ']:\n",
      "        print med   \n",
      "        pheno_outstream.write(med + '\\n')\n",
      "pheno_outstream.close()"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "===== phenotype 5=================================================================\n",
        "proportion of pts: 0.119397064657\n",
        "lambda: 16186.2895539\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Other diseases of respiratory system\n",
        "Nephritis, nephrotic syndrome, and nephrosis\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypolipidemic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Vasodilator Agents\n",
        "===== phenotype 47=================================================================\n",
        "proportion of pts: 0.138437128124\n",
        "lambda: 15273.2333299\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Vasodilator Agents\n",
        "===== phenotype 2=================================================================\n",
        "proportion of pts: 0.122173740579\n",
        "lambda: 15230.1836366\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Nonspecific findings on examination of blood\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Calcium Channel Blockers\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Vasodilator Agents\n",
        "===== phenotype 44=================================================================\n",
        "proportion of pts: 0.11106703689\n",
        "lambda: 14807.7481093\n",
        "----------------------------------------\n",
        "Mycoses\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of intestines and peritoneum\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypolipidemic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "===== phenotype 27=================================================================\n",
        "proportion of pts: 0.120983736612\n",
        "lambda: 14398.6275401\n",
        "----------------------------------------\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Anemias\n",
        "Disorders of the eye and adnexa\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Other diseases of intestines and peritoneum\n",
        "Dorsopathies\n",
        "General symptoms\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving urinary system\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Antihypertensive Agents\n",
        "Antioxidants\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "===== phenotype 13=================================================================\n",
        "proportion of pts: 0.142403808013\n",
        "lambda: 14356.2044318\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Sympatholytics\n",
        "Vasodilator Agents\n",
        "===== phenotype 9=================================================================\n",
        "proportion of pts: 0.121380404601\n",
        "lambda: 13142.6951011\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Organic sleep disorders\n",
        "Disorders of the eye and adnexa\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Other diseases of the upper respiratory tract\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving urinary system\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "===== phenotype 46=================================================================\n",
        "proportion of pts: 0.126537088457\n",
        "lambda: 12967.7578454\n",
        "----------------------------------------\n",
        "Disorders of thyroid gland\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Overweight, obesity and other hyperalimentation\n",
        "Organic sleep disorders\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Dorsopathies\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Calcium Channel Blockers\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Vasodilator Agents\n",
        "===== phenotype 0=================================================================\n",
        "proportion of pts: 0.126933756446\n",
        "lambda: 11833.8350177\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Hereditary and degenerative diseases of the central nervous system\n",
        "Hypertensive disease\n",
        "Cerebrovascular disease\n",
        "Other diseases of urinary system\n",
        "Diseases of male genital organs\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "General symptoms\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving urinary system\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypolipidemic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Vasodilator Agents\n",
        "===== phenotype 48=================================================================\n",
        "proportion of pts: 0.109083696946\n",
        "lambda: 11354.1764497\n",
        "----------------------------------------\n",
        "Disorders of thyroid gland\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Nonspecific findings on examination of blood\n",
        "----------------------------------------\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "===== phenotype 34=================================================================\n",
        "proportion of pts: 0.114240380801\n",
        "lambda: 10956.1843624\n",
        "----------------------------------------\n",
        "Disorders of thyroid gland\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Arrhythmia Agents\n",
        "Anticholesteremic Agents\n",
        "Anticoagulants\n",
        "Antihypertensive Agents\n",
        "Calcium Channel Blockers\n",
        "Diuretics\n",
        "Rodenticides\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Vasodilator Agents\n",
        "===== phenotype 22=================================================================\n",
        "proportion of pts: 0.116620388735\n",
        "lambda: 10644.7870989\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Dorsopathies\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "----------------------------------------\n",
        "Adrenergic beta-2 Receptor Agonists\n",
        "Anti-Allergic Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Ulcer Agents\n",
        "Antihypertensive Agents\n",
        "Bronchodilator Agents\n",
        "Dermatologic Agents\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Lipoxygenase Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "===== phenotype 42=================================================================\n",
        "proportion of pts: 0.109083696946\n",
        "lambda: 10289.8203224\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Analgesics\n",
        "Anti-Anxiety Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antiemetics\n",
        "GABA Modulators\n",
        "Histamine H1 Antagonists\n",
        "Hypnotics and Sedatives\n",
        "Serotonin Uptake Inhibitors\n",
        "===== phenotype 20=================================================================\n",
        "proportion of pts: 0.112257040857\n",
        "lambda: 10143.6265497\n",
        "----------------------------------------\n",
        "Malignant neoplasm of skin\n",
        "Neoplasm of uncertain behavior of other sites & tissues\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Infections of skin and subcutaneous tissue\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Fibrinolytic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "===== phenotype 12=================================================================\n",
        "proportion of pts: 0.101943673146\n",
        "lambda: 10042.9241363\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Organic sleep disorders\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Acute respiratory infections\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Anticoagulants\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypolipidemic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Rodenticides\n",
        "Sympatholytics\n",
        "===== phenotype 21=================================================================\n",
        "proportion of pts: 0.104720349068\n",
        "lambda: 9814.33701392\n",
        "----------------------------------------\n",
        "Anemias\n",
        "Disorders of the peripheral nervous system\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of urinary system\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving urinary system\n",
        "Fractures\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Analgesics\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticonvulsants\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Calcium Channel Blockers\n",
        "Cyclooxygenase Inhibitors\n",
        "Serotonin Uptake Inhibitors\n",
        "===== phenotype 17=================================================================\n",
        "proportion of pts: 0.0987703292344\n",
        "lambda: 8637.87212332\n",
        "----------------------------------------\n",
        "Benign neoplasm of other parts of digestive system\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Gout\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Diseases of male genital organs\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Antimetabolites\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Enzyme Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Free Radical Scavengers\n",
        "Gout Suppressants\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Vasodilator Agents\n",
        "===== phenotype 11=================================================================\n",
        "proportion of pts: 0.115430384768\n",
        "lambda: 8191.96639526\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Analgesics, Opioid\n",
        "Anti-Infective Agents\n",
        "Anti-Infective Agents, Local\n",
        "Anti-Infective Agents, Urinary\n",
        "Antifungal Agents\n",
        "Antimalarials\n",
        "Antirheumatic Agents\n",
        "Enzyme Inhibitors\n",
        "Gastrointestinal Agents\n",
        "Immunosuppressive Agents\n",
        "Narcotics\n",
        "===== phenotype 45=================================================================\n",
        "proportion of pts: 0.0975803252678\n",
        "lambda: 8007.38485514\n",
        "----------------------------------------\n",
        "Benign neoplasm of skin\n",
        "Neoplasm of uncertain behavior of other sites & tissues\n",
        "Disorders of thyroid gland\n",
        "Disorders of lipoid metabolism\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Bronchodilator Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "===== phenotype 39=================================================================\n",
        "proportion of pts: 0.123760412535\n",
        "lambda: 8000.08030548\n",
        "----------------------------------------\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Anemias\n",
        "Na\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Arthropathies and related disorders\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Antioxidants\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Serotonin Uptake Inhibitors\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 28=================================================================\n",
        "proportion of pts: 0.0944069813566\n",
        "lambda: 7573.64773738\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Cerebrovascular disease\n",
        "Acute respiratory infections\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Explosive Agents\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypolipidemic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Vasodilator Agents\n",
        "===== phenotype 25=================================================================\n",
        "proportion of pts: 0.115827052757\n",
        "lambda: 7017.02414836\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the peripheral nervous system\n",
        "Hypertensive disease\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Glucocorticoids\n",
        "===== phenotype 24=================================================================\n",
        "proportion of pts: 0.085680285601\n",
        "lambda: 6936.43841699\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Abortifacient Agents, Nonsteroidal\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Antimetabolites, Antineoplastic\n",
        "Antirheumatic Agents\n",
        "Dermatologic Agents\n",
        "Enzyme Inhibitors\n",
        "Folic Acid Antagonists\n",
        "Immunosuppressive Agents\n",
        "Nucleic Acid Synthesis Inhibitors\n",
        "Sympatholytics\n",
        "===== phenotype 19=================================================================\n",
        "proportion of pts: 0.0805236017453\n",
        "lambda: 6822.7840568\n",
        "----------------------------------------\n",
        "Disorders of thyroid gland\n",
        "Diabetes\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Other diseases of the upper respiratory tract\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving digestive system\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Abortifacient Agents, Nonsteroidal\n",
        "Anti-Allergic Agents\n",
        "Anti-Inflammatory Agents\n",
        "Antimetabolites, Antineoplastic\n",
        "Antirheumatic Agents\n",
        "Bronchodilator Agents\n",
        "Dermatologic Agents\n",
        "Enzyme Inhibitors\n",
        "Folic Acid Antagonists\n",
        "Immunosuppressive Agents\n",
        "Nucleic Acid Synthesis Inhibitors\n",
        "===== phenotype 32=================================================================\n",
        "proportion of pts: 0.0944069813566\n",
        "lambda: 6454.71400953\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Diseases of oral cavity, salivary glands, and jaws\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Sprains and strains of joints and adjacent muscles\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anesthetics, Local\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Bronchodilator Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Vasodilator Agents\n",
        "===== phenotype 31=================================================================\n",
        "proportion of pts: 0.101150337168\n",
        "lambda: 6206.3740215\n",
        "----------------------------------------\n",
        "Other bacterial diseases\n",
        "Malignant neoplasm of male and female genital organs\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Diseases of arteries, arterioles, and capillaries\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Other diseases of intestines and peritoneum\n",
        "Other diseases of urinary system\n",
        "Diseases of male genital organs\n",
        "Symptoms involving cardiovascular system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Other and unspecified effects of external causes\n",
        "----------------------------------------\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Vasodilator Agents\n",
        "===== phenotype 8=================================================================\n",
        "proportion of pts: 0.09678698929\n",
        "lambda: 6177.71505624\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Hernia of abdominal cavity\n",
        "Dorsopathies\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Anxiety Agents\n",
        "Anti-Ulcer Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "GABA Modulators\n",
        "Hypnotics and Sedatives\n",
        "Proton Pump Inhibitors\n",
        "===== phenotype 43=================================================================\n",
        "proportion of pts: 0.0963903213011\n",
        "lambda: 5795.7673116\n",
        "----------------------------------------\n",
        "Benign neoplasm of other parts of digestive system\n",
        "Diseases of other endocrine glands\n",
        "Disorders of lipoid metabolism\n",
        "Coagulation or hemorrhagic diseases\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Other diseases of intestines and peritoneum\n",
        "Infections of skin and subcutaneous tissue\n",
        "General symptoms\n",
        "Symptoms concerning nutrition, metabolism, and development\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Fibrinolytic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Vasodilator Agents\n",
        "===== phenotype 40=================================================================\n",
        "proportion of pts: 0.0674335581119\n",
        "lambda: 5773.09931406\n",
        "----------------------------------------\n",
        "nan\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Drug dependence\n",
        "Operations on the cardiovascular system\n",
        "Other forms of heart disease\n",
        "Diseases of arteries, arterioles, and capillaries\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Other diseases of respiratory system\n",
        "Operations on the musculoskeletal system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Nonspecific findings on examination of blood\n",
        "Miscellaneous diagnostic and therapeutic procedures\n",
        "----------------------------------------\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "===== phenotype 7=================================================================\n",
        "proportion of pts: 0.0920269734232\n",
        "lambda: 5559.46739926\n",
        "----------------------------------------\n",
        "Malignant neoplasm of breast\n",
        "Disorders of thyroid gland\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Hypnotics and Sedatives\n",
        "Vitamins\n",
        "===== phenotype 49=================================================================\n",
        "proportion of pts: 0.104720349068\n",
        "lambda: 5511.10986638\n",
        "----------------------------------------\n",
        "Anemias\n",
        "Organic sleep disorders\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Acute respiratory infections\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Arthropathies and related disorders\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\n",
        "Anti-Inflammatory Agents\n",
        "Antihypertensive Agents\n",
        "Bronchodilator Agents\n",
        "Diuretics\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "===== phenotype 35=================================================================\n",
        "proportion of pts: 0.0952003173344\n",
        "lambda: 5387.77229977\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of urinary system\n",
        "Other disorders of female genital tract\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic beta-2 Receptor Agonists\n",
        "Anti-Allergic Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Ulcer Agents\n",
        "Antihypertensive Agents\n",
        "Bronchodilator Agents\n",
        "Estrogens\n",
        "Proton Pump Inhibitors\n",
        "===== phenotype 38=================================================================\n",
        "proportion of pts: 0.107100357001\n",
        "lambda: 5363.04749434\n",
        "----------------------------------------\n",
        "Mycoses\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Anemias\n",
        "Disorders of the peripheral nervous system\n",
        "Hypertensive disease\n",
        "Nephritis, nephrotic syndrome, and nephrosis\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Certain traumatic complications and unspecified injuries\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Analgesics\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antihypertensive Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypoglycemic Agents\n",
        "===== phenotype 37=================================================================\n",
        "proportion of pts: 0.110670368901\n",
        "lambda: 5159.72067404\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Na\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Drug dependence\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "----------------------------------------\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Serotonin Uptake Inhibitors\n",
        "===== phenotype 18=================================================================\n",
        "proportion of pts: 0.0912336374455\n",
        "lambda: 4830.42519247\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Na\n",
        "Disorders of the peripheral nervous system\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Analgesics\n",
        "Anti-Anxiety Agents\n",
        "Anticonvulsants\n",
        "Antihypertensive Agents\n",
        "Antiparkinson Agents\n",
        "Excitatory Amino Acid Antagonists\n",
        "Serotonin Uptake Inhibitors\n",
        "===== phenotype 16=================================================================\n",
        "proportion of pts: 0.0916303054344\n",
        "lambda: 4453.15791422\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Pneumonia and influenza\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Other diseases of respiratory system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic beta-2 Receptor Agonists\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Bronchodilator Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Tocolytic Agents\n",
        "Vasodilator Agents\n",
        "===== phenotype 3=================================================================\n",
        "proportion of pts: 0.0983736612455\n",
        "lambda: 4230.51145973\n",
        "----------------------------------------\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of intestines and peritoneum\n",
        "Other diseases of digestive system\n",
        "Other diseases of urinary system\n",
        "Symptoms involving digestive system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Certain traumatic complications and unspecified injuries\n",
        "Complications of surgical and medical care, not elsewhere classified\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Analgesics, Opioid\n",
        "Anti-Anxiety Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Hypnotics and Sedatives\n",
        "Narcotics\n",
        "===== phenotype 36=================================================================\n",
        "proportion of pts: 0.0924236414121\n",
        "lambda: 4012.31989703\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Pain\n",
        "Other disorders of the central nervous system\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Other diseases of urinary system\n",
        "Other disorders of female genital tract\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving urinary system\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Analgesics, Non-Narcotic\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Estrogens\n",
        "===== phenotype 29=================================================================\n",
        "proportion of pts: 0.0900436334788\n",
        "lambda: 3942.2034969\n",
        "----------------------------------------\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Other diseases of the blood\n",
        "Hypertensive disease\n",
        "Liver\n",
        "Other diseases of urinary system\n",
        "Dorsopathies\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving digestive system\n",
        "Symptoms involving urinary system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Nonspecific findings on examination of blood\n",
        "----------------------------------------\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Vasodilator Agents\n",
        "===== phenotype 15=================================================================\n",
        "proportion of pts: 0.0908369694566\n",
        "lambda: 3458.8431866\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Organic sleep disorders\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of urinary system\n",
        "Diseases of male genital organs\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving urinary system\n",
        "Nonspecific findings on examination of blood\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Ulcer Agents\n",
        "Bronchodilator Agents\n",
        "===== phenotype 30=================================================================\n",
        "proportion of pts: 0.0920269734232\n",
        "lambda: 3301.25499568\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Other diseases of respiratory system\n",
        "General symptoms\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Antimetabolites, Antineoplastic\n",
        "Antirheumatic Agents\n",
        "Dermatologic Agents\n",
        "Enzyme Inhibitors\n",
        "Immunosuppressive Agents\n",
        "===== phenotype 1=================================================================\n",
        "proportion of pts: 0.0995636652122\n",
        "lambda: 3256.85495007\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Gout\n",
        "Organic sleep disorders\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Arthropathies and related disorders\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Nonspecific findings on examination of blood\n",
        "Abnormal results of function studies\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Analgesics\n",
        "Antihypertensive Agents\n",
        "Calcium Channel Blockers\n",
        "Vasodilator Agents\n",
        "===== phenotype 33=================================================================\n",
        "proportion of pts: 0.0971836572789\n",
        "lambda: 2966.03992486\n",
        "----------------------------------------\n",
        "Other disorders of the central nervous system\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Pneumonia and influenza\n",
        "Other diseases of respiratory system\n",
        "Other diseases of urinary system\n",
        "General symptoms\n",
        "Symptoms involving nervous and musculoskeletal systems\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving urinary system\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\n",
        "Anti-Bacterial Agents\n",
        "Antihypertensive Agents\n",
        "Bronchodilator Agents\n",
        "===== phenotype 14=================================================================\n",
        "proportion of pts: 0.0880602935343\n",
        "lambda: 2792.22726412\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Anemias\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of intestines and peritoneum\n",
        "Nephritis, nephrotic syndrome, and nephrosis\n",
        "Other diseases of urinary system\n",
        "Operations on the musculoskeletal system\n",
        "Symptoms involving urinary system\n",
        "Nonspecific findings on examination of blood\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Antihypertensive Agents\n",
        "Antirheumatic Agents\n",
        "Dermatologic Agents\n",
        "Enzyme Inhibitors\n",
        "Immunosuppressive Agents\n",
        "===== phenotype 6=================================================================\n",
        "proportion of pts: 0.078143593812\n",
        "lambda: 2639.53337082\n",
        "----------------------------------------\n",
        "Overweight, obesity and other hyperalimentation\n",
        "Na\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Organic sleep disorders\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of intestines and peritoneum\n",
        "Other diseases of urinary system\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Anxiety Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antihypertensive Agents\n",
        "Serotonin Uptake Inhibitors\n",
        "===== phenotype 4=================================================================\n",
        "proportion of pts: 0.0833002776676\n",
        "lambda: 1303.75745431\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Overweight, obesity and other hyperalimentation\n",
        "Anemias\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Organic sleep disorders\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Dorsopathies\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "----------------------------------------\n",
        "Antihypertensive Agents\n",
        "Calcium Channel Blockers\n",
        "===== phenotype 26=================================================================\n",
        "proportion of pts: 0.0610868702896\n",
        "lambda: 912.984509752\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Cerebrovascular disease\n",
        "Diseases of arteries, arterioles, and capillaries\n",
        "Other diseases of respiratory system\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Surface-Active Agents\n",
        "===== phenotype 10=================================================================\n",
        "proportion of pts: 0.0714002380008\n",
        "lambda: 738.671514815\n",
        "----------------------------------------\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Pain\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Pneumonia and influenza\n",
        "Other diseases of respiratory system\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Anxiety Agents\n",
        "===== phenotype 41=================================================================\n",
        "proportion of pts: 0.0\n",
        "lambda: 1.0\n",
        "----------------------------------------\n",
        "----------------------------------------\n"
       ]
      }
     ],
     "prompt_number": 29
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "ktensor_phenotypes.U\n"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 31,
       "text": [
        "[array([[ 0.        ,  0.        ,  0.00194513, ...,  0.        ,\n",
        "          0.        ,  0.        ],\n",
        "        [ 0.        ,  0.        ,  0.        , ...,  0.        ,\n",
        "          0.        ,  0.        ],\n",
        "        [ 0.        ,  0.00426993,  0.        , ...,  0.00419642,\n",
        "          0.        ,  0.        ],\n",
        "        ..., \n",
        "        [ 0.        ,  0.        ,  0.        , ...,  0.        ,\n",
        "          0.        ,  0.        ],\n",
        "        [ 0.        ,  0.        ,  0.        , ...,  0.        ,\n",
        "          0.0042735 ,  0.        ],\n",
        "        [ 0.        ,  0.        ,  0.        , ...,  0.        ,\n",
        "          0.        ,  0.        ]]),\n",
        " array([[ 0.        ,  0.        ,  0.        , ...,  0.        ,\n",
        "          0.        ,  0.        ],\n",
        "        [ 0.        ,  0.        ,  0.        , ...,  0.        ,\n",
        "          0.        ,  0.        ],\n",
        "        [ 0.        ,  0.        ,  0.        , ...,  0.        ,\n",
        "          0.        ,  0.        ],\n",
        "        ..., \n",
        "        [ 0.        ,  0.        ,  0.        , ...,  0.        ,\n",
        "          0.        ,  0.        ],\n",
        "        [ 0.        ,  0.        ,  0.        , ...,  0.        ,\n",
        "          0.        ,  0.        ],\n",
        "        [ 0.05952184,  0.07175167,  0.08474958, ...,  0.06678351,\n",
        "          0.        ,  0.0911276 ]]),\n",
        " array([[ 0.        ,  0.        ,  0.        , ...,  0.        ,\n",
        "          0.        ,  0.        ],\n",
        "        [ 0.        ,  0.        ,  0.        , ...,  0.        ,\n",
        "          0.        ,  0.        ],\n",
        "        [ 0.        ,  0.        ,  0.        , ...,  0.        ,\n",
        "          0.        ,  0.        ],\n",
        "        ..., \n",
        "        [ 0.        ,  0.        ,  0.        , ...,  0.        ,\n",
        "          0.        ,  0.        ],\n",
        "        [ 0.        ,  0.        ,  0.        , ...,  0.        ,\n",
        "          0.08896774,  0.        ],\n",
        "        [ 0.        ,  0.        ,  0.        , ...,  0.        ,\n",
        "          0.        ,  0.        ]])]"
       ]
      }
     ],
     "prompt_number": 31
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "l_pheno_proportions = []\n",
      "for i in range(R):\n",
      "    l_pheno_proportions.append(d_pheno_nonzero_labels[i]['PERCENT_PTS'])\n",
      "print l_pheno_proportions\n",
      "print sum(l_pheno_proportions)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "[0.1269337564458548, 0.09956366521221738, 0.12217374057913527, 0.09837366124553748, 0.08330027766759222, 0.11939706465688218, 0.07814359381197937, 0.09202697342324474, 0.0967869892899643, 0.12138040460134868, 0.07140023800079334, 0.11543038476794923, 0.10194367314557715, 0.14240380801269337, 0.08806029353431179, 0.09083696945656486, 0.09163030543435145, 0.09877032923443078, 0.09123363744545815, 0.08052360174533915, 0.11225704085680285, 0.10472034906783023, 0.11662038873462911, 0.0, 0.085680285600952, 0.11582705275684252, 0.061086870289567635, 0.12098373661245537, 0.09440698135660452, 0.09004363347877826, 0.09202697342324474, 0.10115033716779057, 0.09440698135660452, 0.0971836572788576, 0.11424038080126933, 0.09520031733439112, 0.09242364141213805, 0.11067036890122967, 0.10710035700119, 0.12376041253470844, 0.06743355811186037, 0.0, 0.10908369694565649, 0.096390321301071, 0.11106703689012297, 0.09758032526775089, 0.12653708845696152, 0.1384371281237604, 0.10908369694565649, 0.10472034906783023]\n",
        "4.90043633479\n"
       ]
      }
     ],
     "prompt_number": 65
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "d_pheno_nonzero_labels[2]"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 38,
       "text": [
        "{'JDRANGE_NAMES_NZ': [u'Disorders of lipoid metabolism',\n",
        "  u'Hypertensive disease',\n",
        "  u'Ischemic heart disease',\n",
        "  u'Other forms of heart disease',\n",
        "  u'Arthropathies and related disorders',\n",
        "  u'Rheumatism, excluding the back',\n",
        "  u'General symptoms',\n",
        "  u'Symptoms involving skin and other integumentary tissue',\n",
        "  u'Symptoms involving cardiovascular system',\n",
        "  u'Symptoms involving respiratory system and other chest symptoms',\n",
        "  u'Nonspecific findings on examination of blood',\n",
        "  u'Range name na'],\n",
        " 'JDRANGE_NZ': ['272-272.99',\n",
        "  '401-405.99',\n",
        "  '410-414.99',\n",
        "  '420-429.99',\n",
        "  '710-719.99',\n",
        "  '725-729.99',\n",
        "  '780-780.99',\n",
        "  '782-782.99',\n",
        "  '785-785.99',\n",
        "  '786-786.99',\n",
        "  '790-790.99',\n",
        "  'RANGE NA'],\n",
        " 'LAMBDA': 15230.183636550049,\n",
        " 'MEDS_NZ': [u'Adrenergic beta-1 Receptor Antagonists',\n",
        "  u'Angiotensin-Converting Enzyme Inhibitors',\n",
        "  u'Anti-Arrhythmia Agents',\n",
        "  u'Anti-Inflammatory Agents, Non-Steroidal',\n",
        "  u'Anticholesteremic Agents',\n",
        "  u'Antihypertensive Agents',\n",
        "  u'Antipyretics',\n",
        "  u'Calcium Channel Blockers',\n",
        "  u'Cyclooxygenase Inhibitors',\n",
        "  u'Diuretics',\n",
        "  u'Fibrinolytic Agents',\n",
        "  u'Hydroxymethylglutaryl-CoA Reductase Inhibitors',\n",
        "  u'Platelet Aggregation Inhibitors',\n",
        "  u'Sodium Chloride Symporter Inhibitors',\n",
        "  u'Sympatholytics',\n",
        "  u'Vasodilator Agents'],\n",
        " 'PERCENT_PTS': 0.12217374057913527}"
       ]
      }
     ],
     "prompt_number": 38
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "len(l_phenoNumbers_sorted_by_lambda)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 40,
       "text": [
        "49"
       ]
      }
     ],
     "prompt_number": 40
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "len(ktensor_phenotypes.lmbda)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 42,
       "text": [
        "50"
       ]
      }
     ],
     "prompt_number": 42
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "len(OrderedDict(zip(list(ktensor_phenotypes.lmbda),\n",
      "                                        list(range(R) )\n",
      "                                        ))\n",
      "    )"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 49,
       "text": [
        "49"
       ]
      }
     ],
     "prompt_number": 49
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "OrderedDict(zip(list(ktensor_phenotypes.lmbda), list(range(R) )))"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 52,
       "text": [
        "OrderedDict([(11833.835017718413, 0), (3256.8549500725103, 1), (15230.183636550049, 2), (4230.5114597274815, 3), (1303.7574543068242, 4), (16186.289553850198, 5), (2639.5333708157809, 6), (5559.467399264855, 7), (6177.7150562420202, 8), (13142.695101146264, 9), (738.67151481529254, 10), (8191.9663952561859, 11), (10042.924136329215, 12), (14356.204431782757, 13), (2792.2272641247509, 14), (3458.8431865962789, 15), (4453.1579142244655, 16), (8637.8721233181186, 17), (4830.4251924652517, 18), (6822.7840568037591, 19), (10143.626549702785, 20), (9814.3370139163617, 21), (10644.787098918441, 22), (1.0, 41), (6936.438416994346, 24), (7017.0241483601976, 25), (912.98450975162575, 26), (14398.627540075508, 27), (7573.6477373813659, 28), (3942.2034968950375, 29), (3301.2549956790908, 30), (6206.374021495637, 31), (6454.714009527238, 32), (2966.0399248618446, 33), (10956.184362436223, 34), (5387.772299769611, 35), (4012.3198970337166, 36), (5159.7206740354177, 37), (5363.0474943443269, 38), (8000.0803054785256, 39), (5773.099314063933, 40), (10289.820322355141, 42), (5795.7673115991593, 43), (14807.748109322352, 44), (8007.3848551375522, 45), (12967.757845354065, 46), (15273.233329944334, 47), (11354.176449731955, 48), (5511.1098663789235, 49)])"
       ]
      }
     ],
     "prompt_number": 52
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "d_lambda_phenoNumber = OrderedDict(zip( list(range(R)), \n",
      "                                        list(ktensor_phenotypes.lmbda)\n",
      "                                        ))"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 54
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "d_lambda_phenoNumber"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 55,
       "text": [
        "OrderedDict([(0, 11833.835017718413), (1, 3256.8549500725103), (2, 15230.183636550049), (3, 4230.5114597274815), (4, 1303.7574543068242), (5, 16186.289553850198), (6, 2639.5333708157809), (7, 5559.467399264855), (8, 6177.7150562420202), (9, 13142.695101146264), (10, 738.67151481529254), (11, 8191.9663952561859), (12, 10042.924136329215), (13, 14356.204431782757), (14, 2792.2272641247509), (15, 3458.8431865962789), (16, 4453.1579142244655), (17, 8637.8721233181186), (18, 4830.4251924652517), (19, 6822.7840568037591), (20, 10143.626549702785), (21, 9814.3370139163617), (22, 10644.787098918441), (23, 1.0), (24, 6936.438416994346), (25, 7017.0241483601976), (26, 912.98450975162575), (27, 14398.627540075508), (28, 7573.6477373813659), (29, 3942.2034968950375), (30, 3301.2549956790908), (31, 6206.374021495637), (32, 6454.714009527238), (33, 2966.0399248618446), (34, 10956.184362436223), (35, 5387.772299769611), (36, 4012.3198970337166), (37, 5159.7206740354177), (38, 5363.0474943443269), (39, 8000.0803054785256), (40, 5773.099314063933), (41, 1.0), (42, 10289.820322355141), (43, 5795.7673115991593), (44, 14807.748109322352), (45, 8007.3848551375522), (46, 12967.757845354065), (47, 15273.233329944334), (48, 11354.176449731955), (49, 5511.1098663789235)])"
       ]
      }
     ],
     "prompt_number": 55
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "import operator\n",
      "x = {1: 2, 3: 4, 4:3, 2:1, 0:0}\n",
      "sorted_x = sorted(x.iteritems(), key=operator.itemgetter(1))"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 56
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "sorted_x"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 57,
       "text": [
        "[(0, 0), (2, 1), (1, 2), (4, 3), (3, 4)]"
       ]
      }
     ],
     "prompt_number": 57
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "[x[0] for x in sorted_x]"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 59,
       "text": [
        "[0, 2, 1, 4, 3]"
       ]
      }
     ],
     "prompt_number": 59
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "d_lambda_phenoNumber = OrderedDict(zip( list(range(R)), \n",
      "                                        list(ktensor_phenotypes.lmbda)\n",
      "                                        ))\n",
      "l_phenoNumbers_sorted_by_lambda = [tup[0] for tup in sorted(d_lambda_phenoNumber.iteritems(), key=operator.itemgetter(1))]     "
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 60
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "##############################################################################################################\n",
      "\n",
      "#tensor with all phenotypes (factorization)\n",
      "ktensor_phenotypes = pheno_htn_subset_analyzed_REG_withGamma[0]\n",
      "l_pts = loaded_axisDict[0].keys()\n",
      "l_jdrange = loaded_axisDict[1].keys()\n",
      "l_meds= loaded_axisDict[2].keys()\n",
      "\n",
      "#will store all the data\n",
      "d_pheno_nonzero_labels = OrderedDict()\n",
      "\n",
      "\n",
      "#sort phenotypes by lambda values:\n",
      "d_lambda_phenoNumber = OrderedDict(zip( list(range(R)), \n",
      "                                        list(ktensor_phenotypes.lmbda)\n",
      "                                        ))\n",
      "l_phenoNumbers_sorted_by_lambda = [tup[0] for tup in sorted(d_lambda_phenoNumber.iteritems(), key=operator.itemgetter(1))]  #get a sorted list of phenotype numbers, which are sorted by using the operator.itemgetter                                \n",
      "\n",
      "#print phenotype feature names #################\n",
      "#for i in range(10):\n",
      "for i in l_phenoNumbers_sorted_by_lambda:\n",
      "    print \"===== phenotype \" + str(i) + \"=================================================================\"\n",
      "    pheno_outstream.write(\"===== phenotype \" + str(i) + \"=================================================================\" + '\\n')\n",
      "    this_lmbda = ktensor_phenotypes.lmbda[i]\n",
      "    this_pheno_pt_factor = ktensor_phenotypes.U[0][:,i]\n",
      "    this_pheno_jdrange_factor = ktensor_phenotypes.U[1][:,i]\n",
      "    this_pheno_med_factor = ktensor_phenotypes.U[2][:,i]\n",
      "    \n",
      "    this_pheno_pt_nnz = np.nonzero(this_pheno_pt_factor)[0]\n",
      "    this_pheno_jdrange_nnz = np.nonzero(this_pheno_jdrange_factor)[0]\n",
      "    this_pheno_med_nnz = np.nonzero(this_pheno_med_factor)[0]\n",
      "    \n",
      "    l_nonzero_pt_thisPheno = []\n",
      "    l_nonzero_meds_thisPheno = []\n",
      "    l_nonzero_jdrange_thisPheno = []\n",
      "    l_nonzero_jdrange_names_thisPheno = []\n",
      "    \n",
      "    for j in this_pheno_pt_nnz:\n",
      "        l_nonzero_pt_thisPheno.append(l_pts[j])\n",
      "    for j in this_pheno_jdrange_nnz:\n",
      "        l_nonzero_jdrange_thisPheno.append(l_jdrange[j])\n",
      "        l_nonzero_jdrange_names_thisPheno.append(d_jdrange_lookup[l_jdrange[j]])\n",
      "    for j in this_pheno_med_nnz:\n",
      "        l_nonzero_meds_thisPheno.append(l_meds[j])\n",
      "    \n",
      "    #data\n",
      "    d_pheno_nonzero_labels[i] = dict() #for phenotype i\n",
      "    d_pheno_nonzero_labels[i]['LAMBDA'] = this_lmbda #lambda value\n",
      "    d_pheno_nonzero_labels[i]['PERCENT_PTS'] = len(l_nonzero_pt_thisPheno) / float(len(this_pheno_pt_factor))\n",
      "    d_pheno_nonzero_labels[i]['MEDS_NZ'] = l_nonzero_meds_thisPheno #for phenotype i\n",
      "    d_pheno_nonzero_labels[i]['JDRANGE_NZ'] = l_nonzero_jdrange_thisPheno #for phenotype i   \n",
      "    d_pheno_nonzero_labels[i]['JDRANGE_NAMES_NZ'] = l_nonzero_jdrange_names_thisPheno #for phenotype i \n",
      "    \n",
      "    print \"proportion of pts: \" + str(d_pheno_nonzero_labels[i]['PERCENT_PTS'])\n",
      "    pheno_outstream.write(\"proportion of pts: \" + str(d_pheno_nonzero_labels[i]['PERCENT_PTS']) + '\\n')\n",
      "    print \"lambda: \" + str(this_lmbda)\n",
      "    pheno_outstream.write(\"lambda: \" + str(this_lmbda) + '\\n')\n",
      "    print \"----------------------------------------\" #divider\n",
      "    pheno_outstream.write(\"----------------------------------------\" + '\\n')\n",
      "    #print \"\\tnumber jdrange: \" + str(len(d_pheno_nonzero_labels[i]['JDRANGE_NZ']))\n",
      "    #print \"\\tjdrange: \" + str(d_pheno_nonzero_labels[i]['JDRANGE_NZ'])\n",
      "    for jdrange in d_pheno_nonzero_labels[i]['JDRANGE_NZ']:\n",
      "        print d_jdrange_lookup[jdrange]\n",
      "        pheno_outstream.write(str(d_jdrange_lookup[jdrange]) + '\\n')\n",
      "    #print \"\\tnumber meds: \" + str(len(d_pheno_nonzero_labels[i]['MEDS_NZ']))\n",
      "    #print \"\\tmeds: \" + str(d_pheno_nonzero_labels[i]['MEDS_NZ'])\n",
      "    print \"----------------------------------------\" #divider between diagnostic codes and meds\n",
      "    pheno_outstream.write(\"----------------------------------------\" + '\\n')\n",
      "    for med in d_pheno_nonzero_labels[i]['MEDS_NZ']:\n",
      "        print med   \n",
      "        pheno_outstream.write(med + '\\n')\n",
      "pheno_outstream.close()"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "===== phenotype 23=================================================================\n"
       ]
      },
      {
       "ename": "ValueError",
       "evalue": "I/O operation on closed file",
       "output_type": "pyerr",
       "traceback": [
        "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m\n\u001b[0;31mValueError\u001b[0m                                Traceback (most recent call last)",
        "\u001b[0;32m<ipython-input-63-6bcdfc8550e8>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m()\u001b[0m\n\u001b[1;32m     21\u001b[0m \u001b[0;32mfor\u001b[0m \u001b[0mi\u001b[0m \u001b[0;32min\u001b[0m \u001b[0ml_phenoNumbers_sorted_by_lambda\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     22\u001b[0m     \u001b[0;32mprint\u001b[0m \u001b[0;34m\"===== phenotype \"\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0mstr\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mi\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0;34m\"=================================================================\"\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 23\u001b[0;31m     \u001b[0mpheno_outstream\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mwrite\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"===== phenotype \"\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0mstr\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mi\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0;34m\"=================================================================\"\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0;34m'\\n'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     24\u001b[0m     \u001b[0mthis_lmbda\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mktensor_phenotypes\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mlmbda\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mi\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     25\u001b[0m     \u001b[0mthis_pheno_pt_factor\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mktensor_phenotypes\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mU\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;36m0\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0mi\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
        "\u001b[0;31mValueError\u001b[0m: I/O operation on closed file"
       ]
      }
     ],
     "prompt_number": 63
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "#write output file\n",
      "pheno_outstream = open(pickle_folder + \"phenotypes\"+gamma_str+\".out\", 'w+')\n",
      "    \n",
      "\n",
      "##############################################################################################################\n",
      "\n",
      "#tensor with all phenotypes (factorization)\n",
      "ktensor_phenotypes = pheno_htn_subset_analyzed_REG_withGamma[0]\n",
      "l_pts = loaded_axisDict[0].keys()\n",
      "l_jdrange = loaded_axisDict[1].keys()\n",
      "l_meds= loaded_axisDict[2].keys()\n",
      "\n",
      "#will store all the data\n",
      "d_pheno_nonzero_labels = OrderedDict()\n",
      "\n",
      "\n",
      "#sort phenotypes by lambda values:\n",
      "d_lambda_phenoNumber = OrderedDict(zip( list(range(R)), \n",
      "                                        list(ktensor_phenotypes.lmbda)\n",
      "                                        ))\n",
      "l_phenoNumbers_sorted_by_lambda = [tup[0] for tup in sorted(d_lambda_phenoNumber.iteritems(), key=operator.itemgetter(1))]  #get a sorted list of phenotype numbers, which are sorted by using the operator.itemgetter                                \n",
      "\n",
      "#print phenotype feature names #################\n",
      "#for i in range(10):\n",
      "for i in l_phenoNumbers_sorted_by_lambda:\n",
      "    print \"===== phenotype \" + str(i) + \"=================================================================\"\n",
      "    pheno_outstream.write(\"===== phenotype \" + str(i) + \"=================================================================\" + '\\n')\n",
      "    this_lmbda = ktensor_phenotypes.lmbda[i]\n",
      "    this_pheno_pt_factor = ktensor_phenotypes.U[0][:,i]\n",
      "    this_pheno_jdrange_factor = ktensor_phenotypes.U[1][:,i]\n",
      "    this_pheno_med_factor = ktensor_phenotypes.U[2][:,i]\n",
      "    \n",
      "    this_pheno_pt_nnz = np.nonzero(this_pheno_pt_factor)[0]\n",
      "    this_pheno_jdrange_nnz = np.nonzero(this_pheno_jdrange_factor)[0]\n",
      "    this_pheno_med_nnz = np.nonzero(this_pheno_med_factor)[0]\n",
      "    \n",
      "    l_nonzero_pt_thisPheno = []\n",
      "    l_nonzero_meds_thisPheno = []\n",
      "    l_nonzero_jdrange_thisPheno = []\n",
      "    l_nonzero_jdrange_names_thisPheno = []\n",
      "    \n",
      "    for j in this_pheno_pt_nnz:\n",
      "        l_nonzero_pt_thisPheno.append(l_pts[j])\n",
      "    for j in this_pheno_jdrange_nnz:\n",
      "        l_nonzero_jdrange_thisPheno.append(l_jdrange[j])\n",
      "        l_nonzero_jdrange_names_thisPheno.append(d_jdrange_lookup[l_jdrange[j]])\n",
      "    for j in this_pheno_med_nnz:\n",
      "        l_nonzero_meds_thisPheno.append(l_meds[j])\n",
      "    \n",
      "    #data\n",
      "    d_pheno_nonzero_labels[i] = dict() #for phenotype i\n",
      "    d_pheno_nonzero_labels[i]['LAMBDA'] = this_lmbda #lambda value\n",
      "    d_pheno_nonzero_labels[i]['PERCENT_PTS'] = len(l_nonzero_pt_thisPheno) / float(len(this_pheno_pt_factor))\n",
      "    d_pheno_nonzero_labels[i]['MEDS_NZ'] = l_nonzero_meds_thisPheno #for phenotype i\n",
      "    d_pheno_nonzero_labels[i]['JDRANGE_NZ'] = l_nonzero_jdrange_thisPheno #for phenotype i   \n",
      "    d_pheno_nonzero_labels[i]['JDRANGE_NAMES_NZ'] = l_nonzero_jdrange_names_thisPheno #for phenotype i \n",
      "    \n",
      "    print \"proportion of pts: \" + str(d_pheno_nonzero_labels[i]['PERCENT_PTS'])\n",
      "    pheno_outstream.write(\"proportion of pts: \" + str(d_pheno_nonzero_labels[i]['PERCENT_PTS']) + '\\n')\n",
      "    print \"lambda: \" + str(this_lmbda)\n",
      "    pheno_outstream.write(\"lambda: \" + str(this_lmbda) + '\\n')\n",
      "    print \"----------------------------------------\" #divider\n",
      "    pheno_outstream.write(\"----------------------------------------\" + '\\n')\n",
      "    #print \"\\tnumber jdrange: \" + str(len(d_pheno_nonzero_labels[i]['JDRANGE_NZ']))\n",
      "    #print \"\\tjdrange: \" + str(d_pheno_nonzero_labels[i]['JDRANGE_NZ'])\n",
      "    for jdrange in d_pheno_nonzero_labels[i]['JDRANGE_NZ']:\n",
      "        print d_jdrange_lookup[jdrange]\n",
      "        pheno_outstream.write(str(d_jdrange_lookup[jdrange]) + '\\n')\n",
      "    #print \"\\tnumber meds: \" + str(len(d_pheno_nonzero_labels[i]['MEDS_NZ']))\n",
      "    #print \"\\tmeds: \" + str(d_pheno_nonzero_labels[i]['MEDS_NZ'])\n",
      "    print \"----------------------------------------\" #divider between diagnostic codes and meds\n",
      "    pheno_outstream.write(\"----------------------------------------\" + '\\n')\n",
      "    for med in d_pheno_nonzero_labels[i]['MEDS_NZ']:\n",
      "        print med   \n",
      "        pheno_outstream.write(med + '\\n')\n",
      "pheno_outstream.close()"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "===== phenotype 23=================================================================\n",
        "proportion of pts: 0.0\n",
        "lambda: 1.0\n",
        "----------------------------------------\n",
        "----------------------------------------\n",
        "===== phenotype 41=================================================================\n",
        "proportion of pts: 0.0\n",
        "lambda: 1.0\n",
        "----------------------------------------\n",
        "----------------------------------------\n",
        "===== phenotype 10=================================================================\n",
        "proportion of pts: 0.0714002380008\n",
        "lambda: 738.671514815\n",
        "----------------------------------------\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Pain\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Pneumonia and influenza\n",
        "Other diseases of respiratory system\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Anxiety Agents\n",
        "===== phenotype 26=================================================================\n",
        "proportion of pts: 0.0610868702896\n",
        "lambda: 912.984509752\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Cerebrovascular disease\n",
        "Diseases of arteries, arterioles, and capillaries\n",
        "Other diseases of respiratory system\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Surface-Active Agents\n",
        "===== phenotype 4=================================================================\n",
        "proportion of pts: 0.0833002776676\n",
        "lambda: 1303.75745431\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Overweight, obesity and other hyperalimentation\n",
        "Anemias\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Organic sleep disorders\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Dorsopathies\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "----------------------------------------\n",
        "Antihypertensive Agents\n",
        "Calcium Channel Blockers\n",
        "===== phenotype 6=================================================================\n",
        "proportion of pts: 0.078143593812\n",
        "lambda: 2639.53337082\n",
        "----------------------------------------\n",
        "Overweight, obesity and other hyperalimentation\n",
        "Na\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Organic sleep disorders\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of intestines and peritoneum\n",
        "Other diseases of urinary system\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Anxiety Agents\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antihypertensive Agents\n",
        "Serotonin Uptake Inhibitors\n",
        "===== phenotype 14=================================================================\n",
        "proportion of pts: 0.0880602935343\n",
        "lambda: 2792.22726412\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Anemias\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of intestines and peritoneum\n",
        "Nephritis, nephrotic syndrome, and nephrosis\n",
        "Other diseases of urinary system\n",
        "Operations on the musculoskeletal system\n",
        "Symptoms involving urinary system\n",
        "Nonspecific findings on examination of blood\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Antihypertensive Agents\n",
        "Antirheumatic Agents\n",
        "Dermatologic Agents\n",
        "Enzyme Inhibitors\n",
        "Immunosuppressive Agents\n",
        "===== phenotype 33=================================================================\n",
        "proportion of pts: 0.0971836572789\n",
        "lambda: 2966.03992486\n",
        "----------------------------------------\n",
        "Other disorders of the central nervous system\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Pneumonia and influenza\n",
        "Other diseases of respiratory system\n",
        "Other diseases of urinary system\n",
        "General symptoms\n",
        "Symptoms involving nervous and musculoskeletal systems\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving urinary system\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\n",
        "Anti-Bacterial Agents\n",
        "Antihypertensive Agents\n",
        "Bronchodilator Agents\n",
        "===== phenotype 1=================================================================\n",
        "proportion of pts: 0.0995636652122\n",
        "lambda: 3256.85495007\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Gout\n",
        "Organic sleep disorders\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Arthropathies and related disorders\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Nonspecific findings on examination of blood\n",
        "Abnormal results of function studies\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Analgesics\n",
        "Antihypertensive Agents\n",
        "Calcium Channel Blockers\n",
        "Vasodilator Agents\n",
        "===== phenotype 30=================================================================\n",
        "proportion of pts: 0.0920269734232\n",
        "lambda: 3301.25499568\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Other diseases of respiratory system\n",
        "General symptoms\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Antimetabolites, Antineoplastic\n",
        "Antirheumatic Agents\n",
        "Dermatologic Agents\n",
        "Enzyme Inhibitors\n",
        "Immunosuppressive Agents\n",
        "===== phenotype 15=================================================================\n",
        "proportion of pts: 0.0908369694566\n",
        "lambda: 3458.8431866\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Organic sleep disorders\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of urinary system\n",
        "Diseases of male genital organs\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving urinary system\n",
        "Nonspecific findings on examination of blood\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Ulcer Agents\n",
        "Bronchodilator Agents\n",
        "===== phenotype 29=================================================================\n",
        "proportion of pts: 0.0900436334788\n",
        "lambda: 3942.2034969\n",
        "----------------------------------------\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Other diseases of the blood\n",
        "Hypertensive disease\n",
        "Liver\n",
        "Other diseases of urinary system\n",
        "Dorsopathies\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving digestive system\n",
        "Symptoms involving urinary system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Nonspecific findings on examination of blood\n",
        "----------------------------------------\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Vasodilator Agents\n",
        "===== phenotype 36=================================================================\n",
        "proportion of pts: 0.0924236414121\n",
        "lambda: 4012.31989703\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Pain\n",
        "Other disorders of the central nervous system\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Other diseases of urinary system\n",
        "Other disorders of female genital tract\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving urinary system\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Analgesics, Non-Narcotic\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Estrogens\n",
        "===== phenotype 3=================================================================\n",
        "proportion of pts: 0.0983736612455\n",
        "lambda: 4230.51145973\n",
        "----------------------------------------\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of intestines and peritoneum\n",
        "Other diseases of digestive system\n",
        "Other diseases of urinary system\n",
        "Symptoms involving digestive system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Certain traumatic complications and unspecified injuries\n",
        "Complications of surgical and medical care, not elsewhere classified\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Analgesics, Opioid\n",
        "Anti-Anxiety Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Hypnotics and Sedatives\n",
        "Narcotics\n",
        "===== phenotype 16=================================================================\n",
        "proportion of pts: 0.0916303054344\n",
        "lambda: 4453.15791422\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Pneumonia and influenza\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Other diseases of respiratory system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic beta-2 Receptor Agonists\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Bronchodilator Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Tocolytic Agents\n",
        "Vasodilator Agents\n",
        "===== phenotype 18=================================================================\n",
        "proportion of pts: 0.0912336374455\n",
        "lambda: 4830.42519247\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Na\n",
        "Disorders of the peripheral nervous system\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Analgesics\n",
        "Anti-Anxiety Agents\n",
        "Anticonvulsants\n",
        "Antihypertensive Agents\n",
        "Antiparkinson Agents\n",
        "Excitatory Amino Acid Antagonists\n",
        "Serotonin Uptake Inhibitors\n",
        "===== phenotype 37=================================================================\n",
        "proportion of pts: 0.110670368901\n",
        "lambda: 5159.72067404\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Na\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Drug dependence\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "----------------------------------------\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Serotonin Uptake Inhibitors\n",
        "===== phenotype 38=================================================================\n",
        "proportion of pts: 0.107100357001\n",
        "lambda: 5363.04749434\n",
        "----------------------------------------\n",
        "Mycoses\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Anemias\n",
        "Disorders of the peripheral nervous system\n",
        "Hypertensive disease\n",
        "Nephritis, nephrotic syndrome, and nephrosis\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Certain traumatic complications and unspecified injuries\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Analgesics\n",
        "Anticholesteremic Agents\n",
        "Anticonvulsants\n",
        "Antihypertensive Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypoglycemic Agents\n",
        "===== phenotype 35=================================================================\n",
        "proportion of pts: 0.0952003173344\n",
        "lambda: 5387.77229977\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of urinary system\n",
        "Other disorders of female genital tract\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic beta-2 Receptor Agonists\n",
        "Anti-Allergic Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Ulcer Agents\n",
        "Antihypertensive Agents\n",
        "Bronchodilator Agents\n",
        "Estrogens\n",
        "Proton Pump Inhibitors\n",
        "===== phenotype 49=================================================================\n",
        "proportion of pts: 0.104720349068\n",
        "lambda: 5511.10986638\n",
        "----------------------------------------\n",
        "Anemias\n",
        "Organic sleep disorders\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Acute respiratory infections\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Arthropathies and related disorders\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\n",
        "Anti-Inflammatory Agents\n",
        "Antihypertensive Agents\n",
        "Bronchodilator Agents\n",
        "Diuretics\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "===== phenotype 7=================================================================\n",
        "proportion of pts: 0.0920269734232\n",
        "lambda: 5559.46739926\n",
        "----------------------------------------\n",
        "Malignant neoplasm of breast\n",
        "Disorders of thyroid gland\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Antineoplastic Agents, Hormonal\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Hypnotics and Sedatives\n",
        "Vitamins\n",
        "===== phenotype 40=================================================================\n",
        "proportion of pts: 0.0674335581119\n",
        "lambda: 5773.09931406\n",
        "----------------------------------------\n",
        "nan\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Drug dependence\n",
        "Operations on the cardiovascular system\n",
        "Other forms of heart disease\n",
        "Diseases of arteries, arterioles, and capillaries\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Other diseases of respiratory system\n",
        "Operations on the musculoskeletal system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Nonspecific findings on examination of blood\n",
        "Miscellaneous diagnostic and therapeutic procedures\n",
        "----------------------------------------\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "===== phenotype 43=================================================================\n",
        "proportion of pts: 0.0963903213011\n",
        "lambda: 5795.7673116\n",
        "----------------------------------------\n",
        "Benign neoplasm of other parts of digestive system\n",
        "Diseases of other endocrine glands\n",
        "Disorders of lipoid metabolism\n",
        "Coagulation or hemorrhagic diseases\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Other diseases of intestines and peritoneum\n",
        "Infections of skin and subcutaneous tissue\n",
        "General symptoms\n",
        "Symptoms concerning nutrition, metabolism, and development\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Diuretics\n",
        "Fibrinolytic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Vasodilator Agents\n",
        "===== phenotype 8=================================================================\n",
        "proportion of pts: 0.09678698929\n",
        "lambda: 6177.71505624\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Hernia of abdominal cavity\n",
        "Dorsopathies\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Anxiety Agents\n",
        "Anti-Ulcer Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "GABA Modulators\n",
        "Hypnotics and Sedatives\n",
        "Proton Pump Inhibitors\n",
        "===== phenotype 31=================================================================\n",
        "proportion of pts: 0.101150337168\n",
        "lambda: 6206.3740215\n",
        "----------------------------------------\n",
        "Other bacterial diseases\n",
        "Malignant neoplasm of male and female genital organs\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Diseases of arteries, arterioles, and capillaries\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Other diseases of intestines and peritoneum\n",
        "Other diseases of urinary system\n",
        "Diseases of male genital organs\n",
        "Symptoms involving cardiovascular system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Other and unspecified effects of external causes\n",
        "----------------------------------------\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Vasodilator Agents\n",
        "===== phenotype 32=================================================================\n",
        "proportion of pts: 0.0944069813566\n",
        "lambda: 6454.71400953\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Diseases of oral cavity, salivary glands, and jaws\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Sprains and strains of joints and adjacent muscles\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anesthetics, Local\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Bronchodilator Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Vasodilator Agents\n",
        "===== phenotype 19=================================================================\n",
        "proportion of pts: 0.0805236017453\n",
        "lambda: 6822.7840568\n",
        "----------------------------------------\n",
        "Disorders of thyroid gland\n",
        "Diabetes\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Other diseases of the upper respiratory tract\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving digestive system\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Abortifacient Agents, Nonsteroidal\n",
        "Anti-Allergic Agents\n",
        "Anti-Inflammatory Agents\n",
        "Antimetabolites, Antineoplastic\n",
        "Antirheumatic Agents\n",
        "Bronchodilator Agents\n",
        "Dermatologic Agents\n",
        "Enzyme Inhibitors\n",
        "Folic Acid Antagonists\n",
        "Immunosuppressive Agents\n",
        "Nucleic Acid Synthesis Inhibitors\n",
        "===== phenotype 24=================================================================\n",
        "proportion of pts: 0.085680285601\n",
        "lambda: 6936.43841699\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Abortifacient Agents, Nonsteroidal\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Antimetabolites, Antineoplastic\n",
        "Antirheumatic Agents\n",
        "Dermatologic Agents\n",
        "Enzyme Inhibitors\n",
        "Folic Acid Antagonists\n",
        "Immunosuppressive Agents\n",
        "Nucleic Acid Synthesis Inhibitors\n",
        "Sympatholytics\n",
        "===== phenotype 25=================================================================\n",
        "proportion of pts: 0.115827052757\n",
        "lambda: 7017.02414836\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the peripheral nervous system\n",
        "Hypertensive disease\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Bronchodilator Agents\n",
        "Calcium Channel Blockers\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Glucocorticoids\n",
        "===== phenotype 28=================================================================\n",
        "proportion of pts: 0.0944069813566\n",
        "lambda: 7573.64773738\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Cerebrovascular disease\n",
        "Acute respiratory infections\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Explosive Agents\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypolipidemic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Vasodilator Agents\n",
        "===== phenotype 39=================================================================\n",
        "proportion of pts: 0.123760412535\n",
        "lambda: 8000.08030548\n",
        "----------------------------------------\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Anemias\n",
        "Na\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Arthropathies and related disorders\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Antioxidants\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Dermatologic Agents\n",
        "Serotonin Uptake Inhibitors\n",
        "Vitamin B Complex\n",
        "Vitamins\n",
        "===== phenotype 45=================================================================\n",
        "proportion of pts: 0.0975803252678\n",
        "lambda: 8007.38485514\n",
        "----------------------------------------\n",
        "Benign neoplasm of skin\n",
        "Neoplasm of uncertain behavior of other sites & tissues\n",
        "Disorders of thyroid gland\n",
        "Disorders of lipoid metabolism\n",
        "Neurotic, personality, nonpsychotic disorders\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Bronchodilator Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "===== phenotype 11=================================================================\n",
        "proportion of pts: 0.115430384768\n",
        "lambda: 8191.96639526\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Analgesics, Opioid\n",
        "Anti-Infective Agents\n",
        "Anti-Infective Agents, Local\n",
        "Anti-Infective Agents, Urinary\n",
        "Antifungal Agents\n",
        "Antimalarials\n",
        "Antirheumatic Agents\n",
        "Enzyme Inhibitors\n",
        "Gastrointestinal Agents\n",
        "Immunosuppressive Agents\n",
        "Narcotics\n",
        "===== phenotype 17=================================================================\n",
        "proportion of pts: 0.0987703292344\n",
        "lambda: 8637.87212332\n",
        "----------------------------------------\n",
        "Benign neoplasm of other parts of digestive system\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Gout\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Diseases of male genital organs\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic alpha-1 Receptor Antagonists\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Antimetabolites\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Enzyme Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Free Radical Scavengers\n",
        "Gout Suppressants\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Vasodilator Agents\n",
        "===== phenotype 21=================================================================\n",
        "proportion of pts: 0.104720349068\n",
        "lambda: 9814.33701392\n",
        "----------------------------------------\n",
        "Anemias\n",
        "Disorders of the peripheral nervous system\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of urinary system\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving urinary system\n",
        "Fractures\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Analgesics\n",
        "Anti-Anxiety Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticonvulsants\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Calcium Channel Blockers\n",
        "Cyclooxygenase Inhibitors\n",
        "Serotonin Uptake Inhibitors\n",
        "===== phenotype 12=================================================================\n",
        "proportion of pts: 0.101943673146\n",
        "lambda: 10042.9241363\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Organic sleep disorders\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Acute respiratory infections\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Anticoagulants\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypolipidemic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Rodenticides\n",
        "Sympatholytics\n",
        "===== phenotype 20=================================================================\n",
        "proportion of pts: 0.112257040857\n",
        "lambda: 10143.6265497\n",
        "----------------------------------------\n",
        "Malignant neoplasm of skin\n",
        "Neoplasm of uncertain behavior of other sites & tissues\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Infections of skin and subcutaneous tissue\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Fibrinolytic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "===== phenotype 42=================================================================\n",
        "proportion of pts: 0.109083696946\n",
        "lambda: 10289.8203224\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Analgesics\n",
        "Anti-Anxiety Agents\n",
        "Anticonvulsants\n",
        "Antidepressive Agents, Second-Generation\n",
        "Antiemetics\n",
        "GABA Modulators\n",
        "Histamine H1 Antagonists\n",
        "Hypnotics and Sedatives\n",
        "Serotonin Uptake Inhibitors\n",
        "===== phenotype 22=================================================================\n",
        "proportion of pts: 0.116620388735\n",
        "lambda: 10644.7870989\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Chronic obstructive pulmonary disease and allied conditions\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Dorsopathies\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "----------------------------------------\n",
        "Adrenergic beta-2 Receptor Agonists\n",
        "Anti-Allergic Agents\n",
        "Anti-Bacterial Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Ulcer Agents\n",
        "Antihypertensive Agents\n",
        "Bronchodilator Agents\n",
        "Dermatologic Agents\n",
        "Glucocorticoids\n",
        "Histamine H1 Antagonists, Non-Sedating\n",
        "Lipoxygenase Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "===== phenotype 34=================================================================\n",
        "proportion of pts: 0.114240380801\n",
        "lambda: 10956.1843624\n",
        "----------------------------------------\n",
        "Disorders of thyroid gland\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Other forms of heart disease\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Arrhythmia Agents\n",
        "Anticholesteremic Agents\n",
        "Anticoagulants\n",
        "Antihypertensive Agents\n",
        "Calcium Channel Blockers\n",
        "Diuretics\n",
        "Rodenticides\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Vasodilator Agents\n",
        "===== phenotype 48=================================================================\n",
        "proportion of pts: 0.109083696946\n",
        "lambda: 11354.1764497\n",
        "----------------------------------------\n",
        "Disorders of thyroid gland\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving digestive system\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Nonspecific findings on examination of blood\n",
        "----------------------------------------\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "===== phenotype 0=================================================================\n",
        "proportion of pts: 0.126933756446\n",
        "lambda: 11833.8350177\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Hereditary and degenerative diseases of the central nervous system\n",
        "Hypertensive disease\n",
        "Cerebrovascular disease\n",
        "Other diseases of urinary system\n",
        "Diseases of male genital organs\n",
        "Arthropathies and related disorders\n",
        "Dorsopathies\n",
        "General symptoms\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving urinary system\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypolipidemic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Vasodilator Agents\n",
        "===== phenotype 46=================================================================\n",
        "proportion of pts: 0.126537088457\n",
        "lambda: 12967.7578454\n",
        "----------------------------------------\n",
        "Disorders of thyroid gland\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Overweight, obesity and other hyperalimentation\n",
        "Organic sleep disorders\n",
        "Hypertensive disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Dorsopathies\n",
        "General symptoms\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Other symptoms involving abdomen and pelvis\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Calcium Channel Blockers\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Vasodilator Agents\n",
        "===== phenotype 9=================================================================\n",
        "proportion of pts: 0.121380404601\n",
        "lambda: 13142.6951011\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Organic sleep disorders\n",
        "Disorders of the eye and adnexa\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Other diseases of the upper respiratory tract\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving urinary system\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "===== phenotype 13=================================================================\n",
        "proportion of pts: 0.142403808013\n",
        "lambda: 14356.2044318\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Dorsopathies\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Sympatholytics\n",
        "Vasodilator Agents\n",
        "===== phenotype 27=================================================================\n",
        "proportion of pts: 0.120983736612\n",
        "lambda: 14398.6275401\n",
        "----------------------------------------\n",
        "Nutritional deficiencies\n",
        "Disorders of lipoid metabolism\n",
        "Anemias\n",
        "Disorders of the eye and adnexa\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Other diseases of intestines and peritoneum\n",
        "Dorsopathies\n",
        "General symptoms\n",
        "Symptoms involving head and neck\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Symptoms involving urinary system\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Allergic Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Antihypertensive Agents\n",
        "Antioxidants\n",
        "Antipyretics\n",
        "Bone Density Conservation Agents\n",
        "Calcium Channel Blockers\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Vasodilator Agents\n",
        "Vitamins\n",
        "===== phenotype 44=================================================================\n",
        "proportion of pts: 0.11106703689\n",
        "lambda: 14807.7481093\n",
        "----------------------------------------\n",
        "Mycoses\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Diseases of esophagus, stomach, and duodenum\n",
        "Other diseases of intestines and peritoneum\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\n",
        "Other diseases of skin and subcutaneous tissue\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anti-Ulcer Agents\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cardiotonic Agents\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypolipidemic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Proton Pump Inhibitors\n",
        "===== phenotype 2=================================================================\n",
        "proportion of pts: 0.122173740579\n",
        "lambda: 15230.1836366\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "General symptoms\n",
        "Symptoms involving skin and other integumentary tissue\n",
        "Symptoms involving cardiovascular system\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Nonspecific findings on examination of blood\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Angiotensin-Converting Enzyme Inhibitors\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Calcium Channel Blockers\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Platelet Aggregation Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Vasodilator Agents\n",
        "===== phenotype 47=================================================================\n",
        "proportion of pts: 0.138437128124\n",
        "lambda: 15273.2333299\n",
        "----------------------------------------\n",
        "Diabetes\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of the eye and adnexa\n",
        "Diseases of the ear and mastoid process\n",
        "Hypertensive disease\n",
        "Acute respiratory infections\n",
        "Other diseases of the upper respiratory tract\n",
        "Arthropathies and related disorders\n",
        "Rheumatism, excluding the back\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\n",
        "Anti-Inflammatory Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypoglycemic Agents\n",
        "Hypolipidemic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Sodium Chloride Symporter Inhibitors\n",
        "Vasodilator Agents\n",
        "===== phenotype 5=================================================================\n",
        "proportion of pts: 0.119397064657\n",
        "lambda: 16186.2895539\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\n",
        "Disorders of fluid, electrolyte, and acid-base balance\n",
        "Anemias\n",
        "Disorders of the eye and adnexa\n",
        "Hypertensive disease\n",
        "Ischemic heart disease\n",
        "Other forms of heart disease\n",
        "Other diseases of respiratory system\n",
        "Nephritis, nephrotic syndrome, and nephrosis\n",
        "Symptoms involving respiratory system and other chest symptoms\n",
        "Range name na\n",
        "----------------------------------------\n",
        "Adrenergic beta-1 Receptor Antagonists\n",
        "Anti-Arrhythmia Agents\n",
        "Anti-Inflammatory Agents, Non-Steroidal\n",
        "Anticholesteremic Agents\n",
        "Antihypertensive Agents\n",
        "Antipyretics\n",
        "Cyclooxygenase Inhibitors\n",
        "Diuretics\n",
        "Fibrinolytic Agents\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\n",
        "Hypolipidemic Agents\n",
        "Platelet Aggregation Inhibitors\n",
        "Sodium Potassium Chloride Symporter Inhibitors\n",
        "Sympatholytics\n",
        "Vasodilator Agents\n"
       ]
      }
     ],
     "prompt_number": 64
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "this_pheno_pt_nnz"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 66,
       "text": [
        "array([   3,    5,   16,   52,   56,   62,   68,   69,   93,   96,  100,\n",
        "        107,  109,  117,  130,  139,  140,  142,  156,  165,  171,  191,\n",
        "        197,  205,  208,  224,  239,  257,  271,  272,  282,  297,  308,\n",
        "        309,  312,  327,  330,  333,  335,  336,  349,  366,  368,  369,\n",
        "        402,  409,  412,  431,  437,  442,  446,  486,  501,  505,  507,\n",
        "        540,  545,  549,  558,  559,  561,  564,  567,  568,  574,  583,\n",
        "        591,  596,  601,  610,  624,  630,  632,  647,  671,  676,  680,\n",
        "        681,  703,  708,  710,  713,  717,  721,  726,  728,  736,  739,\n",
        "        744,  745,  752,  772,  774,  781,  782,  786,  799,  810,  814,\n",
        "        816,  820,  824,  830,  838,  848,  861,  873,  875,  877,  882,\n",
        "        899,  901,  904,  908,  925,  930,  949,  954,  959,  979,  980,\n",
        "        984,  990,  993, 1002, 1049, 1067, 1071, 1085, 1105, 1112, 1115,\n",
        "       1119, 1141, 1152, 1156, 1160, 1161, 1167, 1187, 1192, 1202, 1216,\n",
        "       1244, 1260, 1268, 1269, 1274, 1286, 1302, 1304, 1305, 1307, 1327,\n",
        "       1337, 1352, 1364, 1372, 1375, 1400, 1408, 1414, 1415, 1420, 1428,\n",
        "       1441, 1451, 1454, 1464, 1476, 1479, 1481, 1486, 1489, 1507, 1510,\n",
        "       1517, 1518, 1523, 1524, 1528, 1529, 1555, 1559, 1560, 1565, 1568,\n",
        "       1580, 1583, 1590, 1596, 1598, 1601, 1605, 1608, 1611, 1622, 1628,\n",
        "       1638, 1644, 1649, 1650, 1658, 1673, 1682, 1684, 1695, 1698, 1709,\n",
        "       1711, 1730, 1743, 1756, 1758, 1765, 1772, 1778, 1786, 1793, 1795,\n",
        "       1800, 1807, 1810, 1812, 1820, 1835, 1839, 1840, 1875, 1892, 1899,\n",
        "       1901, 1907, 1911, 1915, 1926, 1929, 1937, 1938, 1943, 1954, 1960,\n",
        "       1964, 1969, 1970, 2008, 2011, 2016, 2038, 2044, 2046, 2047, 2052,\n",
        "       2054, 2100, 2103, 2115, 2123, 2125, 2131, 2169, 2175, 2177, 2183,\n",
        "       2184, 2198, 2201, 2204, 2206, 2214, 2225, 2237, 2241, 2260, 2263,\n",
        "       2285, 2286, 2291, 2293, 2300, 2301, 2312, 2331, 2340, 2364, 2376,\n",
        "       2377, 2385, 2405, 2406, 2426, 2440, 2442, 2444, 2461, 2479, 2487,\n",
        "       2491, 2498, 2502, 2518])"
       ]
      }
     ],
     "prompt_number": 66
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "this_pheno_jdrange_nnz"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 67,
       "text": [
        "array([ 65,  69,  73,  91,  96,  97, 100, 109, 121, 153, 186])"
       ]
      }
     ],
     "prompt_number": 67
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "l_nonzero_pt_thisPheno"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 68,
       "text": [
        "[3,\n",
        " 5,\n",
        " 16,\n",
        " 52,\n",
        " 56,\n",
        " 62,\n",
        " 68,\n",
        " 69,\n",
        " 93,\n",
        " 96,\n",
        " 100,\n",
        " 107,\n",
        " 109,\n",
        " 117,\n",
        " 130,\n",
        " 139,\n",
        " 140,\n",
        " 142,\n",
        " 156,\n",
        " 165,\n",
        " 171,\n",
        " 191,\n",
        " 197,\n",
        " 205,\n",
        " 208,\n",
        " 224,\n",
        " 239,\n",
        " 257,\n",
        " 271,\n",
        " 272,\n",
        " 282,\n",
        " 297,\n",
        " 308,\n",
        " 309,\n",
        " 312,\n",
        " 327,\n",
        " 330,\n",
        " 333,\n",
        " 335,\n",
        " 336,\n",
        " 349,\n",
        " 366,\n",
        " 368,\n",
        " 369,\n",
        " 402,\n",
        " 409,\n",
        " 412,\n",
        " 431,\n",
        " 437,\n",
        " 442,\n",
        " 446,\n",
        " 486,\n",
        " 501,\n",
        " 505,\n",
        " 507,\n",
        " 540,\n",
        " 545,\n",
        " 549,\n",
        " 558,\n",
        " 559,\n",
        " 561,\n",
        " 564,\n",
        " 567,\n",
        " 568,\n",
        " 574,\n",
        " 583,\n",
        " 591,\n",
        " 596,\n",
        " 601,\n",
        " 610,\n",
        " 624,\n",
        " 630,\n",
        " 632,\n",
        " 647,\n",
        " 671,\n",
        " 676,\n",
        " 680,\n",
        " 681,\n",
        " 703,\n",
        " 708,\n",
        " 710,\n",
        " 713,\n",
        " 717,\n",
        " 721,\n",
        " 726,\n",
        " 728,\n",
        " 736,\n",
        " 739,\n",
        " 744,\n",
        " 745,\n",
        " 752,\n",
        " 772,\n",
        " 774,\n",
        " 781,\n",
        " 782,\n",
        " 786,\n",
        " 799,\n",
        " 810,\n",
        " 814,\n",
        " 816,\n",
        " 820,\n",
        " 824,\n",
        " 830,\n",
        " 838,\n",
        " 848,\n",
        " 861,\n",
        " 873,\n",
        " 875,\n",
        " 877,\n",
        " 882,\n",
        " 899,\n",
        " 901,\n",
        " 904,\n",
        " 908,\n",
        " 925,\n",
        " 930,\n",
        " 949,\n",
        " 954,\n",
        " 959,\n",
        " 979,\n",
        " 980,\n",
        " 984,\n",
        " 990,\n",
        " 993,\n",
        " 1002,\n",
        " 1049,\n",
        " 1067,\n",
        " 1071,\n",
        " 1085,\n",
        " 1105,\n",
        " 1112,\n",
        " 1115,\n",
        " 1119,\n",
        " 1141,\n",
        " 1152,\n",
        " 1156,\n",
        " 1160,\n",
        " 1161,\n",
        " 1167,\n",
        " 1187,\n",
        " 1192,\n",
        " 1202,\n",
        " 1216,\n",
        " 1244,\n",
        " 1260,\n",
        " 1268,\n",
        " 1269,\n",
        " 1274,\n",
        " 1286,\n",
        " 1302,\n",
        " 1304,\n",
        " 1305,\n",
        " 1307,\n",
        " 1327,\n",
        " 1337,\n",
        " 1352,\n",
        " 1364,\n",
        " 1372,\n",
        " 1375,\n",
        " 1400,\n",
        " 1408,\n",
        " 1414,\n",
        " 1415,\n",
        " 1420,\n",
        " 1428,\n",
        " 1441,\n",
        " 1451,\n",
        " 1454,\n",
        " 1464,\n",
        " 1476,\n",
        " 1479,\n",
        " 1481,\n",
        " 1486,\n",
        " 1489,\n",
        " 1507,\n",
        " 1510,\n",
        " 1517,\n",
        " 1518,\n",
        " 1523,\n",
        " 1524,\n",
        " 1528,\n",
        " 1529,\n",
        " 1555,\n",
        " 1559,\n",
        " 1560,\n",
        " 1565,\n",
        " 1568,\n",
        " 1580,\n",
        " 1583,\n",
        " 1590,\n",
        " 1596,\n",
        " 1598,\n",
        " 1601,\n",
        " 1605,\n",
        " 1608,\n",
        " 1611,\n",
        " 1622,\n",
        " 1628,\n",
        " 1638,\n",
        " 1644,\n",
        " 1649,\n",
        " 1650,\n",
        " 1658,\n",
        " 1673,\n",
        " 1682,\n",
        " 1684,\n",
        " 1695,\n",
        " 1698,\n",
        " 1709,\n",
        " 1711,\n",
        " 1730,\n",
        " 1743,\n",
        " 1756,\n",
        " 1758,\n",
        " 1765,\n",
        " 1772,\n",
        " 1778,\n",
        " 1786,\n",
        " 1793,\n",
        " 1795,\n",
        " 1800,\n",
        " 1807,\n",
        " 1810,\n",
        " 1812,\n",
        " 1820,\n",
        " 1835,\n",
        " 1839,\n",
        " 1840,\n",
        " 1875,\n",
        " 1892,\n",
        " 1899,\n",
        " 1901,\n",
        " 1907,\n",
        " 1911,\n",
        " 1915,\n",
        " 1926,\n",
        " 1929,\n",
        " 1937,\n",
        " 1938,\n",
        " 1943,\n",
        " 1954,\n",
        " 1960,\n",
        " 1964,\n",
        " 1969,\n",
        " 1970,\n",
        " 2008,\n",
        " 2011,\n",
        " 2016,\n",
        " 2038,\n",
        " 2044,\n",
        " 2046,\n",
        " 2047,\n",
        " 2052,\n",
        " 2054,\n",
        " 2100,\n",
        " 2103,\n",
        " 2115,\n",
        " 2123,\n",
        " 2125,\n",
        " 2131,\n",
        " 2169,\n",
        " 2175,\n",
        " 2177,\n",
        " 2183,\n",
        " 2184,\n",
        " 2198,\n",
        " 2201,\n",
        " 2204,\n",
        " 2206,\n",
        " 2214,\n",
        " 2225,\n",
        " 2237,\n",
        " 2241,\n",
        " 2260,\n",
        " 2263,\n",
        " 2285,\n",
        " 2286,\n",
        " 2291,\n",
        " 2293,\n",
        " 2300,\n",
        " 2301,\n",
        " 2312,\n",
        " 2331,\n",
        " 2340,\n",
        " 2364,\n",
        " 2376,\n",
        " 2377,\n",
        " 2385,\n",
        " 2405,\n",
        " 2406,\n",
        " 2426,\n",
        " 2440,\n",
        " 2442,\n",
        " 2444,\n",
        " 2461,\n",
        " 2479,\n",
        " 2487,\n",
        " 2491,\n",
        " 2498,\n",
        " 2502,\n",
        " 2518]"
       ]
      }
     ],
     "prompt_number": 68
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "ktensor_phenotypes.U[1][3,i]"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 75,
       "text": [
        "0.0"
       ]
      }
     ],
     "prompt_number": 75
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "this_pheno_jdrange_nnz"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 70,
       "text": [
        "array([ 65,  69,  73,  91,  96,  97, 100, 109, 121, 153, 186])"
       ]
      }
     ],
     "prompt_number": 70
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "this_pheno_pt_nnz"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 83,
       "text": [
        "array([   3,    5,   16,   52,   56,   62,   68,   69,   93,   96,  100,\n",
        "        107,  109,  117,  130,  139,  140,  142,  156,  165,  171,  191,\n",
        "        197,  205,  208,  224,  239,  257,  271,  272,  282,  297,  308,\n",
        "        309,  312,  327,  330,  333,  335,  336,  349,  366,  368,  369,\n",
        "        402,  409,  412,  431,  437,  442,  446,  486,  501,  505,  507,\n",
        "        540,  545,  549,  558,  559,  561,  564,  567,  568,  574,  583,\n",
        "        591,  596,  601,  610,  624,  630,  632,  647,  671,  676,  680,\n",
        "        681,  703,  708,  710,  713,  717,  721,  726,  728,  736,  739,\n",
        "        744,  745,  752,  772,  774,  781,  782,  786,  799,  810,  814,\n",
        "        816,  820,  824,  830,  838,  848,  861,  873,  875,  877,  882,\n",
        "        899,  901,  904,  908,  925,  930,  949,  954,  959,  979,  980,\n",
        "        984,  990,  993, 1002, 1049, 1067, 1071, 1085, 1105, 1112, 1115,\n",
        "       1119, 1141, 1152, 1156, 1160, 1161, 1167, 1187, 1192, 1202, 1216,\n",
        "       1244, 1260, 1268, 1269, 1274, 1286, 1302, 1304, 1305, 1307, 1327,\n",
        "       1337, 1352, 1364, 1372, 1375, 1400, 1408, 1414, 1415, 1420, 1428,\n",
        "       1441, 1451, 1454, 1464, 1476, 1479, 1481, 1486, 1489, 1507, 1510,\n",
        "       1517, 1518, 1523, 1524, 1528, 1529, 1555, 1559, 1560, 1565, 1568,\n",
        "       1580, 1583, 1590, 1596, 1598, 1601, 1605, 1608, 1611, 1622, 1628,\n",
        "       1638, 1644, 1649, 1650, 1658, 1673, 1682, 1684, 1695, 1698, 1709,\n",
        "       1711, 1730, 1743, 1756, 1758, 1765, 1772, 1778, 1786, 1793, 1795,\n",
        "       1800, 1807, 1810, 1812, 1820, 1835, 1839, 1840, 1875, 1892, 1899,\n",
        "       1901, 1907, 1911, 1915, 1926, 1929, 1937, 1938, 1943, 1954, 1960,\n",
        "       1964, 1969, 1970, 2008, 2011, 2016, 2038, 2044, 2046, 2047, 2052,\n",
        "       2054, 2100, 2103, 2115, 2123, 2125, 2131, 2169, 2175, 2177, 2183,\n",
        "       2184, 2198, 2201, 2204, 2206, 2214, 2225, 2237, 2241, 2260, 2263,\n",
        "       2285, 2286, 2291, 2293, 2300, 2301, 2312, 2331, 2340, 2364, 2376,\n",
        "       2377, 2385, 2405, 2406, 2426, 2440, 2442, 2444, 2461, 2479, 2487,\n",
        "       2491, 2498, 2502, 2518])"
       ]
      }
     ],
     "prompt_number": 83
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "ktensor_phenotypes.U[1][:,i]"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 76,
       "text": [
        "array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.06599204,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.06073559,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.06142715,  0.        ,  0.        ,\n",
        "        0.        ,  0.10198579,  0.        ,  0.        ,  0.        ,\n",
        "        0.1177209 ,  0.        ,  0.        ,  0.        ,  0.06514787,\n",
        "        0.        ,  0.        ,  0.06171497,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.07786729,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.0837679 ,  0.        ,  0.        ,  0.08144345,\n",
        "        0.        ,  0.        ,  0.05102899,  0.08004045,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.0911276 ])"
       ]
      }
     ],
     "prompt_number": 76
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "nparr_loadedtensor = loaded_X.tondarray()"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 77
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "nparr_loadedtensor[2518][69][149]"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 91,
       "text": [
        "0.0"
       ]
      }
     ],
     "prompt_number": 91
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "this_pheno_med_nnz"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 81,
       "text": [
        "array([ 19,  49,  58,  65,  78,  96, 149, 155, 175, 209, 212, 277, 307,\n",
        "       312, 329])"
       ]
      }
     ],
     "prompt_number": 81
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "470*6.5"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 92,
       "text": [
        "3055.0"
       ]
      }
     ],
     "prompt_number": 92
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "1768/2"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 93,
       "text": [
        "884"
       ]
      }
     ],
     "prompt_number": 93
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "28500/12.*.85"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 97,
       "text": [
        "2018.75"
       ]
      }
     ],
     "prompt_number": 97
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "884+100+60+75"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 98,
       "text": [
        "1119"
       ]
      }
     ],
     "prompt_number": 98
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "2018.75-1119"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 99,
       "text": [
        "899.75"
       ]
      }
     ],
     "prompt_number": 99
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "20*100*1"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 100,
       "text": [
        "2000"
       ]
      }
     ],
     "prompt_number": 100
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "2000+3000"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 101,
       "text": [
        "5000"
       ]
      }
     ],
     "prompt_number": 101
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "1365-1119"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 102,
       "text": [
        "246"
       ]
      }
     ],
     "prompt_number": 102
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "1700/2"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 103,
       "text": [
        "850"
       ]
      }
     ],
     "prompt_number": 103
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "305*200"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 104,
       "text": [
        "61000"
       ]
      }
     ],
     "prompt_number": 104
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "3.5*200"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 105,
       "text": [
        "700.0"
       ]
      }
     ],
     "prompt_number": 105
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "13*200"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 106,
       "text": [
        "2600"
       ]
      }
     ],
     "prompt_number": 106
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "6*200"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 107,
       "text": [
        "1200"
       ]
      }
     ],
     "prompt_number": 107
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "2*270"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 108,
       "text": [
        "540"
       ]
      }
     ],
     "prompt_number": 108
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "this_pheno_jdrange_nnz"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 109,
       "text": [
        "array([ 65,  69,  73,  91,  96,  97, 100, 109, 121, 153, 186])"
       ]
      }
     ],
     "prompt_number": 109
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "jdrange"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 110,
       "text": [
        "'RANGE NA'"
       ]
      }
     ],
     "prompt_number": 110
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "d_pheno_nonzero_labels"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 111,
       "text": [
        "OrderedDict([(23, {'JDRANGE_NAMES_NZ': [], 'MEDS_NZ': [], 'JDRANGE_NZ': [], 'PERCENT_PTS': 0.0, 'LAMBDA': 1.0}), (41, {'JDRANGE_NAMES_NZ': [], 'MEDS_NZ': [], 'JDRANGE_NZ': [], 'PERCENT_PTS': 0.0, 'LAMBDA': 1.0}), (10, {'JDRANGE_NAMES_NZ': [u'Disorders of fluid, electrolyte, and acid-base balance', u'Anemias', u'Pain', u'Hypertensive disease', u'Other forms of heart disease', u'Pneumonia and influenza', u'Other diseases of respiratory system', u'Osteopathies, chondropathies, and acquired musculoskeletal deformities', u'Symptoms involving cardiovascular system', u'Symptoms involving respiratory system and other chest symptoms', u'Range name na'], 'MEDS_NZ': [u'Anti-Anxiety Agents'], 'JDRANGE_NZ': ['276-276.99', '280-285.99', '338-338.9', '401-405.99', '420-429.99', '480-488.99', '510-519.99', '730-739.99', '785-785.99', '786-786.99', 'RANGE NA'], 'PERCENT_PTS': 0.07140023800079334, 'LAMBDA': 738.67151481529254}), (26, {'JDRANGE_NAMES_NZ': [u'Disorders of lipoid metabolism', u'Hypertensive disease', u'Ischemic heart disease', u'Other forms of heart disease', u'Cerebrovascular disease', u'Diseases of arteries, arterioles, and capillaries', u'Other diseases of respiratory system', u'Rheumatism, excluding the back', u'General symptoms', u'Symptoms involving respiratory system and other chest symptoms', u'Range name na'], 'MEDS_NZ': [u'Surface-Active Agents'], 'JDRANGE_NZ': ['272-272.99', '401-405.99', '410-414.99', '420-429.99', '430-438.99', '440-449.99', '510-519.99', '725-729.99', '780-780.99', '786-786.99', 'RANGE NA'], 'PERCENT_PTS': 0.061086870289567635, 'LAMBDA': 912.98450975162575}), (4, {'JDRANGE_NAMES_NZ': [u'Diabetes', u'Disorders of lipoid metabolism', u'Overweight, obesity and other hyperalimentation', u'Anemias', u'Neurotic, personality, nonpsychotic disorders', u'Organic sleep disorders', u'Hypertensive disease', u'Acute respiratory infections', u'Dorsopathies', u'Symptoms involving skin and other integumentary tissue', u'Symptoms involving head and neck', u'Symptoms involving respiratory system and other chest symptoms'], 'MEDS_NZ': [u'Antihypertensive Agents', u'Calcium Channel Blockers'], 'JDRANGE_NZ': ['249-250.99', '272-272.99', '278-278.99', '280-285.99', '300-315.99', '327-327.9', '401-405.99', '460-466.99', '720-724.99', '782-782.99', '784-784.99', '786-786.99'], 'PERCENT_PTS': 0.08330027766759222, 'LAMBDA': 1303.7574543068242}), (6, {'JDRANGE_NAMES_NZ': [u'Overweight, obesity and other hyperalimentation', u'Na', u'Neurotic, personality, nonpsychotic disorders', u'Organic sleep disorders', u'Hypertensive disease', u'Diseases of esophagus, stomach, and duodenum', u'Other diseases of intestines and peritoneum', u'Other diseases of urinary system', u'General symptoms', u'Symptoms involving respiratory system and other chest symptoms', u'Other symptoms involving abdomen and pelvis', u'Range name na'], 'MEDS_NZ': [u'Anti-Anxiety Agents', u'Antidepressive Agents, Second-Generation', u'Antihypertensive Agents', u'Serotonin Uptake Inhibitors'], 'JDRANGE_NZ': ['278-278.99', '295-298.99', '300-315.99', '327-327.9', '401-405.99', '530-538', '560-569.99', '590-599.99', '780-780.99', '786-786.99', '789-789.99', 'RANGE NA'], 'PERCENT_PTS': 0.07814359381197937, 'LAMBDA': 2639.5333708157809}), (14, {'JDRANGE_NAMES_NZ': [u'Disorders of lipoid metabolism', u'Anemias', u'Hypertensive disease', u'Diseases of esophagus, stomach, and duodenum', u'Other diseases of intestines and peritoneum', u'Nephritis, nephrotic syndrome, and nephrosis', u'Other diseases of urinary system', u'Operations on the musculoskeletal system', u'Symptoms involving urinary system', u'Nonspecific findings on examination of blood', u'Range name na'], 'MEDS_NZ': [u'Antihypertensive Agents', u'Antirheumatic Agents', u'Dermatologic Agents', u'Enzyme Inhibitors', u'Immunosuppressive Agents'], 'JDRANGE_NZ': ['272-272.99', '280-285.99', '401-405.99', '530-538', '560-569.99', '580-589.99', '590-599.99', '76-84.99', '788-788.99', '790-790.99', 'RANGE NA'], 'PERCENT_PTS': 0.08806029353431179, 'LAMBDA': 2792.2272641247509}), (33, {'JDRANGE_NAMES_NZ': [u'Other disorders of the central nervous system', u'Hypertensive disease', u'Other forms of heart disease', u'Acute respiratory infections', u'Other diseases of the upper respiratory tract', u'Pneumonia and influenza', u'Other diseases of respiratory system', u'Other diseases of urinary system', u'General symptoms', u'Symptoms involving nervous and musculoskeletal systems', u'Symptoms involving respiratory system and other chest symptoms', u'Symptoms involving urinary system'], 'MEDS_NZ': [u'Anti-Allergic Agents', u'Anti-Bacterial Agents', u'Antihypertensive Agents', u'Bronchodilator Agents'], 'JDRANGE_NZ': ['340-349.99', '401-405.99', '420-429.99', '460-466.99', '470-478.99', '480-488.99', '510-519.99', '590-599.99', '780-780.99', '781-781.99', '786-786.99', '788-788.99'], 'PERCENT_PTS': 0.0971836572788576, 'LAMBDA': 2966.0399248618446}), (1, {'JDRANGE_NAMES_NZ': [u'Diabetes', u'Nutritional deficiencies', u'Disorders of lipoid metabolism', u'Gout', u'Organic sleep disorders', u'Disorders of the eye and adnexa', u'Hypertensive disease', u'Diseases of esophagus, stomach, and duodenum', u'Arthropathies and related disorders', u'Symptoms involving respiratory system and other chest symptoms', u'Nonspecific findings on examination of blood', u'Abnormal results of function studies', u'Range name na'], 'MEDS_NZ': [u'Analgesics', u'Antihypertensive Agents', u'Calcium Channel Blockers', u'Vasodilator Agents'], 'JDRANGE_NZ': ['249-250.99', '260-269.99', '272-272.99', '274-274.99', '327-327.9', '360-379.99', '401-405.99', '530-538', '710-719.99', '786-786.99', '790-790.99', '794-794.99', 'RANGE NA'], 'PERCENT_PTS': 0.09956366521221738, 'LAMBDA': 3256.8549500725103}), (30, {'JDRANGE_NAMES_NZ': [u'Disorders of lipoid metabolism', u'Disorders of the eye and adnexa', u'Hypertensive disease', u'Ischemic heart disease', u'Other forms of heart disease', u'Other diseases of respiratory system', u'General symptoms', u'Symptoms involving cardiovascular system', u'Symptoms involving respiratory system and other chest symptoms', u'Range name na'], 'MEDS_NZ': [u'Antimetabolites, Antineoplastic', u'Antirheumatic Agents', u'Dermatologic Agents', u'Enzyme Inhibitors', u'Immunosuppressive Agents'], 'JDRANGE_NZ': ['272-272.99', '360-379.99', '401-405.99', '410-414.99', '420-429.99', '510-519.99', '780-780.99', '785-785.99', '786-786.99', 'RANGE NA'], 'PERCENT_PTS': 0.09202697342324474, 'LAMBDA': 3301.2549956790908}), (15, {'JDRANGE_NAMES_NZ': [u'Disorders of lipoid metabolism', u'Organic sleep disorders', u'Disorders of the eye and adnexa', u'Hypertensive disease', u'Diseases of esophagus, stomach, and duodenum', u'Other diseases of urinary system', u'Diseases of male genital organs', u'Arthropathies and related disorders', u'Dorsopathies', u'Rheumatism, excluding the back', u'General symptoms', u'Symptoms involving urinary system', u'Nonspecific findings on examination of blood', u'Range name na'], 'MEDS_NZ': [u'Anti-Allergic Agents', u'Anti-Inflammatory Agents', u'Anti-Ulcer Agents', u'Bronchodilator Agents'], 'JDRANGE_NZ': ['272-272.99', '327-327.9', '360-379.99', '401-405.99', '530-538', '590-599.99', '600-608.99', '710-719.99', '720-724.99', '725-729.99', '780-780.99', '788-788.99', '790-790.99', 'RANGE NA'], 'PERCENT_PTS': 0.09083696945656486, 'LAMBDA': 3458.8431865962789}), (29, {'JDRANGE_NAMES_NZ': [u'Disorders of fluid, electrolyte, and acid-base balance', u'Anemias', u'Other diseases of the blood', u'Hypertensive disease', u'Liver', u'Other diseases of urinary system', u'Dorsopathies', u'Symptoms involving skin and other integumentary tissue', u'Symptoms involving digestive system', u'Symptoms involving urinary system', u'Other symptoms involving abdomen and pelvis', u'Nonspecific findings on examination of blood'], 'MEDS_NZ': [u'Anti-Arrhythmia Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Anti-Ulcer Agents', u'Antihypertensive Agents', u'Antipyretics', u'Cyclooxygenase Inhibitors', u'Vasodilator Agents'], 'JDRANGE_NZ': ['276-276.99', '280-285.99', '288-289.99', '401-405.99', '570-573.99', '590-599.99', '720-724.99', '782-782.99', '787-787.99', '788-788.99', '789-789.99', '790-790.99'], 'PERCENT_PTS': 0.09004363347877826, 'LAMBDA': 3942.2034968950375}), (36, {'JDRANGE_NAMES_NZ': [u'Disorders of lipoid metabolism', u'Pain', u'Other disorders of the central nervous system', u'Disorders of the eye and adnexa', u'Hypertensive disease', u'Other diseases of urinary system', u'Other disorders of female genital tract', u'Arthropathies and related disorders', u'Dorsopathies', u'Rheumatism, excluding the back', u'General symptoms', u'Symptoms involving urinary system', u'Range name na'], 'MEDS_NZ': [u'Analgesics, Non-Narcotic', u'Anti-Inflammatory Agents, Non-Steroidal', u'Antihypertensive Agents', u'Antipyretics', u'Cyclooxygenase Inhibitors', u'Estrogens'], 'JDRANGE_NZ': ['272-272.99', '338-338.9', '340-349.99', '360-379.99', '401-405.99', '590-599.99', '617-629.99', '710-719.99', '720-724.99', '725-729.99', '780-780.99', '788-788.99', 'RANGE NA'], 'PERCENT_PTS': 0.09242364141213805, 'LAMBDA': 4012.3198970337166}), (3, {'JDRANGE_NAMES_NZ': [u'Hypertensive disease', u'Diseases of esophagus, stomach, and duodenum', u'Other diseases of intestines and peritoneum', u'Other diseases of digestive system', u'Other diseases of urinary system', u'Symptoms involving digestive system', u'Other symptoms involving abdomen and pelvis', u'Certain traumatic complications and unspecified injuries', u'Complications of surgical and medical care, not elsewhere classified', u'Range name na'], 'MEDS_NZ': [u'Analgesics, Opioid', u'Anti-Anxiety Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Antihypertensive Agents', u'Antipyretics', u'Hypnotics and Sedatives', u'Narcotics'], 'JDRANGE_NZ': ['401-405.99', '530-538', '560-569.99', '577-579.99', '590-599.99', '787-787.99', '789-789.99', '958-959.99', '996-999.99', 'RANGE NA'], 'PERCENT_PTS': 0.09837366124553748, 'LAMBDA': 4230.5114597274815}), (16, {'JDRANGE_NAMES_NZ': [u'Diabetes', u'Disorders of lipoid metabolism', u'Hypertensive disease', u'Ischemic heart disease', u'Pneumonia and influenza', u'Chronic obstructive pulmonary disease and allied conditions', u'Other diseases of respiratory system', u'Symptoms involving respiratory system and other chest symptoms', u'Range name na'], 'MEDS_NZ': [u'Adrenergic beta-2 Receptor Agonists', u'Antihypertensive Agents', u'Antipyretics', u'Bronchodilator Agents', u'Hydroxymethylglutaryl-CoA Reductase Inhibitors', u'Tocolytic Agents', u'Vasodilator Agents'], 'JDRANGE_NZ': ['249-250.99', '272-272.99', '401-405.99', '410-414.99', '480-488.99', '490-496.99', '510-519.99', '786-786.99', 'RANGE NA'], 'PERCENT_PTS': 0.09163030543435145, 'LAMBDA': 4453.1579142244655}), (18, {'JDRANGE_NAMES_NZ': [u'Diabetes', u'Disorders of lipoid metabolism', u'Na', u'Disorders of the peripheral nervous system', u'Disorders of the eye and adnexa', u'Hypertensive disease', u'Other inflammatory conditions of skin and subcutaneous tissue', u'Other diseases of skin and subcutaneous tissue', u'Rheumatism, excluding the back', u'General symptoms', u'Range name na'], 'MEDS_NZ': [u'Analgesics', u'Anti-Anxiety Agents', u'Anticonvulsants', u'Antihypertensive Agents', u'Antiparkinson Agents', u'Excitatory Amino Acid Antagonists', u'Serotonin Uptake Inhibitors'], 'JDRANGE_NZ': ['249-250.99', '272-272.99', '295-298.99', '350-359.99', '360-379.99', '401-405.99', '690-698.99', '700-709.99', '725-729.99', '780-780.99', 'RANGE NA'], 'PERCENT_PTS': 0.09123363744545815, 'LAMBDA': 4830.4251924652517}), (37, {'JDRANGE_NAMES_NZ': [u'Disorders of lipoid metabolism', u'Na', u'Neurotic, personality, nonpsychotic disorders', u'Drug dependence', u'Hypertensive disease', u'Ischemic heart disease', u'Chronic obstructive pulmonary disease and allied conditions', u'Arthropathies and related disorders', u'Dorsopathies', u'Rheumatism, excluding the back', u'General symptoms', u'Symptoms involving respiratory system and other chest symptoms'], 'MEDS_NZ': [u'Anti-Inflammatory Agents, Non-Steroidal', u'Antidepressive Agents, Second-Generation', u'Antihypertensive Agents', u'Antipyretics', u'Cyclooxygenase Inhibitors', u'Serotonin Uptake Inhibitors'], 'JDRANGE_NZ': ['272-272.99', '295-298.99', '300-315.99', '316-316.99', '401-405.99', '410-414.99', '490-496.99', '710-719.99', '720-724.99', '725-729.99', '780-780.99', '786-786.99'], 'PERCENT_PTS': 0.11067036890122967, 'LAMBDA': 5159.7206740354177}), (38, {'JDRANGE_NAMES_NZ': [u'Mycoses', u'Diabetes', u'Disorders of lipoid metabolism', u'Anemias', u'Disorders of the peripheral nervous system', u'Hypertensive disease', u'Nephritis, nephrotic syndrome, and nephrosis', u'Arthropathies and related disorders', u'Rheumatism, excluding the back', u'General symptoms', u'Symptoms involving skin and other integumentary tissue', u'Certain traumatic complications and unspecified injuries', u'Range name na'], 'MEDS_NZ': [u'Analgesics', u'Anticholesteremic Agents', u'Anticonvulsants', u'Antihypertensive Agents', u'Hydroxymethylglutaryl-CoA Reductase Inhibitors', u'Hypoglycemic Agents'], 'JDRANGE_NZ': ['110-118.99', '249-250.99', '272-272.99', '280-285.99', '350-359.99', '401-405.99', '580-589.99', '710-719.99', '725-729.99', '780-780.99', '782-782.99', '958-959.99', 'RANGE NA'], 'PERCENT_PTS': 0.10710035700119, 'LAMBDA': 5363.0474943443269}), (35, {'JDRANGE_NAMES_NZ': [u'Diabetes', u'Disorders of lipoid metabolism', u'Hypertensive disease', u'Acute respiratory infections', u'Chronic obstructive pulmonary disease and allied conditions', u'Diseases of esophagus, stomach, and duodenum', u'Other diseases of urinary system', u'Other disorders of female genital tract', u'Arthropathies and related disorders', u'Rheumatism, excluding the back', u'Symptoms involving respiratory system and other chest symptoms', u'Symptoms involving digestive system', u'Range name na'], 'MEDS_NZ': [u'Adrenergic beta-2 Receptor Agonists', u'Anti-Allergic Agents', u'Anti-Inflammatory Agents', u'Anti-Ulcer Agents', u'Antihypertensive Agents', u'Bronchodilator Agents', u'Estrogens', u'Proton Pump Inhibitors'], 'JDRANGE_NZ': ['249-250.99', '272-272.99', '401-405.99', '460-466.99', '490-496.99', '530-538', '590-599.99', '617-629.99', '710-719.99', '725-729.99', '786-786.99', '787-787.99', 'RANGE NA'], 'PERCENT_PTS': 0.09520031733439112, 'LAMBDA': 5387.772299769611}), (49, {'JDRANGE_NAMES_NZ': [u'Anemias', u'Organic sleep disorders', u'Diseases of the ear and mastoid process', u'Hypertensive disease', u'Other forms of heart disease', u'Acute respiratory infections', u'Chronic obstructive pulmonary disease and allied conditions', u'Arthropathies and related disorders', u'General symptoms', u'Symptoms involving skin and other integumentary tissue', u'Symptoms involving cardiovascular system', u'Symptoms involving respiratory system and other chest symptoms', u'Range name na'], 'MEDS_NZ': [u'Anti-Allergic Agents', u'Anti-Inflammatory Agents', u'Antihypertensive Agents', u'Bronchodilator Agents', u'Diuretics', u'Sodium Potassium Chloride Symporter Inhibitors'], 'JDRANGE_NZ': ['280-285.99', '327-327.9', '380-389.99', '401-405.99', '420-429.99', '460-466.99', '490-496.99', '710-719.99', '780-780.99', '782-782.99', '785-785.99', '786-786.99', 'RANGE NA'], 'PERCENT_PTS': 0.10472034906783023, 'LAMBDA': 5511.1098663789235}), (7, {'JDRANGE_NAMES_NZ': [u'Malignant neoplasm of breast', u'Disorders of thyroid gland', u'Disorders of lipoid metabolism', u'Hypertensive disease', u'Diseases of veins and lymphatics, and other diseases of circulatory system', u'Other diseases of skin and subcutaneous tissue', u'Arthropathies and related disorders', u'Dorsopathies', u'Rheumatism, excluding the back', u'Osteopathies, chondropathies, and acquired musculoskeletal deformities', u'General symptoms', u'Range name na'], 'MEDS_NZ': [u'Angiotensin-Converting Enzyme Inhibitors', u'Anti-Inflammatory Agents, Non-Steroidal', u'Antihypertensive Agents', u'Antineoplastic Agents, Hormonal', u'Antipyretics', u'Bone Density Conservation Agents', u'Cyclooxygenase Inhibitors', u'Fibrinolytic Agents', u'Hypnotics and Sedatives', u'Vitamins'], 'JDRANGE_NZ': ['174-175.99', '240-246.99', '272-272.99', '401-405.99', '451-459.99', '700-709.99', '710-719.99', '720-724.99', '725-729.99', '730-739.99', '780-780.99', 'RANGE NA'], 'PERCENT_PTS': 0.09202697342324474, 'LAMBDA': 5559.467399264855}), (40, {'JDRANGE_NAMES_NZ': [nan, u'Disorders of fluid, electrolyte, and acid-base balance', u'Anemias', u'Drug dependence', u'Operations on the cardiovascular system', u'Other forms of heart disease', u'Diseases of arteries, arterioles, and capillaries', u'Diseases of veins and lymphatics, and other diseases of circulatory system', u'Other diseases of respiratory system', u'Operations on the musculoskeletal system', u'Symptoms involving respiratory system and other chest symptoms', u'Nonspecific findings on examination of blood', u'Miscellaneous diagnostic and therapeutic procedures'], 'MEDS_NZ': [u'Anti-Arrhythmia Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Antihypertensive Agents', u'Antipyretics', u'Cyclooxygenase Inhibitors', u'Fibrinolytic Agents', u'Hydroxymethylglutaryl-CoA Reductase Inhibitors', u'Platelet Aggregation Inhibitors'], 'JDRANGE_NZ': ['0', '276-276.99', '280-285.99', '316-316.99', '35-39.99', '420-429.99', '440-449.99', '451-459.99', '510-519.99', '76-84.99', '786-786.99', '790-790.99', '87-99.99'], 'PERCENT_PTS': 0.06743355811186037, 'LAMBDA': 5773.099314063933}), (43, {'JDRANGE_NAMES_NZ': [u'Benign neoplasm of other parts of digestive system', u'Diseases of other endocrine glands', u'Disorders of lipoid metabolism', u'Coagulation or hemorrhagic diseases', u'Disorders of the eye and adnexa', u'Hypertensive disease', u'Acute respiratory infections', u'Other diseases of intestines and peritoneum', u'Infections of skin and subcutaneous tissue', u'General symptoms', u'Symptoms concerning nutrition, metabolism, and development', u'Symptoms involving respiratory system and other chest symptoms', u'Other symptoms involving abdomen and pelvis', u'Range name na'], 'MEDS_NZ': [u'Anti-Inflammatory Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Antihypertensive Agents', u'Antipyretics', u'Cyclooxygenase Inhibitors', u'Dermatologic Agents', u'Diuretics', u'Fibrinolytic Agents', u'Platelet Aggregation Inhibitors', u'Vasodilator Agents'], 'JDRANGE_NZ': ['211-211.99', '252-259.99', '272-272.99', '286-287.99', '360-379.99', '401-405.99', '460-466.99', '560-569.99', '680-686.99', '780-780.99', '783-783.99', '786-786.99', '789-789.99', 'RANGE NA'], 'PERCENT_PTS': 0.096390321301071, 'LAMBDA': 5795.7673115991593}), (8, {'JDRANGE_NAMES_NZ': [u'Diabetes', u'Nutritional deficiencies', u'Disorders of lipoid metabolism', u'Hypertensive disease', u'Ischemic heart disease', u'Diseases of veins and lymphatics, and other diseases of circulatory system', u'Diseases of esophagus, stomach, and duodenum', u'Hernia of abdominal cavity', u'Dorsopathies', u'General symptoms', u'Symptoms involving respiratory system and other chest symptoms', u'Other symptoms involving abdomen and pelvis', u'Range name na'], 'MEDS_NZ': [u'Anti-Anxiety Agents', u'Anti-Ulcer Agents', u'Antihypertensive Agents', u'Antipyretics', u'GABA Modulators', u'Hypnotics and Sedatives', u'Proton Pump Inhibitors'], 'JDRANGE_NZ': ['249-250.99', '260-269.99', '272-272.99', '401-405.99', '410-414.99', '451-459.99', '530-538', '550-553.99', '720-724.99', '780-780.99', '786-786.99', '789-789.99', 'RANGE NA'], 'PERCENT_PTS': 0.0967869892899643, 'LAMBDA': 6177.7150562420202}), (31, {'JDRANGE_NAMES_NZ': [u'Other bacterial diseases', u'Malignant neoplasm of male and female genital organs', u'Disorders of lipoid metabolism', u'Hypertensive disease', u'Other forms of heart disease', u'Diseases of arteries, arterioles, and capillaries', u'Diseases of veins and lymphatics, and other diseases of circulatory system', u'Other diseases of intestines and peritoneum', u'Other diseases of urinary system', u'Diseases of male genital organs', u'Symptoms involving cardiovascular system', u'Other symptoms involving abdomen and pelvis', u'Other and unspecified effects of external causes'], 'MEDS_NZ': [u'Anti-Arrhythmia Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Anticholesteremic Agents', u'Antihypertensive Agents', u'Antipyretics', u'Cyclooxygenase Inhibitors', u'Fibrinolytic Agents', u'Hydroxymethylglutaryl-CoA Reductase Inhibitors', u'Platelet Aggregation Inhibitors', u'Vasodilator Agents'], 'JDRANGE_NZ': ['030-041.99', '179-187.99', '272-272.99', '401-405.99', '420-429.99', '440-449.99', '451-459.99', '560-569.99', '590-599.99', '600-608.99', '785-785.99', '789-789.99', '990-995.99'], 'PERCENT_PTS': 0.10115033716779057, 'LAMBDA': 6206.374021495637}), (32, {'JDRANGE_NAMES_NZ': [u'Disorders of lipoid metabolism', u'Disorders of the eye and adnexa', u'Hypertensive disease', u'Diseases of oral cavity, salivary glands, and jaws', u'Other inflammatory conditions of skin and subcutaneous tissue', u'Other diseases of skin and subcutaneous tissue', u'Arthropathies and related disorders', u'Dorsopathies', u'Rheumatism, excluding the back', u'Symptoms involving head and neck', u'Symptoms involving respiratory system and other chest symptoms', u'Sprains and strains of joints and adjacent muscles', u'Range name na'], 'MEDS_NZ': [u'Anesthetics, Local', u'Anti-Allergic Agents', u'Anti-Arrhythmia Agents', u'Anti-Inflammatory Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Antihypertensive Agents', u'Antipyretics', u'Bronchodilator Agents', u'Cyclooxygenase Inhibitors', u'Fibrinolytic Agents', u'Platelet Aggregation Inhibitors', u'Vasodilator Agents'], 'JDRANGE_NZ': ['272-272.99', '360-379.99', '401-405.99', '520-529.99', '690-698.99', '700-709.99', '710-719.99', '720-724.99', '725-729.99', '784-784.99', '786-786.99', '840-848.99', 'RANGE NA'], 'PERCENT_PTS': 0.09440698135660452, 'LAMBDA': 6454.714009527238}), (19, {'JDRANGE_NAMES_NZ': [u'Disorders of thyroid gland', u'Diabetes', u'Nutritional deficiencies', u'Disorders of lipoid metabolism', u'Disorders of the eye and adnexa', u'Hypertensive disease', u'Other diseases of the upper respiratory tract', u'Arthropathies and related disorders', u'Rheumatism, excluding the back', u'Osteopathies, chondropathies, and acquired musculoskeletal deformities', u'Symptoms involving head and neck', u'Symptoms involving digestive system', u'Range name na'], 'MEDS_NZ': [u'Abortifacient Agents, Nonsteroidal', u'Anti-Allergic Agents', u'Anti-Inflammatory Agents', u'Antimetabolites, Antineoplastic', u'Antirheumatic Agents', u'Bronchodilator Agents', u'Dermatologic Agents', u'Enzyme Inhibitors', u'Folic Acid Antagonists', u'Immunosuppressive Agents', u'Nucleic Acid Synthesis Inhibitors'], 'JDRANGE_NZ': ['240-246.99', '249-250.99', '260-269.99', '272-272.99', '360-379.99', '401-405.99', '470-478.99', '710-719.99', '725-729.99', '730-739.99', '784-784.99', '787-787.99', 'RANGE NA'], 'PERCENT_PTS': 0.08052360174533915, 'LAMBDA': 6822.7840568037591}), (24, {'JDRANGE_NAMES_NZ': [u'Diabetes', u'Disorders of lipoid metabolism', u'Hypertensive disease', u'Ischemic heart disease', u'Other inflammatory conditions of skin and subcutaneous tissue', u'Arthropathies and related disorders', u'Rheumatism, excluding the back', u'General symptoms', u'Symptoms involving skin and other integumentary tissue', u'Symptoms involving respiratory system and other chest symptoms', u'Range name na'], 'MEDS_NZ': [u'Abortifacient Agents, Nonsteroidal', u'Adrenergic beta-1 Receptor Antagonists', u'Antimetabolites, Antineoplastic', u'Antirheumatic Agents', u'Dermatologic Agents', u'Enzyme Inhibitors', u'Folic Acid Antagonists', u'Immunosuppressive Agents', u'Nucleic Acid Synthesis Inhibitors', u'Sympatholytics'], 'JDRANGE_NZ': ['249-250.99', '272-272.99', '401-405.99', '410-414.99', '690-698.99', '710-719.99', '725-729.99', '780-780.99', '782-782.99', '786-786.99', 'RANGE NA'], 'PERCENT_PTS': 0.085680285600952, 'LAMBDA': 6936.438416994346}), (25, {'JDRANGE_NAMES_NZ': [u'Disorders of lipoid metabolism', u'Disorders of the peripheral nervous system', u'Hypertensive disease', u'Arthropathies and related disorders', u'Dorsopathies', u'Rheumatism, excluding the back', u'Osteopathies, chondropathies, and acquired musculoskeletal deformities', u'General symptoms', u'Range name na'], 'MEDS_NZ': [u'Anti-Allergic Agents', u'Anti-Inflammatory Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Antihypertensive Agents', u'Bronchodilator Agents', u'Calcium Channel Blockers', u'Cyclooxygenase Inhibitors', u'Dermatologic Agents', u'Glucocorticoids'], 'JDRANGE_NZ': ['272-272.99', '350-359.99', '401-405.99', '710-719.99', '720-724.99', '725-729.99', '730-739.99', '780-780.99', 'RANGE NA'], 'PERCENT_PTS': 0.11582705275684252, 'LAMBDA': 7017.0241483601976}), (28, {'JDRANGE_NAMES_NZ': [u'Disorders of lipoid metabolism', u'Hypertensive disease', u'Ischemic heart disease', u'Cerebrovascular disease', u'Acute respiratory infections', u'Chronic obstructive pulmonary disease and allied conditions', u'Other diseases of skin and subcutaneous tissue', u'Arthropathies and related disorders', u'General symptoms', u'Symptoms involving respiratory system and other chest symptoms', u'Range name na'], 'MEDS_NZ': [u'Anti-Inflammatory Agents, Non-Steroidal', u'Anticholesteremic Agents', u'Antihypertensive Agents', u'Antipyretics', u'Cyclooxygenase Inhibitors', u'Explosive Agents', u'Fibrinolytic Agents', u'Hydroxymethylglutaryl-CoA Reductase Inhibitors', u'Hypolipidemic Agents', u'Platelet Aggregation Inhibitors', u'Vasodilator Agents'], 'JDRANGE_NZ': ['272-272.99', '401-405.99', '410-414.99', '430-438.99', '460-466.99', '490-496.99', '700-709.99', '710-719.99', '780-780.99', '786-786.99', 'RANGE NA'], 'PERCENT_PTS': 0.09440698135660452, 'LAMBDA': 7573.6477373813659}), (39, {'JDRANGE_NAMES_NZ': [u'Nutritional deficiencies', u'Disorders of lipoid metabolism', u'Anemias', u'Na', u'Disorders of the eye and adnexa', u'Hypertensive disease', u'Arthropathies and related disorders', u'Osteopathies, chondropathies, and acquired musculoskeletal deformities', u'General symptoms', u'Range name na'], 'MEDS_NZ': [u'Anti-Inflammatory Agents, Non-Steroidal', u'Antihypertensive Agents', u'Antioxidants', u'Antipyretics', u'Bone Density Conservation Agents', u'Cyclooxygenase Inhibitors', u'Dermatologic Agents', u'Serotonin Uptake Inhibitors', u'Vitamin B Complex', u'Vitamins'], 'JDRANGE_NZ': ['260-269.99', '272-272.99', '280-285.99', '295-298.99', '360-379.99', '401-405.99', '710-719.99', '730-739.99', '780-780.99', 'RANGE NA'], 'PERCENT_PTS': 0.12376041253470844, 'LAMBDA': 8000.0803054785256}), (45, {'JDRANGE_NAMES_NZ': [u'Benign neoplasm of skin', u'Neoplasm of uncertain behavior of other sites & tissues', u'Disorders of thyroid gland', u'Disorders of lipoid metabolism', u'Neurotic, personality, nonpsychotic disorders', u'Hypertensive disease', u'Diseases of esophagus, stomach, and duodenum', u'Other inflammatory conditions of skin and subcutaneous tissue', u'Other diseases of skin and subcutaneous tissue', u'Rheumatism, excluding the back', u'General symptoms', u'Symptoms involving respiratory system and other chest symptoms', u'Range name na'], 'MEDS_NZ': [u'Anti-Allergic Agents', u'Anti-Inflammatory Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Anti-Ulcer Agents', u'Anticholesteremic Agents', u'Antihypertensive Agents', u'Antipyretics', u'Bronchodilator Agents', u'Cyclooxygenase Inhibitors', u'Histamine H1 Antagonists, Non-Sedating', u'Hydroxymethylglutaryl-CoA Reductase Inhibitors', u'Proton Pump Inhibitors'], 'JDRANGE_NZ': ['216-216.99', '238-238.99', '240-246.99', '272-272.99', '300-315.99', '401-405.99', '530-538', '690-698.99', '700-709.99', '725-729.99', '780-780.99', '786-786.99', 'RANGE NA'], 'PERCENT_PTS': 0.09758032526775089, 'LAMBDA': 8007.3848551375522}), (11, {'JDRANGE_NAMES_NZ': [u'Diabetes', u'Disorders of lipoid metabolism', u'Hypertensive disease', u'Other forms of heart disease', u'Arthropathies and related disorders', u'Dorsopathies', u'Rheumatism, excluding the back', u'General symptoms', u'Symptoms involving respiratory system and other chest symptoms', u'Range name na'], 'MEDS_NZ': [u'Analgesics, Opioid', u'Anti-Infective Agents', u'Anti-Infective Agents, Local', u'Anti-Infective Agents, Urinary', u'Antifungal Agents', u'Antimalarials', u'Antirheumatic Agents', u'Enzyme Inhibitors', u'Gastrointestinal Agents', u'Immunosuppressive Agents', u'Narcotics'], 'JDRANGE_NZ': ['249-250.99', '272-272.99', '401-405.99', '420-429.99', '710-719.99', '720-724.99', '725-729.99', '780-780.99', '786-786.99', 'RANGE NA'], 'PERCENT_PTS': 0.11543038476794923, 'LAMBDA': 8191.9663952561859}), (17, {'JDRANGE_NAMES_NZ': [u'Benign neoplasm of other parts of digestive system', u'Diabetes', u'Disorders of lipoid metabolism', u'Gout', u'Disorders of the eye and adnexa', u'Hypertensive disease', u'Ischemic heart disease', u'Other forms of heart disease', u'Diseases of male genital organs', u'Arthropathies and related disorders', u'Dorsopathies', u'Range name na'], 'MEDS_NZ': [u'Adrenergic alpha-1 Receptor Antagonists', u'Anti-Inflammatory Agents, Non-Steroidal', u'Antihypertensive Agents', u'Antimetabolites', u'Antipyretics', u'Cyclooxygenase Inhibitors', u'Enzyme Inhibitors', u'Fibrinolytic Agents', u'Free Radical Scavengers', u'Gout Suppressants', u'Hydroxymethylglutaryl-CoA Reductase Inhibitors', u'Platelet Aggregation Inhibitors', u'Vasodilator Agents'], 'JDRANGE_NZ': ['211-211.99', '249-250.99', '272-272.99', '274-274.99', '360-379.99', '401-405.99', '410-414.99', '420-429.99', '600-608.99', '710-719.99', '720-724.99', 'RANGE NA'], 'PERCENT_PTS': 0.09877032923443078, 'LAMBDA': 8637.8721233181186}), (21, {'JDRANGE_NAMES_NZ': [u'Anemias', u'Disorders of the peripheral nervous system', u'Hypertensive disease', u'Diseases of esophagus, stomach, and duodenum', u'Other diseases of urinary system', u'Arthropathies and related disorders', u'Dorsopathies', u'Rheumatism, excluding the back', u'Osteopathies, chondropathies, and acquired musculoskeletal deformities', u'General symptoms', u'Symptoms involving urinary system', u'Fractures', u'Range name na'], 'MEDS_NZ': [u'Analgesics', u'Anti-Anxiety Agents', u'Anti-Arrhythmia Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Anti-Ulcer Agents', u'Anticonvulsants', u'Antihypertensive Agents', u'Antipyretics', u'Calcium Channel Blockers', u'Cyclooxygenase Inhibitors', u'Serotonin Uptake Inhibitors'], 'JDRANGE_NZ': ['280-285.99', '350-359.99', '401-405.99', '530-538', '590-599.99', '710-719.99', '720-724.99', '725-729.99', '730-739.99', '780-780.99', '788-788.99', '800-829.99', 'RANGE NA'], 'PERCENT_PTS': 0.10472034906783023, 'LAMBDA': 9814.3370139163617}), (12, {'JDRANGE_NAMES_NZ': [u'Disorders of lipoid metabolism', u'Organic sleep disorders', u'Hypertensive disease', u'Ischemic heart disease', u'Other forms of heart disease', u'Acute respiratory infections', u'Arthropathies and related disorders', u'Dorsopathies', u'Rheumatism, excluding the back', u'Symptoms involving respiratory system and other chest symptoms', u'Other symptoms involving abdomen and pelvis', u'Range name na'], 'MEDS_NZ': [u'Anti-Allergic Agents', u'Anti-Arrhythmia Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Anticholesteremic Agents', u'Anticoagulants', u'Antipyretics', u'Cyclooxygenase Inhibitors', u'Fibrinolytic Agents', u'Histamine H1 Antagonists, Non-Sedating', u'Hydroxymethylglutaryl-CoA Reductase Inhibitors', u'Hypolipidemic Agents', u'Platelet Aggregation Inhibitors', u'Rodenticides', u'Sympatholytics'], 'JDRANGE_NZ': ['272-272.99', '327-327.9', '401-405.99', '410-414.99', '420-429.99', '460-466.99', '710-719.99', '720-724.99', '725-729.99', '786-786.99', '789-789.99', 'RANGE NA'], 'PERCENT_PTS': 0.10194367314557715, 'LAMBDA': 10042.924136329215}), (20, {'JDRANGE_NAMES_NZ': [u'Malignant neoplasm of skin', u'Neoplasm of uncertain behavior of other sites & tissues', u'Hypertensive disease', u'Other forms of heart disease', u'Infections of skin and subcutaneous tissue', u'Other inflammatory conditions of skin and subcutaneous tissue', u'Other diseases of skin and subcutaneous tissue', u'Arthropathies and related disorders', u'Dorsopathies', u'Rheumatism, excluding the back', u'Osteopathies, chondropathies, and acquired musculoskeletal deformities', u'Symptoms involving skin and other integumentary tissue', u'Range name na'], 'MEDS_NZ': [u'Anti-Arrhythmia Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Antihypertensive Agents', u'Antipyretics', u'Bone Density Conservation Agents', u'Cyclooxygenase Inhibitors', u'Diuretics', u'Fibrinolytic Agents', u'Platelet Aggregation Inhibitors', u'Vasodilator Agents', u'Vitamins'], 'JDRANGE_NZ': ['172-173.99', '238-238.99', '401-405.99', '420-429.99', '680-686.99', '690-698.99', '700-709.99', '710-719.99', '720-724.99', '725-729.99', '730-739.99', '782-782.99', 'RANGE NA'], 'PERCENT_PTS': 0.11225704085680285, 'LAMBDA': 10143.626549702785}), (42, {'JDRANGE_NAMES_NZ': [u'Disorders of lipoid metabolism', u'Disorders of the eye and adnexa', u'Hypertensive disease', u'Acute respiratory infections', u'Other diseases of the upper respiratory tract', u'Arthropathies and related disorders', u'Dorsopathies', u'Rheumatism, excluding the back', u'General symptoms', u'Symptoms involving head and neck', u'Symptoms involving respiratory system and other chest symptoms', u'Symptoms involving digestive system', u'Range name na'], 'MEDS_NZ': [u'Analgesics', u'Anti-Anxiety Agents', u'Anticonvulsants', u'Antidepressive Agents, Second-Generation', u'Antiemetics', u'GABA Modulators', u'Histamine H1 Antagonists', u'Hypnotics and Sedatives', u'Serotonin Uptake Inhibitors'], 'JDRANGE_NZ': ['272-272.99', '360-379.99', '401-405.99', '460-466.99', '470-478.99', '710-719.99', '720-724.99', '725-729.99', '780-780.99', '784-784.99', '786-786.99', '787-787.99', 'RANGE NA'], 'PERCENT_PTS': 0.10908369694565649, 'LAMBDA': 10289.820322355141}), (22, {'JDRANGE_NAMES_NZ': [u'Disorders of lipoid metabolism', u'Disorders of the eye and adnexa', u'Hypertensive disease', u'Acute respiratory infections', u'Other diseases of the upper respiratory tract', u'Chronic obstructive pulmonary disease and allied conditions', u'Diseases of esophagus, stomach, and duodenum', u'Dorsopathies', u'Symptoms involving skin and other integumentary tissue', u'Symptoms involving head and neck', u'Symptoms involving respiratory system and other chest symptoms'], 'MEDS_NZ': [u'Adrenergic beta-2 Receptor Agonists', u'Anti-Allergic Agents', u'Anti-Bacterial Agents', u'Anti-Inflammatory Agents', u'Anti-Ulcer Agents', u'Antihypertensive Agents', u'Bronchodilator Agents', u'Dermatologic Agents', u'Glucocorticoids', u'Histamine H1 Antagonists, Non-Sedating', u'Lipoxygenase Inhibitors', u'Proton Pump Inhibitors'], 'JDRANGE_NZ': ['272-272.99', '360-379.99', '401-405.99', '460-466.99', '470-478.99', '490-496.99', '530-538', '720-724.99', '782-782.99', '784-784.99', '786-786.99'], 'PERCENT_PTS': 0.11662038873462911, 'LAMBDA': 10644.787098918441}), (34, {'JDRANGE_NAMES_NZ': [u'Disorders of thyroid gland', u'Diabetes', u'Disorders of lipoid metabolism', u'Disorders of the eye and adnexa', u'Hypertensive disease', u'Other forms of heart disease', u'Diseases of veins and lymphatics, and other diseases of circulatory system', u'Arthropathies and related disorders', u'Dorsopathies', u'Rheumatism, excluding the back', u'General symptoms', u'Symptoms involving skin and other integumentary tissue', u'Range name na'], 'MEDS_NZ': [u'Anti-Arrhythmia Agents', u'Anticholesteremic Agents', u'Anticoagulants', u'Antihypertensive Agents', u'Calcium Channel Blockers', u'Diuretics', u'Rodenticides', u'Sodium Potassium Chloride Symporter Inhibitors', u'Sympatholytics', u'Vasodilator Agents'], 'JDRANGE_NZ': ['240-246.99', '249-250.99', '272-272.99', '360-379.99', '401-405.99', '420-429.99', '451-459.99', '710-719.99', '720-724.99', '725-729.99', '780-780.99', '782-782.99', 'RANGE NA'], 'PERCENT_PTS': 0.11424038080126933, 'LAMBDA': 10956.184362436223}), (48, {'JDRANGE_NAMES_NZ': [u'Disorders of thyroid gland', u'Disorders of lipoid metabolism', u'Hypertensive disease', u'Acute respiratory infections', u'Diseases of esophagus, stomach, and duodenum', u'Arthropathies and related disorders', u'Rheumatism, excluding the back', u'Osteopathies, chondropathies, and acquired musculoskeletal deformities', u'General symptoms', u'Symptoms involving respiratory system and other chest symptoms', u'Symptoms involving digestive system', u'Other symptoms involving abdomen and pelvis', u'Nonspecific findings on examination of blood'], 'MEDS_NZ': [u'Anti-Inflammatory Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Anti-Ulcer Agents', u'Antihypertensive Agents', u'Antipyretics', u'Bone Density Conservation Agents', u'Cyclooxygenase Inhibitors', u'Fibrinolytic Agents', u'Hydroxymethylglutaryl-CoA Reductase Inhibitors', u'Platelet Aggregation Inhibitors', u'Proton Pump Inhibitors', u'Vasodilator Agents', u'Vitamins'], 'JDRANGE_NZ': ['240-246.99', '272-272.99', '401-405.99', '460-466.99', '530-538', '710-719.99', '725-729.99', '730-739.99', '780-780.99', '786-786.99', '787-787.99', '789-789.99', '790-790.99'], 'PERCENT_PTS': 0.10908369694565649, 'LAMBDA': 11354.176449731955}), (0, {'JDRANGE_NAMES_NZ': [u'Disorders of lipoid metabolism', u'Hereditary and degenerative diseases of the central nervous system', u'Hypertensive disease', u'Cerebrovascular disease', u'Other diseases of urinary system', u'Diseases of male genital organs', u'Arthropathies and related disorders', u'Dorsopathies', u'General symptoms', u'Symptoms involving head and neck', u'Symptoms involving respiratory system and other chest symptoms', u'Symptoms involving urinary system', u'Range name na'], 'MEDS_NZ': [u'Angiotensin-Converting Enzyme Inhibitors', u'Anti-Arrhythmia Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Anticholesteremic Agents', u'Antihypertensive Agents', u'Antipyretics', u'Cyclooxygenase Inhibitors', u'Fibrinolytic Agents', u'Hydroxymethylglutaryl-CoA Reductase Inhibitors', u'Hypolipidemic Agents', u'Platelet Aggregation Inhibitors', u'Vasodilator Agents'], 'JDRANGE_NZ': ['272-272.99', '330-337.99', '401-405.99', '430-438.99', '590-599.99', '600-608.99', '710-719.99', '720-724.99', '780-780.99', '784-784.99', '786-786.99', '788-788.99', 'RANGE NA'], 'PERCENT_PTS': 0.1269337564458548, 'LAMBDA': 11833.835017718413}), (46, {'JDRANGE_NAMES_NZ': [u'Disorders of thyroid gland', u'Diabetes', u'Disorders of lipoid metabolism', u'Overweight, obesity and other hyperalimentation', u'Organic sleep disorders', u'Hypertensive disease', u'Diseases of esophagus, stomach, and duodenum', u'Dorsopathies', u'General symptoms', u'Symptoms involving respiratory system and other chest symptoms', u'Other symptoms involving abdomen and pelvis', u'Range name na'], 'MEDS_NZ': [u'Anti-Allergic Agents', u'Anti-Arrhythmia Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Anti-Ulcer Agents', u'Anticholesteremic Agents', u'Antihypertensive Agents', u'Antipyretics', u'Calcium Channel Blockers', u'Cyclooxygenase Inhibitors', u'Diuretics', u'Fibrinolytic Agents', u'Hydroxymethylglutaryl-CoA Reductase Inhibitors', u'Platelet Aggregation Inhibitors', u'Sodium Chloride Symporter Inhibitors', u'Vasodilator Agents'], 'JDRANGE_NZ': ['240-246.99', '249-250.99', '272-272.99', '278-278.99', '327-327.9', '401-405.99', '530-538', '720-724.99', '780-780.99', '786-786.99', '789-789.99', 'RANGE NA'], 'PERCENT_PTS': 0.12653708845696152, 'LAMBDA': 12967.757845354065}), (9, {'JDRANGE_NAMES_NZ': [u'Diabetes', u'Nutritional deficiencies', u'Disorders of lipoid metabolism', u'Organic sleep disorders', u'Disorders of the eye and adnexa', u'Diseases of the ear and mastoid process', u'Hypertensive disease', u'Other diseases of the upper respiratory tract', u'Arthropathies and related disorders', u'Rheumatism, excluding the back', u'Symptoms involving skin and other integumentary tissue', u'Symptoms involving urinary system', u'Range name na'], 'MEDS_NZ': [u'Angiotensin-Converting Enzyme Inhibitors', u'Anti-Allergic Agents', u'Anti-Inflammatory Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Anticholesteremic Agents', u'Antihypertensive Agents', u'Antipyretics', u'Cyclooxygenase Inhibitors', u'Fibrinolytic Agents', u'Hydroxymethylglutaryl-CoA Reductase Inhibitors', u'Hypoglycemic Agents', u'Hypolipidemic Agents', u'Platelet Aggregation Inhibitors'], 'JDRANGE_NZ': ['249-250.99', '260-269.99', '272-272.99', '327-327.9', '360-379.99', '380-389.99', '401-405.99', '470-478.99', '710-719.99', '725-729.99', '782-782.99', '788-788.99', 'RANGE NA'], 'PERCENT_PTS': 0.12138040460134868, 'LAMBDA': 13142.695101146264}), (13, {'JDRANGE_NAMES_NZ': [u'Diabetes', u'Disorders of lipoid metabolism', u'Disorders of the eye and adnexa', u'Hypertensive disease', u'Ischemic heart disease', u'Dorsopathies', u'Rheumatism, excluding the back', u'General symptoms', u'Range name na'], 'MEDS_NZ': [u'Adrenergic beta-1 Receptor Antagonists', u'Angiotensin-Converting Enzyme Inhibitors', u'Anti-Arrhythmia Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Anticholesteremic Agents', u'Antihypertensive Agents', u'Antipyretics', u'Cyclooxygenase Inhibitors', u'Fibrinolytic Agents', u'Hydroxymethylglutaryl-CoA Reductase Inhibitors', u'Hypoglycemic Agents', u'Hypolipidemic Agents', u'Platelet Aggregation Inhibitors', u'Sympatholytics', u'Vasodilator Agents'], 'JDRANGE_NZ': ['249-250.99', '272-272.99', '360-379.99', '401-405.99', '410-414.99', '720-724.99', '725-729.99', '780-780.99', 'RANGE NA'], 'PERCENT_PTS': 0.14240380801269337, 'LAMBDA': 14356.204431782757}), (27, {'JDRANGE_NAMES_NZ': [u'Nutritional deficiencies', u'Disorders of lipoid metabolism', u'Anemias', u'Disorders of the eye and adnexa', u'Diseases of the ear and mastoid process', u'Hypertensive disease', u'Other diseases of intestines and peritoneum', u'Dorsopathies', u'General symptoms', u'Symptoms involving head and neck', u'Symptoms involving respiratory system and other chest symptoms', u'Symptoms involving urinary system', u'Range name na'], 'MEDS_NZ': [u'Angiotensin-Converting Enzyme Inhibitors', u'Anti-Allergic Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Anti-Ulcer Agents', u'Antihypertensive Agents', u'Antioxidants', u'Antipyretics', u'Bone Density Conservation Agents', u'Calcium Channel Blockers', u'Cardiotonic Agents', u'Cyclooxygenase Inhibitors', u'Fibrinolytic Agents', u'Hydroxymethylglutaryl-CoA Reductase Inhibitors', u'Platelet Aggregation Inhibitors', u'Vasodilator Agents', u'Vitamins'], 'JDRANGE_NZ': ['260-269.99', '272-272.99', '280-285.99', '360-379.99', '380-389.99', '401-405.99', '560-569.99', '720-724.99', '780-780.99', '784-784.99', '786-786.99', '788-788.99', 'RANGE NA'], 'PERCENT_PTS': 0.12098373661245537, 'LAMBDA': 14398.627540075508}), (44, {'JDRANGE_NAMES_NZ': [u'Mycoses', u'Diabetes', u'Disorders of lipoid metabolism', u'Disorders of the eye and adnexa', u'Hypertensive disease', u'Ischemic heart disease', u'Diseases of esophagus, stomach, and duodenum', u'Other diseases of intestines and peritoneum', u'Other inflammatory conditions of skin and subcutaneous tissue', u'Other diseases of skin and subcutaneous tissue', u'Arthropathies and related disorders', u'Rheumatism, excluding the back', u'Osteopathies, chondropathies, and acquired musculoskeletal deformities', u'Range name na'], 'MEDS_NZ': [u'Angiotensin-Converting Enzyme Inhibitors', u'Anti-Arrhythmia Agents', u'Anti-Inflammatory Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Anti-Ulcer Agents', u'Anticholesteremic Agents', u'Antihypertensive Agents', u'Antipyretics', u'Cardiotonic Agents', u'Cyclooxygenase Inhibitors', u'Diuretics', u'Fibrinolytic Agents', u'Hydroxymethylglutaryl-CoA Reductase Inhibitors', u'Hypolipidemic Agents', u'Platelet Aggregation Inhibitors', u'Proton Pump Inhibitors'], 'JDRANGE_NZ': ['110-118.99', '249-250.99', '272-272.99', '360-379.99', '401-405.99', '410-414.99', '530-538', '560-569.99', '690-698.99', '700-709.99', '710-719.99', '725-729.99', '730-739.99', 'RANGE NA'], 'PERCENT_PTS': 0.11106703689012297, 'LAMBDA': 14807.748109322352}), (2, {'JDRANGE_NAMES_NZ': [u'Disorders of lipoid metabolism', u'Hypertensive disease', u'Ischemic heart disease', u'Other forms of heart disease', u'Arthropathies and related disorders', u'Rheumatism, excluding the back', u'General symptoms', u'Symptoms involving skin and other integumentary tissue', u'Symptoms involving cardiovascular system', u'Symptoms involving respiratory system and other chest symptoms', u'Nonspecific findings on examination of blood', u'Range name na'], 'MEDS_NZ': [u'Adrenergic beta-1 Receptor Antagonists', u'Angiotensin-Converting Enzyme Inhibitors', u'Anti-Arrhythmia Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Anticholesteremic Agents', u'Antihypertensive Agents', u'Antipyretics', u'Calcium Channel Blockers', u'Cyclooxygenase Inhibitors', u'Diuretics', u'Fibrinolytic Agents', u'Hydroxymethylglutaryl-CoA Reductase Inhibitors', u'Platelet Aggregation Inhibitors', u'Sodium Chloride Symporter Inhibitors', u'Sympatholytics', u'Vasodilator Agents'], 'JDRANGE_NZ': ['272-272.99', '401-405.99', '410-414.99', '420-429.99', '710-719.99', '725-729.99', '780-780.99', '782-782.99', '785-785.99', '786-786.99', '790-790.99', 'RANGE NA'], 'PERCENT_PTS': 0.12217374057913527, 'LAMBDA': 15230.183636550049}), (47, {'JDRANGE_NAMES_NZ': [u'Diabetes', u'Disorders of lipoid metabolism', u'Disorders of the eye and adnexa', u'Diseases of the ear and mastoid process', u'Hypertensive disease', u'Acute respiratory infections', u'Other diseases of the upper respiratory tract', u'Arthropathies and related disorders', u'Rheumatism, excluding the back', u'Symptoms involving respiratory system and other chest symptoms', u'Range name na'], 'MEDS_NZ': [u'Anti-Allergic Agents', u'Anti-Inflammatory Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Anticholesteremic Agents', u'Antihypertensive Agents', u'Antipyretics', u'Cyclooxygenase Inhibitors', u'Diuretics', u'Fibrinolytic Agents', u'Hydroxymethylglutaryl-CoA Reductase Inhibitors', u'Hypoglycemic Agents', u'Hypolipidemic Agents', u'Platelet Aggregation Inhibitors', u'Sodium Chloride Symporter Inhibitors', u'Vasodilator Agents'], 'JDRANGE_NZ': ['249-250.99', '272-272.99', '360-379.99', '380-389.99', '401-405.99', '460-466.99', '470-478.99', '710-719.99', '725-729.99', '786-786.99', 'RANGE NA'], 'PERCENT_PTS': 0.1384371281237604, 'LAMBDA': 15273.233329944334}), (5, {'JDRANGE_NAMES_NZ': [u'Disorders of lipoid metabolism', u'Disorders of fluid, electrolyte, and acid-base balance', u'Anemias', u'Disorders of the eye and adnexa', u'Hypertensive disease', u'Ischemic heart disease', u'Other forms of heart disease', u'Other diseases of respiratory system', u'Nephritis, nephrotic syndrome, and nephrosis', u'Symptoms involving respiratory system and other chest symptoms', u'Range name na'], 'MEDS_NZ': [u'Adrenergic beta-1 Receptor Antagonists', u'Anti-Arrhythmia Agents', u'Anti-Inflammatory Agents, Non-Steroidal', u'Anticholesteremic Agents', u'Antihypertensive Agents', u'Antipyretics', u'Cyclooxygenase Inhibitors', u'Diuretics', u'Fibrinolytic Agents', u'Hydroxymethylglutaryl-CoA Reductase Inhibitors', u'Hypolipidemic Agents', u'Platelet Aggregation Inhibitors', u'Sodium Potassium Chloride Symporter Inhibitors', u'Sympatholytics', u'Vasodilator Agents'], 'JDRANGE_NZ': ['272-272.99', '276-276.99', '280-285.99', '360-379.99', '401-405.99', '410-414.99', '420-429.99', '510-519.99', '580-589.99', '786-786.99', 'RANGE NA'], 'PERCENT_PTS': 0.11939706465688218, 'LAMBDA': 16186.289553850198})])"
       ]
      }
     ],
     "prompt_number": 111
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "#write output file\n",
      "pheno_outstream = open(pickle_folder + \"phenotypes\"+gamma_str+\".out\", 'w+')\n",
      "    \n",
      "\n",
      "##############################################################################################################\n",
      "\n",
      "#tensor with all phenotypes (factorization)\n",
      "ktensor_phenotypes = pheno_htn_subset_analyzed_REG_withGamma[0]\n",
      "l_pts = loaded_axisDict[0].keys()\n",
      "l_jdrange = loaded_axisDict[1].keys()\n",
      "l_meds= loaded_axisDict[2].keys()\n",
      "\n",
      "#will store all the data\n",
      "d_pheno_nonzero_labels = OrderedDict()\n",
      "\n",
      "\n",
      "#sort phenotypes by lambda values:\n",
      "d_lambda_phenoNumber = OrderedDict(zip( list(range(R)), \n",
      "                                        list(ktensor_phenotypes.lmbda)\n",
      "                                        ))\n",
      "l_phenoNumbers_sorted_by_lambda = [tup[0] for tup in sorted(d_lambda_phenoNumber.iteritems(), key=operator.itemgetter(1))]  #get a sorted list of phenotype numbers, which are sorted by using the operator.itemgetter                                \n",
      "\n",
      "#print phenotype feature names #################\n",
      "#for i in range(10):\n",
      "for i in l_phenoNumbers_sorted_by_lambda:\n",
      "    print \"===== phenotype \" + str(i) + \"=================================================================\"\n",
      "    pheno_outstream.write(\"===== phenotype \" + str(i) + \"=================================================================\" + '\\n')\n",
      "    this_lmbda = ktensor_phenotypes.lmbda[i]\n",
      "    this_pheno_pt_factor = ktensor_phenotypes.U[0][:,i]\n",
      "    this_pheno_jdrange_factor = ktensor_phenotypes.U[1][:,i]\n",
      "    this_pheno_med_factor = ktensor_phenotypes.U[2][:,i]\n",
      "    \n",
      "    this_pheno_pt_nnz = np.nonzero(this_pheno_pt_factor)[0]\n",
      "    this_pheno_jdrange_nnz = np.nonzero(this_pheno_jdrange_factor)[0]\n",
      "    this_pheno_med_nnz = np.nonzero(this_pheno_med_factor)[0]\n",
      "    \n",
      "    l_nonzero_pt_thisPheno = []\n",
      "    l_nonzero_meds_thisPheno = []\n",
      "    l_nonzero_jdrange_thisPheno = []\n",
      "    l_nonzero_jdrange_names_thisPheno = []\n",
      "    \n",
      "    for j in this_pheno_pt_nnz:\n",
      "        l_nonzero_pt_thisPheno.append(l_pts[j])\n",
      "    for j in this_pheno_jdrange_nnz:\n",
      "        l_nonzero_jdrange_thisPheno.append(l_jdrange[j])\n",
      "        l_nonzero_jdrange_names_thisPheno.append(d_jdrange_lookup[l_jdrange[j]])\n",
      "    for j in this_pheno_med_nnz:\n",
      "        l_nonzero_meds_thisPheno.append(l_meds[j])\n",
      "    \n",
      "    #data\n",
      "    d_pheno_nonzero_labels[i] = dict() #for phenotype i\n",
      "    d_pheno_nonzero_labels[i]['LAMBDA'] = this_lmbda #lambda value\n",
      "    d_pheno_nonzero_labels[i]['PERCENT_PTS'] = len(l_nonzero_pt_thisPheno) / float(len(this_pheno_pt_factor))\n",
      "    d_pheno_nonzero_labels[i]['MEDS_NZ'] = l_nonzero_meds_thisPheno #for phenotype i\n",
      "    d_pheno_nonzero_labels[i]['JDRANGE_NZ'] = l_nonzero_jdrange_thisPheno #for phenotype i   \n",
      "    d_pheno_nonzero_labels[i]['JDRANGE_NAMES_NZ'] = l_nonzero_jdrange_names_thisPheno #for phenotype i \n",
      "    \n",
      "    print \"proportion of pts: \" + str(d_pheno_nonzero_labels[i]['PERCENT_PTS'])\n",
      "    pheno_outstream.write(\"proportion of pts: \" + str(d_pheno_nonzero_labels[i]['PERCENT_PTS']) + '\\n')\n",
      "    print \"lambda: \" + str(this_lmbda)\n",
      "    pheno_outstream.write(\"lambda: \" + str(this_lmbda) + '\\n')\n",
      "    print \"----------------------------------------\" #divider\n",
      "    pheno_outstream.write(\"----------------------------------------\" + '\\n')\n",
      "    #print \"\\tnumber jdrange: \" + str(len(d_pheno_nonzero_labels[i]['JDRANGE_NZ']))\n",
      "    #print \"\\tjdrange: \" + str(d_pheno_nonzero_labels[i]['JDRANGE_NZ'])\n",
      "    for jdrange in d_pheno_nonzero_labels[i]['JDRANGE_NZ']:\n",
      "        index_this_jdrange = loaded_axisDict[1][jdrange]\n",
      "        print d_jdrange_lookup[jdrange] + '\\t' + str(\"%.3f\" %this_pheno_jdrange_factor[index_this_jdrange] )\n",
      "        pheno_outstream.write(str(d_jdrange_lookup[jdrange]) + '\\t' + str(\"%.3f\" %this_pheno_jdrange_factor[index_this_jdrange])  +'\\n')\n",
      "    #print \"\\tnumber meds: \" + str(len(d_pheno_nonzero_labels[i]['MEDS_NZ']))\n",
      "    #print \"\\tmeds: \" + str(d_pheno_nonzero_labels[i]['MEDS_NZ'])\n",
      "    print \"----------------------------------------\" #divider between diagnostic codes and meds\n",
      "    pheno_outstream.write(\"----------------------------------------\" + '\\n')\n",
      "    for med in d_pheno_nonzero_labels[i]['MEDS_NZ']:\n",
      "        index_this_med = loaded_axisDict[2][med]\n",
      "        print med  + '\\t' + str(\"%.3f\" %this_pheno_med_factor[index_this_med])\n",
      "        pheno_outstream.write(med + '\\t' + str(\"%.3f\" %this_pheno_jdrange_factor[index_this_jdrange]) + '\\n')\n",
      "pheno_outstream.close()"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "===== phenotype 23=================================================================\n",
        "proportion of pts: 0.0\n",
        "lambda: 1.0\n",
        "----------------------------------------\n",
        "----------------------------------------\n",
        "===== phenotype 41=================================================================\n",
        "proportion of pts: 0.0\n",
        "lambda: 1.0\n",
        "----------------------------------------\n",
        "----------------------------------------\n",
        "===== phenotype 10=================================================================\n",
        "proportion of pts: 0.0714002380008\n",
        "lambda: 738.671514815\n",
        "----------------------------------------\n",
        "Disorders of fluid, electrolyte, and acid-base balance\t0.095\n",
        "Anemias\t0.100\n",
        "Pain\t0.085\n",
        "Hypertensive disease\t0.096\n",
        "Other forms of heart disease\t0.114\n",
        "Pneumonia and influenza\t0.057\n",
        "Other diseases of respiratory system\t0.116\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\t0.050\n",
        "Symptoms involving cardiovascular system\t0.074\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.118\n",
        "Range name na\t0.094\n",
        "----------------------------------------\n",
        "Anti-Anxiety Agents\t1.000\n",
        "===== phenotype 26=================================================================\n",
        "proportion of pts: 0.0610868702896\n",
        "lambda: 912.984509752\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\t0.097\n",
        "Hypertensive disease\t0.139\n",
        "Ischemic heart disease\t0.090\n",
        "Other forms of heart disease\t0.091\n",
        "Cerebrovascular disease\t0.054\n",
        "Diseases of arteries, arterioles, and capillaries\t0.054\n",
        "Other diseases of respiratory system\t0.065\n",
        "Rheumatism, excluding the back\t0.087\n",
        "General symptoms\t0.085\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.107\n",
        "Range name na\t0.131\n",
        "----------------------------------------\n",
        "Surface-Active Agents\t1.000\n",
        "===== phenotype 4=================================================================\n",
        "proportion of pts: 0.0833002776676\n",
        "lambda: 1303.75745431\n",
        "----------------------------------------\n",
        "Diabetes\t0.082\n",
        "Disorders of lipoid metabolism\t0.073\n",
        "Overweight, obesity and other hyperalimentation\t0.133\n",
        "Anemias\t0.066\n",
        "Neurotic, personality, nonpsychotic disorders\t0.061\n",
        "Organic sleep disorders\t0.079\n",
        "Hypertensive disease\t0.089\n",
        "Acute respiratory infections\t0.092\n",
        "Dorsopathies\t0.079\n",
        "Symptoms involving skin and other integumentary tissue\t0.109\n",
        "Symptoms involving head and neck\t0.059\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.079\n",
        "----------------------------------------\n",
        "Antihypertensive Agents\t0.386\n",
        "Calcium Channel Blockers\t0.614\n",
        "===== phenotype 6=================================================================\n",
        "proportion of pts: 0.078143593812\n",
        "lambda: 2639.53337082\n",
        "----------------------------------------\n",
        "Overweight, obesity and other hyperalimentation\t0.056\n",
        "Na\t0.109\n",
        "Neurotic, personality, nonpsychotic disorders\t0.099\n",
        "Organic sleep disorders\t0.085\n",
        "Hypertensive disease\t0.104\n",
        "Diseases of esophagus, stomach, and duodenum\t0.086\n",
        "Other diseases of intestines and peritoneum\t0.065\n",
        "Other diseases of urinary system\t0.064\n",
        "General symptoms\t0.066\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.070\n",
        "Other symptoms involving abdomen and pelvis\t0.103\n",
        "Range name na\t0.093\n",
        "----------------------------------------\n",
        "Anti-Anxiety Agents\t0.234\n",
        "Antidepressive Agents, Second-Generation\t0.286\n",
        "Antihypertensive Agents\t0.180\n",
        "Serotonin Uptake Inhibitors\t0.299\n",
        "===== phenotype 14=================================================================\n",
        "proportion of pts: 0.0880602935343\n",
        "lambda: 2792.22726412\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\t0.096\n",
        "Anemias\t0.078\n",
        "Hypertensive disease\t0.137\n",
        "Diseases of esophagus, stomach, and duodenum\t0.073\n",
        "Other diseases of intestines and peritoneum\t0.066\n",
        "Nephritis, nephrotic syndrome, and nephrosis\t0.087\n",
        "Other diseases of urinary system\t0.116\n",
        "Operations on the musculoskeletal system\t0.055\n",
        "Symptoms involving urinary system\t0.117\n",
        "Nonspecific findings on examination of blood\t0.067\n",
        "Range name na\t0.107\n",
        "----------------------------------------\n",
        "Antihypertensive Agents\t0.154\n",
        "Antirheumatic Agents\t0.179\n",
        "Dermatologic Agents\t0.215\n",
        "Enzyme Inhibitors\t0.248\n",
        "Immunosuppressive Agents\t0.204\n",
        "===== phenotype 33=================================================================\n",
        "proportion of pts: 0.0971836572789\n",
        "lambda: 2966.03992486\n",
        "----------------------------------------\n",
        "Other disorders of the central nervous system\t0.058\n",
        "Hypertensive disease\t0.118\n",
        "Other forms of heart disease\t0.083\n",
        "Acute respiratory infections\t0.072\n",
        "Other diseases of the upper respiratory tract\t0.066\n",
        "Pneumonia and influenza\t0.086\n",
        "Other diseases of respiratory system\t0.086\n",
        "Other diseases of urinary system\t0.091\n",
        "General symptoms\t0.106\n",
        "Symptoms involving nervous and musculoskeletal systems\t0.055\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.109\n",
        "Symptoms involving urinary system\t0.069\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\t0.248\n",
        "Anti-Bacterial Agents\t0.340\n",
        "Antihypertensive Agents\t0.204\n",
        "Bronchodilator Agents\t0.208\n",
        "===== phenotype 1=================================================================\n",
        "proportion of pts: 0.0995636652122\n",
        "lambda: 3256.85495007\n",
        "----------------------------------------\n",
        "Diabetes\t0.094\n",
        "Nutritional deficiencies\t0.062\n",
        "Disorders of lipoid metabolism\t0.099\n",
        "Gout\t0.054\n",
        "Organic sleep disorders\t0.090\n",
        "Disorders of the eye and adnexa\t0.077\n",
        "Hypertensive disease\t0.115\n",
        "Diseases of esophagus, stomach, and duodenum\t0.062\n",
        "Arthropathies and related disorders\t0.065\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.068\n",
        "Nonspecific findings on examination of blood\t0.090\n",
        "Abnormal results of function studies\t0.053\n",
        "Range name na\t0.072\n",
        "----------------------------------------\n",
        "Analgesics\t0.264\n",
        "Antihypertensive Agents\t0.183\n",
        "Calcium Channel Blockers\t0.315\n",
        "Vasodilator Agents\t0.237\n",
        "===== phenotype 30=================================================================\n",
        "proportion of pts: 0.0920269734232\n",
        "lambda: 3301.25499568\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\t0.104\n",
        "Disorders of the eye and adnexa\t0.095\n",
        "Hypertensive disease\t0.141\n",
        "Ischemic heart disease\t0.064\n",
        "Other forms of heart disease\t0.138\n",
        "Other diseases of respiratory system\t0.063\n",
        "General symptoms\t0.087\n",
        "Symptoms involving cardiovascular system\t0.057\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.136\n",
        "Range name na\t0.116\n",
        "----------------------------------------\n",
        "Antimetabolites, Antineoplastic\t0.180\n",
        "Antirheumatic Agents\t0.181\n",
        "Dermatologic Agents\t0.193\n",
        "Enzyme Inhibitors\t0.233\n",
        "Immunosuppressive Agents\t0.213\n",
        "===== phenotype 15=================================================================\n",
        "proportion of pts: 0.0908369694566\n",
        "lambda: 3458.8431866\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\t0.071\n",
        "Organic sleep disorders\t0.066\n",
        "Disorders of the eye and adnexa\t0.058\n",
        "Hypertensive disease\t0.079\n",
        "Diseases of esophagus, stomach, and duodenum\t0.053\n",
        "Other diseases of urinary system\t0.067\n",
        "Diseases of male genital organs\t0.058\n",
        "Arthropathies and related disorders\t0.076\n",
        "Dorsopathies\t0.096\n",
        "Rheumatism, excluding the back\t0.076\n",
        "General symptoms\t0.058\n",
        "Symptoms involving urinary system\t0.079\n",
        "Nonspecific findings on examination of blood\t0.076\n",
        "Range name na\t0.088\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\t0.245\n",
        "Anti-Inflammatory Agents\t0.243\n",
        "Anti-Ulcer Agents\t0.256\n",
        "Bronchodilator Agents\t0.256\n",
        "===== phenotype 29=================================================================\n",
        "proportion of pts: 0.0900436334788\n",
        "lambda: 3942.2034969\n",
        "----------------------------------------\n",
        "Disorders of fluid, electrolyte, and acid-base balance\t0.074\n",
        "Anemias\t0.074\n",
        "Other diseases of the blood\t0.054\n",
        "Hypertensive disease\t0.066\n",
        "Liver\t0.097\n",
        "Other diseases of urinary system\t0.080\n",
        "Dorsopathies\t0.065\n",
        "Symptoms involving skin and other integumentary tissue\t0.066\n",
        "Symptoms involving digestive system\t0.159\n",
        "Symptoms involving urinary system\t0.059\n",
        "Other symptoms involving abdomen and pelvis\t0.126\n",
        "Nonspecific findings on examination of blood\t0.080\n",
        "----------------------------------------\n",
        "Anti-Arrhythmia Agents\t0.150\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.129\n",
        "Anti-Ulcer Agents\t0.156\n",
        "Antihypertensive Agents\t0.152\n",
        "Antipyretics\t0.132\n",
        "Cyclooxygenase Inhibitors\t0.133\n",
        "Vasodilator Agents\t0.148\n",
        "===== phenotype 36=================================================================\n",
        "proportion of pts: 0.0924236414121\n",
        "lambda: 4012.31989703\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\t0.061\n",
        "Pain\t0.063\n",
        "Other disorders of the central nervous system\t0.054\n",
        "Disorders of the eye and adnexa\t0.055\n",
        "Hypertensive disease\t0.099\n",
        "Other diseases of urinary system\t0.057\n",
        "Other disorders of female genital tract\t0.119\n",
        "Arthropathies and related disorders\t0.078\n",
        "Dorsopathies\t0.094\n",
        "Rheumatism, excluding the back\t0.081\n",
        "General symptoms\t0.072\n",
        "Symptoms involving urinary system\t0.064\n",
        "Range name na\t0.103\n",
        "----------------------------------------\n",
        "Analgesics, Non-Narcotic\t0.285\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.141\n",
        "Antihypertensive Agents\t0.141\n",
        "Antipyretics\t0.144\n",
        "Cyclooxygenase Inhibitors\t0.138\n",
        "Estrogens\t0.151\n",
        "===== phenotype 3=================================================================\n",
        "proportion of pts: 0.0983736612455\n",
        "lambda: 4230.51145973\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.112\n",
        "Diseases of esophagus, stomach, and duodenum\t0.081\n",
        "Other diseases of intestines and peritoneum\t0.174\n",
        "Other diseases of digestive system\t0.063\n",
        "Other diseases of urinary system\t0.077\n",
        "Symptoms involving digestive system\t0.137\n",
        "Other symptoms involving abdomen and pelvis\t0.097\n",
        "Certain traumatic complications and unspecified injuries\t0.071\n",
        "Complications of surgical and medical care, not elsewhere classified\t0.082\n",
        "Range name na\t0.106\n",
        "----------------------------------------\n",
        "Analgesics, Opioid\t0.168\n",
        "Anti-Anxiety Agents\t0.130\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.126\n",
        "Antihypertensive Agents\t0.145\n",
        "Antipyretics\t0.136\n",
        "Hypnotics and Sedatives\t0.134\n",
        "Narcotics\t0.161\n",
        "===== phenotype 16=================================================================\n",
        "proportion of pts: 0.0916303054344\n",
        "lambda: 4453.15791422\n",
        "----------------------------------------\n",
        "Diabetes\t0.120\n",
        "Disorders of lipoid metabolism\t0.111\n",
        "Hypertensive disease\t0.117\n",
        "Ischemic heart disease\t0.095\n",
        "Pneumonia and influenza\t0.082\n",
        "Chronic obstructive pulmonary disease and allied conditions\t0.157\n",
        "Other diseases of respiratory system\t0.097\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.130\n",
        "Range name na\t0.091\n",
        "----------------------------------------\n",
        "Adrenergic beta-2 Receptor Agonists\t0.165\n",
        "Antihypertensive Agents\t0.095\n",
        "Antipyretics\t0.118\n",
        "Bronchodilator Agents\t0.183\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.106\n",
        "Tocolytic Agents\t0.205\n",
        "Vasodilator Agents\t0.128\n",
        "===== phenotype 18=================================================================\n",
        "proportion of pts: 0.0912336374455\n",
        "lambda: 4830.42519247\n",
        "----------------------------------------\n",
        "Diabetes\t0.092\n",
        "Disorders of lipoid metabolism\t0.115\n",
        "Na\t0.054\n",
        "Disorders of the peripheral nervous system\t0.081\n",
        "Disorders of the eye and adnexa\t0.095\n",
        "Hypertensive disease\t0.143\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\t0.056\n",
        "Other diseases of skin and subcutaneous tissue\t0.092\n",
        "Rheumatism, excluding the back\t0.090\n",
        "General symptoms\t0.076\n",
        "Range name na\t0.106\n",
        "----------------------------------------\n",
        "Analgesics\t0.136\n",
        "Anti-Anxiety Agents\t0.161\n",
        "Anticonvulsants\t0.167\n",
        "Antihypertensive Agents\t0.067\n",
        "Antiparkinson Agents\t0.166\n",
        "Excitatory Amino Acid Antagonists\t0.167\n",
        "Serotonin Uptake Inhibitors\t0.136\n",
        "===== phenotype 37=================================================================\n",
        "proportion of pts: 0.110670368901\n",
        "lambda: 5159.72067404\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\t0.083\n",
        "Na\t0.157\n",
        "Neurotic, personality, nonpsychotic disorders\t0.102\n",
        "Drug dependence\t0.082\n",
        "Hypertensive disease\t0.111\n",
        "Ischemic heart disease\t0.053\n",
        "Chronic obstructive pulmonary disease and allied conditions\t0.056\n",
        "Arthropathies and related disorders\t0.065\n",
        "Dorsopathies\t0.067\n",
        "Rheumatism, excluding the back\t0.089\n",
        "General symptoms\t0.061\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.074\n",
        "----------------------------------------\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.140\n",
        "Antidepressive Agents, Second-Generation\t0.227\n",
        "Antihypertensive Agents\t0.132\n",
        "Antipyretics\t0.143\n",
        "Cyclooxygenase Inhibitors\t0.137\n",
        "Serotonin Uptake Inhibitors\t0.221\n",
        "===== phenotype 38=================================================================\n",
        "proportion of pts: 0.107100357001\n",
        "lambda: 5363.04749434\n",
        "----------------------------------------\n",
        "Mycoses\t0.052\n",
        "Diabetes\t0.101\n",
        "Disorders of lipoid metabolism\t0.086\n",
        "Anemias\t0.065\n",
        "Disorders of the peripheral nervous system\t0.132\n",
        "Hypertensive disease\t0.089\n",
        "Nephritis, nephrotic syndrome, and nephrosis\t0.088\n",
        "Arthropathies and related disorders\t0.071\n",
        "Rheumatism, excluding the back\t0.066\n",
        "General symptoms\t0.072\n",
        "Symptoms involving skin and other integumentary tissue\t0.062\n",
        "Certain traumatic complications and unspecified injuries\t0.051\n",
        "Range name na\t0.064\n",
        "----------------------------------------\n",
        "Analgesics\t0.161\n",
        "Anticholesteremic Agents\t0.161\n",
        "Anticonvulsants\t0.171\n",
        "Antihypertensive Agents\t0.127\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.168\n",
        "Hypoglycemic Agents\t0.213\n",
        "===== phenotype 35=================================================================\n",
        "proportion of pts: 0.0952003173344\n",
        "lambda: 5387.77229977\n",
        "----------------------------------------\n",
        "Diabetes\t0.060\n",
        "Disorders of lipoid metabolism\t0.073\n",
        "Hypertensive disease\t0.115\n",
        "Acute respiratory infections\t0.057\n",
        "Chronic obstructive pulmonary disease and allied conditions\t0.055\n",
        "Diseases of esophagus, stomach, and duodenum\t0.091\n",
        "Other diseases of urinary system\t0.075\n",
        "Other disorders of female genital tract\t0.072\n",
        "Arthropathies and related disorders\t0.097\n",
        "Rheumatism, excluding the back\t0.084\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.070\n",
        "Symptoms involving digestive system\t0.069\n",
        "Range name na\t0.082\n",
        "----------------------------------------\n",
        "Adrenergic beta-2 Receptor Agonists\t0.089\n",
        "Anti-Allergic Agents\t0.140\n",
        "Anti-Inflammatory Agents\t0.133\n",
        "Anti-Ulcer Agents\t0.146\n",
        "Antihypertensive Agents\t0.095\n",
        "Bronchodilator Agents\t0.140\n",
        "Estrogens\t0.089\n",
        "Proton Pump Inhibitors\t0.168\n",
        "===== phenotype 49=================================================================\n",
        "proportion of pts: 0.104720349068\n",
        "lambda: 5511.10986638\n",
        "----------------------------------------\n",
        "Anemias\t0.066\n",
        "Organic sleep disorders\t0.061\n",
        "Diseases of the ear and mastoid process\t0.061\n",
        "Hypertensive disease\t0.102\n",
        "Other forms of heart disease\t0.118\n",
        "Acute respiratory infections\t0.065\n",
        "Chronic obstructive pulmonary disease and allied conditions\t0.062\n",
        "Arthropathies and related disorders\t0.078\n",
        "General symptoms\t0.084\n",
        "Symptoms involving skin and other integumentary tissue\t0.081\n",
        "Symptoms involving cardiovascular system\t0.051\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.080\n",
        "Range name na\t0.091\n",
        "----------------------------------------\n",
        "Anti-Allergic Agents\t0.166\n",
        "Anti-Inflammatory Agents\t0.197\n",
        "Antihypertensive Agents\t0.133\n",
        "Bronchodilator Agents\t0.159\n",
        "Diuretics\t0.187\n",
        "Sodium Potassium Chloride Symporter Inhibitors\t0.158\n",
        "===== phenotype 7=================================================================\n",
        "proportion of pts: 0.0920269734232\n",
        "lambda: 5559.46739926\n",
        "----------------------------------------\n",
        "Malignant neoplasm of breast\t0.087\n",
        "Disorders of thyroid gland\t0.086\n",
        "Disorders of lipoid metabolism\t0.093\n",
        "Hypertensive disease\t0.129\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\t0.061\n",
        "Other diseases of skin and subcutaneous tissue\t0.055\n",
        "Arthropathies and related disorders\t0.066\n",
        "Dorsopathies\t0.057\n",
        "Rheumatism, excluding the back\t0.069\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\t0.094\n",
        "General symptoms\t0.072\n",
        "Range name na\t0.130\n",
        "----------------------------------------\n",
        "Angiotensin-Converting Enzyme Inhibitors\t0.109\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.084\n",
        "Antihypertensive Agents\t0.100\n",
        "Antineoplastic Agents, Hormonal\t0.084\n",
        "Antipyretics\t0.089\n",
        "Bone Density Conservation Agents\t0.128\n",
        "Cyclooxygenase Inhibitors\t0.081\n",
        "Fibrinolytic Agents\t0.082\n",
        "Hypnotics and Sedatives\t0.107\n",
        "Vitamins\t0.136\n",
        "===== phenotype 40=================================================================\n",
        "proportion of pts: 0.0674335581119\n",
        "lambda: 5773.09931406\n",
        "----------------------------------------\n"
       ]
      },
      {
       "ename": "TypeError",
       "evalue": "unsupported operand type(s) for +: 'float' and 'str'",
       "output_type": "pyerr",
       "traceback": [
        "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m\n\u001b[0;31mTypeError\u001b[0m                                 Traceback (most recent call last)",
        "\u001b[0;32m<ipython-input-125-d13e3e5c138a>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m()\u001b[0m\n\u001b[1;32m     66\u001b[0m     \u001b[0;32mfor\u001b[0m \u001b[0mjdrange\u001b[0m \u001b[0;32min\u001b[0m \u001b[0md_pheno_nonzero_labels\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mi\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m'JDRANGE_NZ'\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     67\u001b[0m         \u001b[0mindex_this_jdrange\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mloaded_axisDict\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;36m1\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mjdrange\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 68\u001b[0;31m         \u001b[0;32mprint\u001b[0m \u001b[0md_jdrange_lookup\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mjdrange\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0;34m'\\t'\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0mstr\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"%.3f\"\u001b[0m \u001b[0;34m%\u001b[0m\u001b[0mthis_pheno_jdrange_factor\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mindex_this_jdrange\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     69\u001b[0m         \u001b[0mpheno_outstream\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mwrite\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mstr\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0md_jdrange_lookup\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mjdrange\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0;34m'\\t'\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0mstr\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"%.3f\"\u001b[0m \u001b[0;34m%\u001b[0m\u001b[0mthis_pheno_jdrange_factor\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mindex_this_jdrange\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m)\u001b[0m  \u001b[0;34m+\u001b[0m\u001b[0;34m'\\n'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     70\u001b[0m     \u001b[0;31m#print \"\\tnumber meds: \" + str(len(d_pheno_nonzero_labels[i]['MEDS_NZ']))\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
        "\u001b[0;31mTypeError\u001b[0m: unsupported operand type(s) for +: 'float' and 'str'"
       ]
      }
     ],
     "prompt_number": 125
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "print \"fdsafdsa\" + str(\"%.3f\" % this_pheno_jdrange_factor[index_this_jdrange])"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "fdsafdsa0.094\n"
       ]
      }
     ],
     "prompt_number": 124
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      ".097+.139+.09+.091+.054+.054+.065+.087+.085+.107+.131"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 130,
       "text": [
        "1.0"
       ]
      }
     ],
     "prompt_number": 130
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "index_this_jdrange"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 131,
       "text": [
        "0"
       ]
      }
     ],
     "prompt_number": 131
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "this_pheno_jdrange_nnz"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 132,
       "text": [
        "array([  0,  69,  73,  82,  89, 100, 102, 103, 109, 143, 153, 157, 172])"
       ]
      }
     ],
     "prompt_number": 132
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "this_pheno_jdrange_factor"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 133,
       "text": [
        "array([ 0.05802756,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.05561218,\n",
        "        0.        ,  0.        ,  0.        ,  0.05389206,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.05736521,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.12921933,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.05485008,  0.        ,  0.06793431,  0.07013347,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.09762368,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.07148776,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.05839616,  0.        ,\n",
        "        0.        ,  0.        ,  0.05536017,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.17009803,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
        "        0.        ,  0.        ])"
       ]
      }
     ],
     "prompt_number": 133
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "this_pheno_jdrange_factor[this_pheno_jdrange_nnz]"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 134,
       "text": [
        "array([ 0.05802756,  0.05561218,  0.05389206,  0.05736521,  0.12921933,\n",
        "        0.05485008,  0.06793431,  0.07013347,  0.09762368,  0.07148776,\n",
        "        0.05839616,  0.05536017,  0.17009803])"
       ]
      }
     ],
     "prompt_number": 134
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 152
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "this_pheno_jdrange_factor[index_this_jdrange]"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 136,
       "text": [
        "0.050456583527617165"
       ]
      }
     ],
     "prompt_number": 136
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "d_jdrange_lookup[jdrange] "
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 137,
       "text": [
        "nan"
       ]
      }
     ],
     "prompt_number": 137
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "nparr_jdrange_weights"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 138,
       "text": [
        "array([ 0.09476271,  0.10001066,  0.08528715,  0.09556853,  0.11371386,\n",
        "        0.05685797,  0.11642297,  0.05045658,  0.07445613,  0.11813623,\n",
        "        0.09432722])"
       ]
      }
     ],
     "prompt_number": 138
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "d_jdrangeindex_weights"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 139,
       "text": [
        "OrderedDict([(69, 0.094762706293216203), (73, 0.10001065905758159), (86, 0.085287145465893138), (96, 0.095568534396618693), (100, 0.11371385950366558), (106, 0.056857970449029266), (109, 0.11642296991450946), (141, 0.050456583527617165), (152, 0.074456125273945309), (153, 0.11813622557305702), (186, 0.094327220544866475)])"
       ]
      }
     ],
     "prompt_number": 139
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "l_jdrangeindex_sorted"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 140,
       "text": [
        "[141, 106, 152, 86, 186, 69, 96, 73, 100, 109, 153]"
       ]
      }
     ],
     "prompt_number": 140
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "[tup[0] for tup in sorted(d_jdrangeindex_weights.iteritems(), key=operator.itemgetter(1))]"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 141,
       "text": [
        "[141, 106, 152, 86, 186, 69, 96, 73, 100, 109, 153]"
       ]
      }
     ],
     "prompt_number": 141
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "[tup[0] for tup in sorted(d_jdrangeindex_weights.iteritems(), key=operator.itemgetter(0))]"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 142,
       "text": [
        "[69, 73, 86, 96, 100, 106, 109, 141, 152, 153, 186]"
       ]
      }
     ],
     "prompt_number": 142
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "[tup[0] for tup in sorted(d_jdrangeindex_weights.iteritems(), key=operator.itemgetter(1))][::-1]"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 146,
       "text": [
        "[153, 109, 100, 73, 96, 69, 186, 86, 152, 106, 141]"
       ]
      }
     ],
     "prompt_number": 146
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "d_jdrange_lookup[loaded_axisDict[1][0]\n",
      "                ]"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "ename": "KeyError",
       "evalue": "0",
       "output_type": "pyerr",
       "traceback": [
        "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m\n\u001b[0;31mKeyError\u001b[0m                                  Traceback (most recent call last)",
        "\u001b[0;32m<ipython-input-148-736c05c355da>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m()\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m d_jdrange_lookup[loaded_axisDict[1][0]\n\u001b[0m\u001b[1;32m      2\u001b[0m                 ]\n",
        "\u001b[0;31mKeyError\u001b[0m: 0"
       ]
      }
     ],
     "prompt_number": 148
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "loaded_axisDict[1].keys()[1]"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 151,
       "text": [
        "'001-009.99'"
       ]
      }
     ],
     "prompt_number": 151
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 167
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 167
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 167
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 167
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 167
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 167
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 167
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 167
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 167
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 167
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 167
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 167
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "#write output file\n",
      "pheno_outstream = open(pickle_folder + \"phenotypes\"+gamma_str+\".out\", 'w+')\n",
      "    \n",
      "\n",
      "##############################################################################################################\n",
      "\n",
      "#tensor with all phenotypes (factorization)\n",
      "ktensor_phenotypes = pheno_htn_subset_analyzed_REG_withGamma[0]\n",
      "l_pts = loaded_axisDict[0].keys()\n",
      "l_jdrange = loaded_axisDict[1].keys()\n",
      "l_meds= loaded_axisDict[2].keys()\n",
      "\n",
      "#will store all the data\n",
      "d_pheno_nonzero_labels = OrderedDict()\n",
      "\n",
      "\n",
      "#sort phenotypes by lambda values:\n",
      "d_lambda_phenoNumber = OrderedDict(zip( list(range(R)), \n",
      "                                        list(ktensor_phenotypes.lmbda)\n",
      "                                        ))\n",
      "l_phenoNumbers_sorted_by_lambda = [tup[0] for tup in sorted(d_lambda_phenoNumber.iteritems(), key=operator.itemgetter(1))][::-1]  #get a sorted list of phenotype numbers, which are sorted by using the operator.itemgetter                                \n",
      "\n",
      "#print phenotype feature names #################\n",
      "#for i in range(10):\n",
      "for i in l_phenoNumbers_sorted_by_lambda:\n",
      "    print \"===== phenotype \" + str(i) + \"=================================================================\"\n",
      "    pheno_outstream.write(\"===== phenotype \" + str(i) + \"=================================================================\" + '\\n')\n",
      "    this_lmbda = ktensor_phenotypes.lmbda[i]\n",
      "    this_pheno_pt_factor = ktensor_phenotypes.U[0][:,i]\n",
      "    this_pheno_jdrange_factor = ktensor_phenotypes.U[1][:,i]\n",
      "    this_pheno_med_factor = ktensor_phenotypes.U[2][:,i]\n",
      "    \n",
      "    this_pheno_pt_nnz = np.nonzero(this_pheno_pt_factor)[0]\n",
      "    this_pheno_jdrange_nnz = np.nonzero(this_pheno_jdrange_factor)[0]\n",
      "    this_pheno_med_nnz = np.nonzero(this_pheno_med_factor)[0]\n",
      "    \n",
      "    l_nonzero_pt_thisPheno = []\n",
      "    l_nonzero_meds_thisPheno = []\n",
      "    l_nonzero_jdrange_thisPheno = []\n",
      "    l_nonzero_jdrange_names_thisPheno = []\n",
      "    \n",
      "    for j in this_pheno_pt_nnz:\n",
      "        l_nonzero_pt_thisPheno.append(l_pts[j])\n",
      "    for j in this_pheno_jdrange_nnz:\n",
      "        l_nonzero_jdrange_thisPheno.append(l_jdrange[j])\n",
      "        l_nonzero_jdrange_names_thisPheno.append(d_jdrange_lookup[l_jdrange[j]])\n",
      "    for j in this_pheno_med_nnz:\n",
      "        l_nonzero_meds_thisPheno.append(l_meds[j])\n",
      "    \n",
      "    #data\n",
      "    d_pheno_nonzero_labels[i] = dict() #for phenotype i\n",
      "    d_pheno_nonzero_labels[i]['LAMBDA'] = this_lmbda #lambda value\n",
      "    d_pheno_nonzero_labels[i]['PERCENT_PTS'] = len(l_nonzero_pt_thisPheno) / float(len(this_pheno_pt_factor))\n",
      "    d_pheno_nonzero_labels[i]['MEDS_NZ'] = l_nonzero_meds_thisPheno #for phenotype i\n",
      "    d_pheno_nonzero_labels[i]['JDRANGE_NZ'] = l_nonzero_jdrange_thisPheno #for phenotype i   \n",
      "    d_pheno_nonzero_labels[i]['JDRANGE_NAMES_NZ'] = l_nonzero_jdrange_names_thisPheno #for phenotype i \n",
      "    \n",
      "    print \"proportion of pts: \" + str(d_pheno_nonzero_labels[i]['PERCENT_PTS'])\n",
      "    pheno_outstream.write(\"proportion of pts: \" + str(d_pheno_nonzero_labels[i]['PERCENT_PTS']) + '\\n')\n",
      "    print \"lambda: \" + str(this_lmbda)\n",
      "    pheno_outstream.write(\"lambda: \" + str(this_lmbda) + '\\n')\n",
      "    \n",
      "\n",
      "    print \"----------------------------------------\" #divider\n",
      "    pheno_outstream.write(\"----------------------------------------\" + '\\n')\n",
      "    #make ranking of JDRANGE by the weights:\n",
      "    nparr_jdrange_weights = this_pheno_jdrange_factor[this_pheno_jdrange_nnz]\n",
      "    d_jdrangeindex_weights = OrderedDict(zip(this_pheno_jdrange_nnz, nparr_jdrange_weights))\n",
      "    l_jdrangeindex_sorted = [tup[0] for tup in sorted(d_jdrangeindex_weights.iteritems(), key=operator.itemgetter(1))][::-1] #note: use slice [::-1] to reverse list!\n",
      "    for index_this_jdrange in l_jdrangeindex_sorted:\n",
      "        print d_jdrange_lookup[l_jdrange[index_this_jdrange]] + '\\t' + str(\"%.3f\" %this_pheno_jdrange_factor[index_this_jdrange] )\n",
      "        pheno_outstream.write(str(d_jdrange_lookup[l_jdrange[index_this_jdrange]]) + '\\t' + str(\"%.3f\" %this_pheno_jdrange_factor[index_this_jdrange])  +'\\n')\n",
      "    \n",
      "\n",
      "    print \"----------------------------------------\" #divider between diagnostic codes and meds\n",
      "    pheno_outstream.write(\"----------------------------------------\" + '\\n')\n",
      "    #make ranking of MED by the weights:\n",
      "    nparr_med_weights = this_pheno_med_factor[this_pheno_med_nnz]\n",
      "    d_medindex_weights = OrderedDict(zip(this_pheno_med_nnz, nparr_med_weights))\n",
      "    l_medindex_sorted = [tup[0] for tup in sorted(d_medindex_weights.iteritems(), key=operator.itemgetter(1))][::-1]\n",
      "    for index_this_med in l_medindex_sorted:\n",
      "        print l_meds[index_this_med]  + '\\t' + str(\"%.3f\" %this_pheno_med_factor[index_this_med])\n",
      "        pheno_outstream.write(l_meds[index_this_med]  + '\\t' + str(\"%.3f\" %this_pheno_med_factor[index_this_med]) + '\\n')\n",
      "pheno_outstream.close()"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "===== phenotype 5=================================================================\n",
        "proportion of pts: 0.119397064657\n",
        "lambda: 16186.2895539\n",
        "----------------------------------------\n",
        "Ischemic heart disease\t0.140\n",
        "Other forms of heart disease\t0.122\n",
        "Hypertensive disease\t0.105\n",
        "Disorders of lipoid metabolism\t0.104\n",
        "Nephritis, nephrotic syndrome, and nephrosis\t0.092\n",
        "Range name na\t0.084\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.083\n",
        "Anemias\t0.079\n",
        "Other diseases of respiratory system\t0.072\n",
        "Disorders of fluid, electrolyte, and acid-base balance\t0.065\n",
        "Disorders of the eye and adnexa\t0.055\n",
        "----------------------------------------\n",
        "Diuretics\t0.077\n",
        "Adrenergic beta-1 Receptor Antagonists\t0.074\n",
        "Sympatholytics\t0.072\n",
        "Anti-Arrhythmia Agents\t0.072\n",
        "Platelet Aggregation Inhibitors\t0.069\n",
        "Anticholesteremic Agents\t0.069\n",
        "Fibrinolytic Agents\t0.067\n",
        "Vasodilator Agents\t0.065\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.065\n",
        "Cyclooxygenase Inhibitors\t0.065\n",
        "Antihypertensive Agents\t0.063\n",
        "Antipyretics\t0.063\n",
        "Sodium Potassium Chloride Symporter Inhibitors\t0.063\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.061\n",
        "Hypolipidemic Agents\t0.055\n",
        "===== phenotype 47=================================================================\n",
        "proportion of pts: 0.138437128124\n",
        "lambda: 15273.2333299\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\t0.140\n",
        "Hypertensive disease\t0.140\n",
        "Acute respiratory infections\t0.111\n",
        "Arthropathies and related disorders\t0.107\n",
        "Diabetes\t0.091\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.075\n",
        "Other diseases of the upper respiratory tract\t0.070\n",
        "Rheumatism, excluding the back\t0.069\n",
        "Range name na\t0.067\n",
        "Disorders of the eye and adnexa\t0.066\n",
        "Diseases of the ear and mastoid process\t0.065\n",
        "----------------------------------------\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.079\n",
        "Cyclooxygenase Inhibitors\t0.079\n",
        "Antihypertensive Agents\t0.075\n",
        "Antipyretics\t0.074\n",
        "Platelet Aggregation Inhibitors\t0.073\n",
        "Anticholesteremic Agents\t0.073\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.073\n",
        "Fibrinolytic Agents\t0.072\n",
        "Diuretics\t0.064\n",
        "Sodium Chloride Symporter Inhibitors\t0.061\n",
        "Anti-Inflammatory Agents\t0.056\n",
        "Vasodilator Agents\t0.056\n",
        "Hypolipidemic Agents\t0.056\n",
        "Hypoglycemic Agents\t0.055\n",
        "Anti-Allergic Agents\t0.054\n",
        "===== phenotype 2=================================================================\n",
        "proportion of pts: 0.122173740579\n",
        "lambda: 15230.1836366\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.141\n",
        "Disorders of lipoid metabolism\t0.120\n",
        "Other forms of heart disease\t0.114\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.087\n",
        "Range name na\t0.085\n",
        "Symptoms involving cardiovascular system\t0.077\n",
        "Symptoms involving skin and other integumentary tissue\t0.076\n",
        "Nonspecific findings on examination of blood\t0.067\n",
        "Ischemic heart disease\t0.066\n",
        "General symptoms\t0.059\n",
        "Rheumatism, excluding the back\t0.055\n",
        "Arthropathies and related disorders\t0.054\n",
        "----------------------------------------\n",
        "Vasodilator Agents\t0.071\n",
        "Anti-Arrhythmia Agents\t0.069\n",
        "Diuretics\t0.068\n",
        "Antihypertensive Agents\t0.067\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.065\n",
        "Platelet Aggregation Inhibitors\t0.064\n",
        "Fibrinolytic Agents\t0.064\n",
        "Cyclooxygenase Inhibitors\t0.063\n",
        "Calcium Channel Blockers\t0.062\n",
        "Antipyretics\t0.062\n",
        "Adrenergic beta-1 Receptor Antagonists\t0.059\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.059\n",
        "Sympatholytics\t0.058\n",
        "Sodium Chloride Symporter Inhibitors\t0.058\n",
        "Angiotensin-Converting Enzyme Inhibitors\t0.056\n",
        "Anticholesteremic Agents\t0.055\n",
        "===== phenotype 44=================================================================\n",
        "proportion of pts: 0.11106703689\n",
        "lambda: 14807.7481093\n",
        "----------------------------------------\n",
        "Other diseases of skin and subcutaneous tissue\t0.096\n",
        "Hypertensive disease\t0.093\n",
        "Mycoses\t0.088\n",
        "Disorders of lipoid metabolism\t0.085\n",
        "Disorders of the eye and adnexa\t0.075\n",
        "Arthropathies and related disorders\t0.073\n",
        "Ischemic heart disease\t0.070\n",
        "Diabetes\t0.065\n",
        "Range name na\t0.063\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\t0.063\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\t0.062\n",
        "Diseases of esophagus, stomach, and duodenum\t0.058\n",
        "Rheumatism, excluding the back\t0.057\n",
        "Other diseases of intestines and peritoneum\t0.052\n",
        "----------------------------------------\n",
        "Cardiotonic Agents\t0.072\n",
        "Angiotensin-Converting Enzyme Inhibitors\t0.071\n",
        "Anticholesteremic Agents\t0.070\n",
        "Proton Pump Inhibitors\t0.065\n",
        "Anti-Ulcer Agents\t0.065\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.064\n",
        "Antihypertensive Agents\t0.064\n",
        "Diuretics\t0.062\n",
        "Platelet Aggregation Inhibitors\t0.062\n",
        "Hypolipidemic Agents\t0.061\n",
        "Anti-Arrhythmia Agents\t0.061\n",
        "Fibrinolytic Agents\t0.058\n",
        "Cyclooxygenase Inhibitors\t0.057\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.057\n",
        "Antipyretics\t0.055\n",
        "Anti-Inflammatory Agents\t0.055\n",
        "===== phenotype 27=================================================================\n",
        "proportion of pts: 0.120983736612\n",
        "lambda: 14398.6275401\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.119\n",
        "General symptoms\t0.104\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.097\n",
        "Range name na\t0.092\n",
        "Disorders of lipoid metabolism\t0.084\n",
        "Symptoms involving head and neck\t0.076\n",
        "Nutritional deficiencies\t0.072\n",
        "Other diseases of intestines and peritoneum\t0.068\n",
        "Symptoms involving urinary system\t0.063\n",
        "Disorders of the eye and adnexa\t0.061\n",
        "Diseases of the ear and mastoid process\t0.057\n",
        "Dorsopathies\t0.055\n",
        "Anemias\t0.053\n",
        "----------------------------------------\n",
        "Vitamins\t0.075\n",
        "Calcium Channel Blockers\t0.072\n",
        "Angiotensin-Converting Enzyme Inhibitors\t0.071\n",
        "Cardiotonic Agents\t0.068\n",
        "Vasodilator Agents\t0.067\n",
        "Bone Density Conservation Agents\t0.066\n",
        "Platelet Aggregation Inhibitors\t0.065\n",
        "Fibrinolytic Agents\t0.064\n",
        "Antihypertensive Agents\t0.062\n",
        "Antipyretics\t0.061\n",
        "Cyclooxygenase Inhibitors\t0.059\n",
        "Anti-Ulcer Agents\t0.059\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.058\n",
        "Antioxidants\t0.052\n",
        "Anti-Allergic Agents\t0.050\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.050\n",
        "===== phenotype 13=================================================================\n",
        "proportion of pts: 0.142403808013\n",
        "lambda: 14356.2044318\n",
        "----------------------------------------\n",
        "Diabetes\t0.231\n",
        "Hypertensive disease\t0.166\n",
        "Disorders of lipoid metabolism\t0.165\n",
        "Ischemic heart disease\t0.104\n",
        "General symptoms\t0.077\n",
        "Range name na\t0.077\n",
        "Disorders of the eye and adnexa\t0.075\n",
        "Dorsopathies\t0.053\n",
        "Rheumatism, excluding the back\t0.053\n",
        "----------------------------------------\n",
        "Hypoglycemic Agents\t0.104\n",
        "Anti-Arrhythmia Agents\t0.074\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.074\n",
        "Anticholesteremic Agents\t0.071\n",
        "Adrenergic beta-1 Receptor Antagonists\t0.070\n",
        "Sympatholytics\t0.065\n",
        "Angiotensin-Converting Enzyme Inhibitors\t0.064\n",
        "Platelet Aggregation Inhibitors\t0.063\n",
        "Antihypertensive Agents\t0.062\n",
        "Fibrinolytic Agents\t0.062\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.061\n",
        "Cyclooxygenase Inhibitors\t0.061\n",
        "Antipyretics\t0.057\n",
        "Hypolipidemic Agents\t0.057\n",
        "Vasodilator Agents\t0.055\n",
        "===== phenotype 9=================================================================\n",
        "proportion of pts: 0.121380404601\n",
        "lambda: 13142.6951011\n",
        "----------------------------------------\n",
        "Diabetes\t0.152\n",
        "Hypertensive disease\t0.103\n",
        "Disorders of lipoid metabolism\t0.098\n",
        "Rheumatism, excluding the back\t0.079\n",
        "Disorders of the eye and adnexa\t0.078\n",
        "Organic sleep disorders\t0.071\n",
        "Symptoms involving skin and other integumentary tissue\t0.067\n",
        "Range name na\t0.066\n",
        "Diseases of the ear and mastoid process\t0.065\n",
        "Other diseases of the upper respiratory tract\t0.059\n",
        "Arthropathies and related disorders\t0.057\n",
        "Symptoms involving urinary system\t0.053\n",
        "Nutritional deficiencies\t0.052\n",
        "----------------------------------------\n",
        "Hypoglycemic Agents\t0.102\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.086\n",
        "Anticholesteremic Agents\t0.081\n",
        "Platelet Aggregation Inhibitors\t0.080\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.080\n",
        "Antipyretics\t0.079\n",
        "Cyclooxygenase Inhibitors\t0.078\n",
        "Fibrinolytic Agents\t0.076\n",
        "Hypolipidemic Agents\t0.074\n",
        "Antihypertensive Agents\t0.074\n",
        "Angiotensin-Converting Enzyme Inhibitors\t0.067\n",
        "Anti-Inflammatory Agents\t0.063\n",
        "Anti-Allergic Agents\t0.060\n",
        "===== phenotype 46=================================================================\n",
        "proportion of pts: 0.126537088457\n",
        "lambda: 12967.7578454\n",
        "----------------------------------------\n",
        "Disorders of thyroid gland\t0.149\n",
        "Hypertensive disease\t0.123\n",
        "Disorders of lipoid metabolism\t0.116\n",
        "Organic sleep disorders\t0.104\n",
        "Other symptoms involving abdomen and pelvis\t0.072\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.071\n",
        "Dorsopathies\t0.067\n",
        "Diseases of esophagus, stomach, and duodenum\t0.064\n",
        "General symptoms\t0.062\n",
        "Range name na\t0.059\n",
        "Diabetes\t0.057\n",
        "Overweight, obesity and other hyperalimentation\t0.056\n",
        "----------------------------------------\n",
        "Diuretics\t0.081\n",
        "Anti-Arrhythmia Agents\t0.079\n",
        "Anticholesteremic Agents\t0.070\n",
        "Antihypertensive Agents\t0.069\n",
        "Calcium Channel Blockers\t0.069\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.068\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.068\n",
        "Cyclooxygenase Inhibitors\t0.066\n",
        "Sodium Chloride Symporter Inhibitors\t0.066\n",
        "Anti-Allergic Agents\t0.062\n",
        "Anti-Ulcer Agents\t0.062\n",
        "Platelet Aggregation Inhibitors\t0.061\n",
        "Antipyretics\t0.061\n",
        "Vasodilator Agents\t0.058\n",
        "Fibrinolytic Agents\t0.058\n",
        "===== phenotype 0=================================================================\n",
        "proportion of pts: 0.126933756446\n",
        "lambda: 11833.8350177\n",
        "----------------------------------------\n",
        "Other diseases of urinary system\t0.124\n",
        "Hypertensive disease\t0.101\n",
        "Disorders of lipoid metabolism\t0.099\n",
        "Symptoms involving urinary system\t0.094\n",
        "General symptoms\t0.089\n",
        "Diseases of male genital organs\t0.073\n",
        "Arthropathies and related disorders\t0.070\n",
        "Dorsopathies\t0.064\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.063\n",
        "Range name na\t0.060\n",
        "Cerebrovascular disease\t0.059\n",
        "Hereditary and degenerative diseases of the central nervous system\t0.054\n",
        "Symptoms involving head and neck\t0.050\n",
        "----------------------------------------\n",
        "Anticholesteremic Agents\t0.095\n",
        "Platelet Aggregation Inhibitors\t0.093\n",
        "Fibrinolytic Agents\t0.091\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.091\n",
        "Antipyretics\t0.085\n",
        "Cyclooxygenase Inhibitors\t0.084\n",
        "Antihypertensive Agents\t0.084\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.083\n",
        "Hypolipidemic Agents\t0.083\n",
        "Vasodilator Agents\t0.076\n",
        "Angiotensin-Converting Enzyme Inhibitors\t0.072\n",
        "Anti-Arrhythmia Agents\t0.063\n",
        "===== phenotype 48=================================================================\n",
        "proportion of pts: 0.109083696946\n",
        "lambda: 11354.1764497\n",
        "----------------------------------------\n",
        "Diseases of esophagus, stomach, and duodenum\t0.136\n",
        "Hypertensive disease\t0.100\n",
        "Arthropathies and related disorders\t0.092\n",
        "Disorders of lipoid metabolism\t0.085\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.082\n",
        "Rheumatism, excluding the back\t0.079\n",
        "General symptoms\t0.078\n",
        "Disorders of thyroid gland\t0.067\n",
        "Symptoms involving digestive system\t0.063\n",
        "Other symptoms involving abdomen and pelvis\t0.059\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\t0.054\n",
        "Acute respiratory infections\t0.053\n",
        "Nonspecific findings on examination of blood\t0.053\n",
        "----------------------------------------\n",
        "Proton Pump Inhibitors\t0.102\n",
        "Anti-Ulcer Agents\t0.091\n",
        "Vitamins\t0.089\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.082\n",
        "Cyclooxygenase Inhibitors\t0.081\n",
        "Platelet Aggregation Inhibitors\t0.079\n",
        "Bone Density Conservation Agents\t0.078\n",
        "Fibrinolytic Agents\t0.074\n",
        "Antipyretics\t0.072\n",
        "Antihypertensive Agents\t0.070\n",
        "Vasodilator Agents\t0.063\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.060\n",
        "Anti-Inflammatory Agents\t0.058\n",
        "===== phenotype 34=================================================================\n",
        "proportion of pts: 0.114240380801\n",
        "lambda: 10956.1843624\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.104\n",
        "Range name na\t0.099\n",
        "Rheumatism, excluding the back\t0.089\n",
        "Diabetes\t0.084\n",
        "Other forms of heart disease\t0.083\n",
        "Disorders of lipoid metabolism\t0.080\n",
        "Arthropathies and related disorders\t0.078\n",
        "General symptoms\t0.072\n",
        "Disorders of the eye and adnexa\t0.071\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\t0.066\n",
        "Symptoms involving skin and other integumentary tissue\t0.060\n",
        "Disorders of thyroid gland\t0.058\n",
        "Dorsopathies\t0.056\n",
        "----------------------------------------\n",
        "Diuretics\t0.134\n",
        "Calcium Channel Blockers\t0.122\n",
        "Sodium Potassium Chloride Symporter Inhibitors\t0.118\n",
        "Vasodilator Agents\t0.107\n",
        "Anti-Arrhythmia Agents\t0.105\n",
        "Sympatholytics\t0.100\n",
        "Anticoagulants\t0.089\n",
        "Rodenticides\t0.083\n",
        "Antihypertensive Agents\t0.074\n",
        "Anticholesteremic Agents\t0.069\n",
        "===== phenotype 22=================================================================\n",
        "proportion of pts: 0.116620388735\n",
        "lambda: 10644.7870989\n",
        "----------------------------------------\n",
        "Other diseases of the upper respiratory tract\t0.148\n",
        "Hypertensive disease\t0.136\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.120\n",
        "Acute respiratory infections\t0.116\n",
        "Disorders of lipoid metabolism\t0.090\n",
        "Chronic obstructive pulmonary disease and allied conditions\t0.090\n",
        "Disorders of the eye and adnexa\t0.075\n",
        "Diseases of esophagus, stomach, and duodenum\t0.064\n",
        "Symptoms involving skin and other integumentary tissue\t0.054\n",
        "Dorsopathies\t0.054\n",
        "Symptoms involving head and neck\t0.052\n",
        "----------------------------------------\n",
        "Bronchodilator Agents\t0.104\n",
        "Anti-Inflammatory Agents\t0.097\n",
        "Dermatologic Agents\t0.096\n",
        "Anti-Allergic Agents\t0.095\n",
        "Histamine H1 Antagonists, Non-Sedating\t0.094\n",
        "Glucocorticoids\t0.090\n",
        "Anti-Bacterial Agents\t0.087\n",
        "Proton Pump Inhibitors\t0.079\n",
        "Anti-Ulcer Agents\t0.078\n",
        "Antihypertensive Agents\t0.075\n",
        "Adrenergic beta-2 Receptor Agonists\t0.052\n",
        "Lipoxygenase Inhibitors\t0.052\n",
        "===== phenotype 42=================================================================\n",
        "proportion of pts: 0.109083696946\n",
        "lambda: 10289.8203224\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.122\n",
        "General symptoms\t0.098\n",
        "Range name na\t0.089\n",
        "Disorders of lipoid metabolism\t0.084\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.083\n",
        "Arthropathies and related disorders\t0.080\n",
        "Rheumatism, excluding the back\t0.075\n",
        "Symptoms involving head and neck\t0.073\n",
        "Dorsopathies\t0.069\n",
        "Disorders of the eye and adnexa\t0.065\n",
        "Symptoms involving digestive system\t0.056\n",
        "Acute respiratory infections\t0.055\n",
        "Other diseases of the upper respiratory tract\t0.052\n",
        "----------------------------------------\n",
        "Anticonvulsants\t0.134\n",
        "Hypnotics and Sedatives\t0.134\n",
        "Anti-Anxiety Agents\t0.129\n",
        "Antiemetics\t0.123\n",
        "GABA Modulators\t0.121\n",
        "Serotonin Uptake Inhibitors\t0.093\n",
        "Histamine H1 Antagonists\t0.091\n",
        "Analgesics\t0.090\n",
        "Antidepressive Agents, Second-Generation\t0.085\n",
        "===== phenotype 20=================================================================\n",
        "proportion of pts: 0.112257040857\n",
        "lambda: 10143.6265497\n",
        "----------------------------------------\n",
        "Other diseases of skin and subcutaneous tissue\t0.139\n",
        "Hypertensive disease\t0.085\n",
        "Malignant neoplasm of skin\t0.084\n",
        "Neoplasm of uncertain behavior of other sites & tissues\t0.079\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\t0.076\n",
        "Symptoms involving skin and other integumentary tissue\t0.075\n",
        "Infections of skin and subcutaneous tissue\t0.072\n",
        "Rheumatism, excluding the back\t0.072\n",
        "Arthropathies and related disorders\t0.071\n",
        "Other forms of heart disease\t0.066\n",
        "Range name na\t0.065\n",
        "Dorsopathies\t0.063\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\t0.055\n",
        "----------------------------------------\n",
        "Platelet Aggregation Inhibitors\t0.104\n",
        "Fibrinolytic Agents\t0.100\n",
        "Antipyretics\t0.099\n",
        "Vitamins\t0.094\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.093\n",
        "Cyclooxygenase Inhibitors\t0.092\n",
        "Antihypertensive Agents\t0.092\n",
        "Bone Density Conservation Agents\t0.085\n",
        "Anti-Arrhythmia Agents\t0.081\n",
        "Vasodilator Agents\t0.080\n",
        "Diuretics\t0.079\n",
        "===== phenotype 12=================================================================\n",
        "proportion of pts: 0.101943673146\n",
        "lambda: 10042.9241363\n",
        "----------------------------------------\n",
        "Other forms of heart disease\t0.130\n",
        "Range name na\t0.108\n",
        "Ischemic heart disease\t0.099\n",
        "Hypertensive disease\t0.098\n",
        "Disorders of lipoid metabolism\t0.097\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.081\n",
        "Arthropathies and related disorders\t0.076\n",
        "Other symptoms involving abdomen and pelvis\t0.070\n",
        "Rheumatism, excluding the back\t0.063\n",
        "Organic sleep disorders\t0.060\n",
        "Dorsopathies\t0.060\n",
        "Acute respiratory infections\t0.058\n",
        "----------------------------------------\n",
        "Anticoagulants\t0.087\n",
        "Rodenticides\t0.079\n",
        "Anti-Arrhythmia Agents\t0.079\n",
        "Sympatholytics\t0.075\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.074\n",
        "Histamine H1 Antagonists, Non-Sedating\t0.073\n",
        "Anticholesteremic Agents\t0.073\n",
        "Anti-Allergic Agents\t0.072\n",
        "Hypolipidemic Agents\t0.071\n",
        "Platelet Aggregation Inhibitors\t0.067\n",
        "Fibrinolytic Agents\t0.066\n",
        "Antipyretics\t0.062\n",
        "Cyclooxygenase Inhibitors\t0.061\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.061\n",
        "===== phenotype 21=================================================================\n",
        "proportion of pts: 0.104720349068\n",
        "lambda: 9814.33701392\n",
        "----------------------------------------\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\t0.111\n",
        "Arthropathies and related disorders\t0.104\n",
        "Rheumatism, excluding the back\t0.092\n",
        "Hypertensive disease\t0.091\n",
        "Range name na\t0.079\n",
        "Other diseases of urinary system\t0.075\n",
        "Dorsopathies\t0.073\n",
        "Symptoms involving urinary system\t0.070\n",
        "General symptoms\t0.066\n",
        "Disorders of the peripheral nervous system\t0.066\n",
        "Diseases of esophagus, stomach, and duodenum\t0.063\n",
        "Anemias\t0.057\n",
        "Fractures\t0.052\n",
        "----------------------------------------\n",
        "Calcium Channel Blockers\t0.121\n",
        "Anti-Ulcer Agents\t0.105\n",
        "Anticonvulsants\t0.104\n",
        "Anti-Arrhythmia Agents\t0.102\n",
        "Anti-Anxiety Agents\t0.101\n",
        "Analgesics\t0.101\n",
        "Serotonin Uptake Inhibitors\t0.088\n",
        "Antipyretics\t0.081\n",
        "Antihypertensive Agents\t0.067\n",
        "Cyclooxygenase Inhibitors\t0.066\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.065\n",
        "===== phenotype 17=================================================================\n",
        "proportion of pts: 0.0987703292344\n",
        "lambda: 8637.87212332\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.125\n",
        "Gout\t0.124\n",
        "Range name na\t0.105\n",
        "Disorders of lipoid metabolism\t0.105\n",
        "Ischemic heart disease\t0.092\n",
        "Other forms of heart disease\t0.085\n",
        "Arthropathies and related disorders\t0.069\n",
        "Dorsopathies\t0.068\n",
        "Diabetes\t0.062\n",
        "Diseases of male genital organs\t0.058\n",
        "Benign neoplasm of other parts of digestive system\t0.054\n",
        "Disorders of the eye and adnexa\t0.053\n",
        "----------------------------------------\n",
        "Gout Suppressants\t0.105\n",
        "Adrenergic alpha-1 Receptor Antagonists\t0.090\n",
        "Enzyme Inhibitors\t0.088\n",
        "Antimetabolites\t0.086\n",
        "Antihypertensive Agents\t0.074\n",
        "Free Radical Scavengers\t0.074\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.072\n",
        "Antipyretics\t0.072\n",
        "Cyclooxygenase Inhibitors\t0.071\n",
        "Vasodilator Agents\t0.070\n",
        "Platelet Aggregation Inhibitors\t0.068\n",
        "Fibrinolytic Agents\t0.067\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.062\n",
        "===== phenotype 11=================================================================\n",
        "proportion of pts: 0.115430384768\n",
        "lambda: 8191.96639526\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.145\n",
        "Range name na\t0.143\n",
        "Rheumatism, excluding the back\t0.108\n",
        "Arthropathies and related disorders\t0.108\n",
        "General symptoms\t0.100\n",
        "Disorders of lipoid metabolism\t0.096\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.084\n",
        "Dorsopathies\t0.082\n",
        "Other forms of heart disease\t0.073\n",
        "Diabetes\t0.062\n",
        "----------------------------------------\n",
        "Analgesics, Opioid\t0.132\n",
        "Narcotics\t0.125\n",
        "Immunosuppressive Agents\t0.096\n",
        "Anti-Infective Agents, Urinary\t0.095\n",
        "Antimalarials\t0.094\n",
        "Enzyme Inhibitors\t0.087\n",
        "Antifungal Agents\t0.084\n",
        "Antirheumatic Agents\t0.080\n",
        "Anti-Infective Agents, Local\t0.077\n",
        "Anti-Infective Agents\t0.066\n",
        "Gastrointestinal Agents\t0.064\n",
        "===== phenotype 45=================================================================\n",
        "proportion of pts: 0.0975803252678\n",
        "lambda: 8007.38485514\n",
        "----------------------------------------\n",
        "Other diseases of skin and subcutaneous tissue\t0.116\n",
        "Hypertensive disease\t0.101\n",
        "Neoplasm of uncertain behavior of other sites & tissues\t0.097\n",
        "Disorders of lipoid metabolism\t0.091\n",
        "Diseases of esophagus, stomach, and duodenum\t0.075\n",
        "General symptoms\t0.075\n",
        "Range name na\t0.071\n",
        "Benign neoplasm of skin\t0.069\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.067\n",
        "Disorders of thyroid gland\t0.064\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\t0.063\n",
        "Rheumatism, excluding the back\t0.060\n",
        "Neurotic, personality, nonpsychotic disorders\t0.051\n",
        "----------------------------------------\n",
        "Proton Pump Inhibitors\t0.109\n",
        "Anti-Ulcer Agents\t0.104\n",
        "Anti-Allergic Agents\t0.096\n",
        "Antihypertensive Agents\t0.087\n",
        "Histamine H1 Antagonists, Non-Sedating\t0.085\n",
        "Anti-Inflammatory Agents\t0.085\n",
        "Bronchodilator Agents\t0.083\n",
        "Anticholesteremic Agents\t0.083\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.078\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.067\n",
        "Cyclooxygenase Inhibitors\t0.062\n",
        "Antipyretics\t0.060\n",
        "===== phenotype 39=================================================================\n",
        "proportion of pts: 0.123760412535\n",
        "lambda: 8000.08030548\n",
        "----------------------------------------\n",
        "Nutritional deficiencies\t0.151\n",
        "Hypertensive disease\t0.149\n",
        "Range name na\t0.115\n",
        "Disorders of lipoid metabolism\t0.107\n",
        "Arthropathies and related disorders\t0.098\n",
        "Disorders of the eye and adnexa\t0.091\n",
        "Anemias\t0.079\n",
        "General symptoms\t0.077\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\t0.069\n",
        "Na\t0.063\n",
        "----------------------------------------\n",
        "Vitamins\t0.141\n",
        "Bone Density Conservation Agents\t0.134\n",
        "Vitamin B Complex\t0.126\n",
        "Antioxidants\t0.116\n",
        "Antihypertensive Agents\t0.094\n",
        "Serotonin Uptake Inhibitors\t0.089\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.080\n",
        "Cyclooxygenase Inhibitors\t0.075\n",
        "Antipyretics\t0.075\n",
        "Dermatologic Agents\t0.070\n",
        "===== phenotype 28=================================================================\n",
        "proportion of pts: 0.0944069813566\n",
        "lambda: 7573.64773738\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\t0.124\n",
        "Ischemic heart disease\t0.118\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.109\n",
        "Hypertensive disease\t0.108\n",
        "Chronic obstructive pulmonary disease and allied conditions\t0.095\n",
        "Other diseases of skin and subcutaneous tissue\t0.089\n",
        "Cerebrovascular disease\t0.084\n",
        "General symptoms\t0.075\n",
        "Acute respiratory infections\t0.068\n",
        "Arthropathies and related disorders\t0.067\n",
        "Range name na\t0.063\n",
        "----------------------------------------\n",
        "Anticholesteremic Agents\t0.116\n",
        "Hypolipidemic Agents\t0.105\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.103\n",
        "Vasodilator Agents\t0.101\n",
        "Platelet Aggregation Inhibitors\t0.094\n",
        "Fibrinolytic Agents\t0.089\n",
        "Explosive Agents\t0.087\n",
        "Cyclooxygenase Inhibitors\t0.080\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.080\n",
        "Antipyretics\t0.075\n",
        "Antihypertensive Agents\t0.071\n",
        "===== phenotype 25=================================================================\n",
        "proportion of pts: 0.115827052757\n",
        "lambda: 7017.02414836\n",
        "----------------------------------------\n",
        "Dorsopathies\t0.155\n",
        "Arthropathies and related disorders\t0.144\n",
        "Hypertensive disease\t0.130\n",
        "Rheumatism, excluding the back\t0.128\n",
        "Range name na\t0.112\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\t0.094\n",
        "Disorders of lipoid metabolism\t0.091\n",
        "General symptoms\t0.080\n",
        "Disorders of the peripheral nervous system\t0.066\n",
        "----------------------------------------\n",
        "Anti-Inflammatory Agents\t0.135\n",
        "Calcium Channel Blockers\t0.134\n",
        "Glucocorticoids\t0.132\n",
        "Anti-Allergic Agents\t0.122\n",
        "Dermatologic Agents\t0.111\n",
        "Bronchodilator Agents\t0.101\n",
        "Antihypertensive Agents\t0.094\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.089\n",
        "Cyclooxygenase Inhibitors\t0.084\n",
        "===== phenotype 24=================================================================\n",
        "proportion of pts: 0.085680285601\n",
        "lambda: 6936.43841699\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.147\n",
        "Range name na\t0.124\n",
        "Arthropathies and related disorders\t0.106\n",
        "Disorders of lipoid metabolism\t0.103\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.098\n",
        "Rheumatism, excluding the back\t0.080\n",
        "General symptoms\t0.080\n",
        "Diabetes\t0.073\n",
        "Ischemic heart disease\t0.073\n",
        "Symptoms involving skin and other integumentary tissue\t0.061\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\t0.054\n",
        "----------------------------------------\n",
        "Adrenergic beta-1 Receptor Antagonists\t0.116\n",
        "Enzyme Inhibitors\t0.113\n",
        "Immunosuppressive Agents\t0.105\n",
        "Sympatholytics\t0.103\n",
        "Folic Acid Antagonists\t0.100\n",
        "Dermatologic Agents\t0.095\n",
        "Nucleic Acid Synthesis Inhibitors\t0.094\n",
        "Antirheumatic Agents\t0.093\n",
        "Antimetabolites, Antineoplastic\t0.091\n",
        "Abortifacient Agents, Nonsteroidal\t0.090\n",
        "===== phenotype 19=================================================================\n",
        "proportion of pts: 0.0805236017453\n",
        "lambda: 6822.7840568\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.142\n",
        "Disorders of lipoid metabolism\t0.101\n",
        "Range name na\t0.083\n",
        "Arthropathies and related disorders\t0.082\n",
        "Disorders of thyroid gland\t0.080\n",
        "Diabetes\t0.075\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\t0.075\n",
        "Nutritional deficiencies\t0.069\n",
        "Rheumatism, excluding the back\t0.068\n",
        "Other diseases of the upper respiratory tract\t0.064\n",
        "Disorders of the eye and adnexa\t0.058\n",
        "Symptoms involving digestive system\t0.052\n",
        "Symptoms involving head and neck\t0.051\n",
        "----------------------------------------\n",
        "Dermatologic Agents\t0.117\n",
        "Enzyme Inhibitors\t0.107\n",
        "Bronchodilator Agents\t0.099\n",
        "Immunosuppressive Agents\t0.096\n",
        "Anti-Allergic Agents\t0.092\n",
        "Antirheumatic Agents\t0.090\n",
        "Abortifacient Agents, Nonsteroidal\t0.080\n",
        "Anti-Inflammatory Agents\t0.080\n",
        "Folic Acid Antagonists\t0.080\n",
        "Nucleic Acid Synthesis Inhibitors\t0.079\n",
        "Antimetabolites, Antineoplastic\t0.079\n",
        "===== phenotype 32=================================================================\n",
        "proportion of pts: 0.0944069813566\n",
        "lambda: 6454.71400953\n",
        "----------------------------------------\n",
        "Sprains and strains of joints and adjacent muscles\t0.101\n",
        "Rheumatism, excluding the back\t0.101\n",
        "Hypertensive disease\t0.099\n",
        "Arthropathies and related disorders\t0.086\n",
        "Diseases of oral cavity, salivary glands, and jaws\t0.086\n",
        "Dorsopathies\t0.081\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.076\n",
        "Other diseases of skin and subcutaneous tissue\t0.068\n",
        "Range name na\t0.064\n",
        "Disorders of lipoid metabolism\t0.064\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\t0.060\n",
        "Disorders of the eye and adnexa\t0.059\n",
        "Symptoms involving head and neck\t0.054\n",
        "----------------------------------------\n",
        "Anti-Arrhythmia Agents\t0.115\n",
        "Anesthetics, Local\t0.101\n",
        "Antihypertensive Agents\t0.089\n",
        "Anti-Inflammatory Agents\t0.086\n",
        "Vasodilator Agents\t0.083\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.080\n",
        "Anti-Allergic Agents\t0.078\n",
        "Cyclooxygenase Inhibitors\t0.077\n",
        "Antipyretics\t0.077\n",
        "Bronchodilator Agents\t0.075\n",
        "Platelet Aggregation Inhibitors\t0.071\n",
        "Fibrinolytic Agents\t0.069\n",
        "===== phenotype 31=================================================================\n",
        "proportion of pts: 0.101150337168\n",
        "lambda: 6206.3740215\n",
        "----------------------------------------\n",
        "Diseases of arteries, arterioles, and capillaries\t0.123\n",
        "Symptoms involving cardiovascular system\t0.098\n",
        "Other diseases of urinary system\t0.091\n",
        "Malignant neoplasm of male and female genital organs\t0.084\n",
        "Diseases of male genital organs\t0.083\n",
        "Other symptoms involving abdomen and pelvis\t0.072\n",
        "Other diseases of intestines and peritoneum\t0.071\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\t0.069\n",
        "Other and unspecified effects of external causes\t0.069\n",
        "Other forms of heart disease\t0.063\n",
        "Hypertensive disease\t0.062\n",
        "Disorders of lipoid metabolism\t0.059\n",
        "Other bacterial diseases\t0.057\n",
        "----------------------------------------\n",
        "Anticholesteremic Agents\t0.108\n",
        "Antihypertensive Agents\t0.107\n",
        "Antipyretics\t0.102\n",
        "Platelet Aggregation Inhibitors\t0.101\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.100\n",
        "Cyclooxygenase Inhibitors\t0.098\n",
        "Fibrinolytic Agents\t0.097\n",
        "Vasodilator Agents\t0.097\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.095\n",
        "Anti-Arrhythmia Agents\t0.095\n",
        "===== phenotype 8=================================================================\n",
        "proportion of pts: 0.09678698929\n",
        "lambda: 6177.71505624\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.103\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.098\n",
        "Disorders of lipoid metabolism\t0.095\n",
        "Diseases of esophagus, stomach, and duodenum\t0.093\n",
        "Range name na\t0.090\n",
        "Ischemic heart disease\t0.077\n",
        "Diabetes\t0.075\n",
        "General symptoms\t0.069\n",
        "Hernia of abdominal cavity\t0.065\n",
        "Other symptoms involving abdomen and pelvis\t0.063\n",
        "Nutritional deficiencies\t0.060\n",
        "Dorsopathies\t0.060\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\t0.051\n",
        "----------------------------------------\n",
        "Proton Pump Inhibitors\t0.209\n",
        "Anti-Ulcer Agents\t0.186\n",
        "Hypnotics and Sedatives\t0.165\n",
        "Anti-Anxiety Agents\t0.150\n",
        "GABA Modulators\t0.125\n",
        "Antipyretics\t0.084\n",
        "Antihypertensive Agents\t0.082\n",
        "===== phenotype 43=================================================================\n",
        "proportion of pts: 0.0963903213011\n",
        "lambda: 5795.7673116\n",
        "----------------------------------------\n",
        "General symptoms\t0.097\n",
        "Acute respiratory infections\t0.097\n",
        "Disorders of the eye and adnexa\t0.096\n",
        "Range name na\t0.093\n",
        "Hypertensive disease\t0.082\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.077\n",
        "Infections of skin and subcutaneous tissue\t0.068\n",
        "Other symptoms involving abdomen and pelvis\t0.062\n",
        "Symptoms concerning nutrition, metabolism, and development\t0.057\n",
        "Diseases of other endocrine glands\t0.057\n",
        "Other diseases of intestines and peritoneum\t0.056\n",
        "Disorders of lipoid metabolism\t0.054\n",
        "Coagulation or hemorrhagic diseases\t0.052\n",
        "Benign neoplasm of other parts of digestive system\t0.051\n",
        "----------------------------------------\n",
        "Antihypertensive Agents\t0.117\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.106\n",
        "Diuretics\t0.104\n",
        "Anti-Inflammatory Agents\t0.104\n",
        "Cyclooxygenase Inhibitors\t0.103\n",
        "Antipyretics\t0.100\n",
        "Vasodilator Agents\t0.096\n",
        "Dermatologic Agents\t0.093\n",
        "Platelet Aggregation Inhibitors\t0.091\n",
        "Fibrinolytic Agents\t0.087\n",
        "===== phenotype 40=================================================================\n",
        "proportion of pts: 0.0674335581119\n",
        "lambda: 5773.09931406\n",
        "----------------------------------------\n",
        "Miscellaneous diagnostic and therapeutic procedures\t0.170\n",
        "Operations on the cardiovascular system\t0.129\n",
        "Other diseases of respiratory system\t0.098\n",
        "Operations on the musculoskeletal system\t0.071\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\t0.070\n",
        "Diseases of arteries, arterioles, and capillaries\t0.068\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.058\n"
       ]
      },
      {
       "ename": "TypeError",
       "evalue": "unsupported operand type(s) for +: 'float' and 'str'",
       "output_type": "pyerr",
       "traceback": [
        "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m\n\u001b[0;31mTypeError\u001b[0m                                 Traceback (most recent call last)",
        "\u001b[0;32m<ipython-input-168-6e1e805d9cb8>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m()\u001b[0m\n\u001b[1;32m     69\u001b[0m     \u001b[0ml_jdrangeindex_sorted\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;34m[\u001b[0m\u001b[0mtup\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;36m0\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;32mfor\u001b[0m \u001b[0mtup\u001b[0m \u001b[0;32min\u001b[0m \u001b[0msorted\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0md_jdrangeindex_weights\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0miteritems\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mkey\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0moperator\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mitemgetter\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;36m1\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m-\u001b[0m\u001b[0;36m1\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;31m#note: use slice [::-1] to reverse list!\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     70\u001b[0m     \u001b[0;32mfor\u001b[0m \u001b[0mindex_this_jdrange\u001b[0m \u001b[0;32min\u001b[0m \u001b[0ml_jdrangeindex_sorted\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 71\u001b[0;31m         \u001b[0;32mprint\u001b[0m \u001b[0md_jdrange_lookup\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0ml_jdrange\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mindex_this_jdrange\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0;34m'\\t'\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0mstr\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"%.3f\"\u001b[0m \u001b[0;34m%\u001b[0m\u001b[0mthis_pheno_jdrange_factor\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mindex_this_jdrange\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     72\u001b[0m         \u001b[0mpheno_outstream\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mwrite\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mstr\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0md_jdrange_lookup\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0ml_jdrange\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mindex_this_jdrange\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0;34m'\\t'\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0mstr\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"%.3f\"\u001b[0m \u001b[0;34m%\u001b[0m\u001b[0mthis_pheno_jdrange_factor\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mindex_this_jdrange\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m)\u001b[0m  \u001b[0;34m+\u001b[0m\u001b[0;34m'\\n'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     73\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
        "\u001b[0;31mTypeError\u001b[0m: unsupported operand type(s) for +: 'float' and 'str'"
       ]
      }
     ],
     "prompt_number": 168
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "#do the factorization with the list of patients in question \n",
      "#\n",
      "# last modified aug 6, 2014\n",
      "\n",
      "R = 50\n",
      "alpha = 1\n",
      "gammaForTF = [0.001, 0.1, 0.1]\n",
      "save_folder = './pickle_folder_20140814/'\n",
      "\n",
      "\n",
      "#create output folder if it does not exist\n",
      "if not os.path.exists(save_folder):\n",
      "\tos.makedirs(save_folder)\n",
      "\n",
      "\n",
      "#do tensor factorization on the SUBSET - with GAMMA as set above ##################################################################################################\n",
      "#laod the tensor for the subset!\n",
      "loaded_X_subset_to_analyze, loaded_axisDict_subset_to_analyze, loaded_classDict_subset_to_analyze = tensorIO.loadSingleTensor(\"htn-tensor-subsetforanalysis-20140811-{0}.dat\")\n",
      "\n",
      "startTime = time.time()#start time -- to time it\n",
      "##factorization\n",
      "print \"running factorization\"\n",
      "spntf_htn_subset_analyzed_withGamma = SP_NTF.SP_NTF(loaded_X_subset_to_analyze, R=R, alpha=alpha)\n",
      "Yinfo_htn_subset_analyzed_withGamma = spntf_htn_subset_analyzed_withGamma.computeDecomp(gamma=gammaForTF)\n",
      "marbleElapse = time.time() - startTime #elapsed time\n",
      "\n",
      "#tensor decomposition factors (\"phenotypes\"):\n",
      "pheno_htn_subset_analyzed_withGamma_REG = spntf_htn_subset_analyzed_withGamma.M[0]\n",
      "pheno_htn_subset_analyzed_withGamma_AUG = spntf_htn_subset_analyzed_withGamma.M[1]\n",
      "pheno_htn_subset_analyzed_withGamma = (pheno_htn_subset_analyzed_withGamma_REG, pheno_htn_subset_analyzed_withGamma_AUG) \n",
      "\n",
      "\n",
      "#string for saving the file based upon gamma\n",
      "gamma_str = '_gamma'\n",
      "for num in gammaForTF:\n",
      "    gamma_str = gamma_str + '-' + str(num)\n",
      "gamma_str = gamma_str + '.pickle'\n",
      "\n",
      "\n",
      "\n",
      "#save factorization in pickle\n",
      "outfile_str = save_folder + \"pheno_htn_subset_analyzed_REG\" + gamma_str\n",
      "with open(outfile_str, \"wb\") as output_file: ##IMPT! phenotype stored in this pickle\n",
      "    pickle.dump(pheno_htn_subset_analyzed_withGamma, output_file)\n",
      "output_file.close()\n",
      "outfile_str = save_folder + \"pheno_htn_subset_analyzed_AUG\" + gamma_str\n",
      "with open(outfile_str, \"wb\") as output_file: ##IMPT! phenotype stored in this pickle\n",
      "    pickle.dump(pheno_htn_subset_analyzed_withGamma, output_file)\n",
      "output_file.close()\n",
      "outfile_str = save_folder + \"Yinfo_htn_subset_analyzed\" + gamma_str\n",
      "with open(outfile_str, \"wb\") as output_file:\n",
      "    pickle.dump(Yinfo_htn_subset_analyzed_withGamma, output_file)\n",
      "output_file.close()\n",
      "\n",
      "\n",
      "#gamma_str = '_gamma-0.001-0.01-0.01.pickle'\n",
      "\n",
      "import operator\n",
      "\n",
      "def calculateValues(TM, M):\n",
      "    fms = TM.greedy_fms(M)\n",
      "    fos = TM.greedy_fos(M)\n",
      "    nnz = tensorTools.countTensorNNZ(M)\n",
      "    return fms, fos, nnz\n",
      "\n",
      "## load the tensor #######\n",
      "loaded_X, loaded_axisDict, loaded_classDict = tensorIO.loadSingleTensor(\"htn-tensor-subsetforanalysis-20140811-{0}.dat\")\n",
      "\n",
      "\n",
      "##read in the pickles:\n",
      "pickle_folder = \"./pickle_folder_20140814/\"\n",
      "\n",
      "outfile_str = pickle_folder + \"pheno_htn_subset_analyzed_REG\" + gamma_str\n",
      "matrix_pkl = open(outfile_str, \"rb\")\n",
      "pheno_htn_subset_analyzed_REG_withGamma = pickle.load(matrix_pkl)\n",
      "matrix_pkl.close()\n",
      "\n",
      "outfile_str = pickle_folder + \"Yinfo_htn_subset_analyzed\" + gamma_str  \n",
      "matrix_pkl = open(outfile_str, \"rb\")\n",
      "Yinfo_htn_subset_analyzed_withGamma = pickle.load(matrix_pkl)\n",
      "matrix_pkl.close()\n",
      "\n",
      "#write output file\n",
      "pheno_outstream = open(pickle_folder + \"phenotypes\"+gamma_str+\".out\", 'w+')\n",
      "    \n",
      "\n",
      "##############################################################################################################\n",
      "\n",
      "#tensor with all phenotypes (factorization)\n",
      "ktensor_phenotypes = pheno_htn_subset_analyzed_REG_withGamma[0]\n",
      "l_pts = loaded_axisDict[0].keys()\n",
      "l_jdrange = loaded_axisDict[1].keys()\n",
      "l_meds= loaded_axisDict[2].keys()\n",
      "\n",
      "#will store all the data\n",
      "d_pheno_nonzero_labels = OrderedDict()\n",
      "\n",
      "\n",
      "#sort phenotypes by lambda values:\n",
      "d_lambda_phenoNumber = OrderedDict(zip( list(range(R)), \n",
      "                                        list(ktensor_phenotypes.lmbda)\n",
      "                                        ))\n",
      "l_phenoNumbers_sorted_by_lambda = [tup[0] for tup in sorted(d_lambda_phenoNumber.iteritems(), key=operator.itemgetter(1))][::-1]  #get a sorted list of phenotype numbers, which are sorted by using the operator.itemgetter                                \n",
      "\n",
      "#print phenotype feature names #################\n",
      "#for i in range(10):\n",
      "for i in l_phenoNumbers_sorted_by_lambda:\n",
      "    print \"===== phenotype \" + str(i) + \"=================================================================\"\n",
      "    pheno_outstream.write(\"===== phenotype \" + str(i) + \"=================================================================\" + '\\n')\n",
      "    this_lmbda = ktensor_phenotypes.lmbda[i]\n",
      "    this_pheno_pt_factor = ktensor_phenotypes.U[0][:,i]\n",
      "    this_pheno_jdrange_factor = ktensor_phenotypes.U[1][:,i]\n",
      "    this_pheno_med_factor = ktensor_phenotypes.U[2][:,i]\n",
      "    \n",
      "    this_pheno_pt_nnz = np.nonzero(this_pheno_pt_factor)[0]\n",
      "    this_pheno_jdrange_nnz = np.nonzero(this_pheno_jdrange_factor)[0]\n",
      "    this_pheno_med_nnz = np.nonzero(this_pheno_med_factor)[0]\n",
      "    \n",
      "    l_nonzero_pt_thisPheno = []\n",
      "    l_nonzero_meds_thisPheno = []\n",
      "    l_nonzero_jdrange_thisPheno = []\n",
      "    l_nonzero_jdrange_names_thisPheno = []\n",
      "    \n",
      "    for j in this_pheno_pt_nnz:\n",
      "        l_nonzero_pt_thisPheno.append(l_pts[j])\n",
      "    for j in this_pheno_jdrange_nnz:\n",
      "        l_nonzero_jdrange_thisPheno.append(l_jdrange[j])\n",
      "        l_nonzero_jdrange_names_thisPheno.append(d_jdrange_lookup[l_jdrange[j]])\n",
      "    for j in this_pheno_med_nnz:\n",
      "        l_nonzero_meds_thisPheno.append(l_meds[j])\n",
      "    \n",
      "    #data\n",
      "    d_pheno_nonzero_labels[i] = dict() #for phenotype i\n",
      "    d_pheno_nonzero_labels[i]['LAMBDA'] = this_lmbda #lambda value\n",
      "    d_pheno_nonzero_labels[i]['PERCENT_PTS'] = len(l_nonzero_pt_thisPheno) / float(len(this_pheno_pt_factor))\n",
      "    d_pheno_nonzero_labels[i]['MEDS_NZ'] = l_nonzero_meds_thisPheno #for phenotype i\n",
      "    d_pheno_nonzero_labels[i]['JDRANGE_NZ'] = l_nonzero_jdrange_thisPheno #for phenotype i   \n",
      "    d_pheno_nonzero_labels[i]['JDRANGE_NAMES_NZ'] = l_nonzero_jdrange_names_thisPheno #for phenotype i \n",
      "    \n",
      "    print \"proportion of pts: \" + str(d_pheno_nonzero_labels[i]['PERCENT_PTS'])\n",
      "    pheno_outstream.write(\"proportion of pts: \" + str(d_pheno_nonzero_labels[i]['PERCENT_PTS']) + '\\n')\n",
      "    print \"lambda: \" + str(this_lmbda)\n",
      "    pheno_outstream.write(\"lambda: \" + str(this_lmbda) + '\\n')\n",
      "    \n",
      "\n",
      "    print \"----------------------------------------\" #divider\n",
      "    pheno_outstream.write(\"----------------------------------------\" + '\\n')\n",
      "    #make ranking of JDRANGE by the weights:\n",
      "    nparr_jdrange_weights = this_pheno_jdrange_factor[this_pheno_jdrange_nnz]\n",
      "    d_jdrangeindex_weights = OrderedDict(zip(this_pheno_jdrange_nnz, nparr_jdrange_weights))\n",
      "    l_jdrangeindex_sorted = [tup[0] for tup in sorted(d_jdrangeindex_weights.iteritems(), key=operator.itemgetter(1))][::-1] #note: use slice [::-1] to reverse list!\n",
      "    for index_this_jdrange in l_jdrangeindex_sorted:\n",
      "        print d_jdrange_lookup[l_jdrange[index_this_jdrange]] + '\\t' + str(\"%.3f\" %this_pheno_jdrange_factor[index_this_jdrange] )\n",
      "        pheno_outstream.write(str(d_jdrange_lookup[l_jdrange[index_this_jdrange]]) + '\\t' + str(\"%.3f\" %this_pheno_jdrange_factor[index_this_jdrange])  +'\\n')\n",
      "    \n",
      "\n",
      "    print \"----------------------------------------\" #divider between diagnostic codes and meds\n",
      "    pheno_outstream.write(\"----------------------------------------\" + '\\n')\n",
      "    #make ranking of MED by the weights:\n",
      "    nparr_med_weights = this_pheno_med_factor[this_pheno_med_nnz]\n",
      "    d_medindex_weights = OrderedDict(zip(this_pheno_med_nnz, nparr_med_weights))\n",
      "    l_medindex_sorted = [tup[0] for tup in sorted(d_medindex_weights.iteritems(), key=operator.itemgetter(1))][::-1]\n",
      "    for index_this_med in l_medindex_sorted:\n",
      "        print l_meds[index_this_med]  + '\\t' + str(\"%.3f\" %this_pheno_med_factor[index_this_med])\n",
      "        pheno_outstream.write(l_meds[index_this_med]  + '\\t' + str(\"%.3f\" %this_pheno_med_factor[index_this_med]) + '\\n')\n",
      "pheno_outstream.close()\n",
      "        \n",
      "\n",
      "\n",
      "\n",
      "\n"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "running factorization\n",
        "Iteration 0: Xi = 0.499999999956, dll = 0.00105213932693, time = 153.481752157"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 1: Xi = 0.749999999959, dll = 0.000444365665317, time = 152.323295116"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 2: Xi = 0.874999999973, dll = 0.000165222212672, time = 153.136168003"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 3: Xi = 0.937499999984, dll = 6.13331794739e-05, time = 153.055009127"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 4: Xi = 0.968749999991, dll = 2.24728137255e-05, time = 153.066718817"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 5: Xi = 0.984374999995, dll = 8.16956162453e-06, time = 152.984858036"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "Iteration 6: Xi = 0.992187499997, dll = 3.58745455742e-06, time = 153.497719049"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "===== phenotype 5================================================================="
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "proportion of pts: 0.116620388735\n",
        "lambda: 13818.3201133\n",
        "----------------------------------------\n",
        "Ischemic heart disease\t0.157\n",
        "Other forms of heart disease\t0.139\n",
        "Disorders of lipoid metabolism\t0.125\n",
        "Hypertensive disease\t0.119\n",
        "Range name na\t0.101\n",
        "Nephritis, nephrotic syndrome, and nephrosis\t0.097\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.096\n",
        "Anemias\t0.093\n",
        "Disorders of fluid, electrolyte, and acid-base balance\t0.075\n",
        "----------------------------------------\n",
        "Anti-Arrhythmia Agents\t0.084\n",
        "Adrenergic beta-1 Receptor Antagonists\t0.083\n",
        "Sympatholytics\t0.080\n",
        "Diuretics\t0.079\n",
        "Platelet Aggregation Inhibitors\t0.078\n",
        "Antipyretics\t0.078\n",
        "Fibrinolytic Agents\t0.076\n",
        "Cyclooxygenase Inhibitors\t0.076\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.076\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.074\n",
        "Anticholesteremic Agents\t0.073\n",
        "Antihypertensive Agents\t0.072\n",
        "Vasodilator Agents\t0.072\n",
        "===== phenotype 13=================================================================\n",
        "proportion of pts: 0.138040460135\n",
        "lambda: 11356.026408\n",
        "----------------------------------------\n",
        "Diabetes\t0.247\n",
        "Disorders of lipoid metabolism\t0.181\n",
        "Hypertensive disease\t0.180\n",
        "Ischemic heart disease\t0.117\n",
        "Disorders of the eye and adnexa\t0.102\n",
        "Range name na\t0.088\n",
        "General symptoms\t0.084\n",
        "----------------------------------------\n",
        "Hypoglycemic Agents\t0.117\n",
        "Anti-Arrhythmia Agents\t0.091\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.088\n",
        "Anticholesteremic Agents\t0.086\n",
        "Adrenergic beta-1 Receptor Antagonists\t0.080\n",
        "Cyclooxygenase Inhibitors\t0.079\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.079\n",
        "Platelet Aggregation Inhibitors\t0.078\n",
        "Fibrinolytic Agents\t0.077\n",
        "Angiotensin-Converting Enzyme Inhibitors\t0.077\n",
        "Antihypertensive Agents\t0.075\n",
        "Sympatholytics\t0.074\n",
        "===== phenotype 0=================================================================\n",
        "proportion of pts: 0.120190400635\n",
        "lambda: 10317.6198918\n",
        "----------------------------------------\n",
        "Other diseases of urinary system\t0.134\n",
        "Disorders of lipoid metabolism\t0.128\n",
        "Hypertensive disease\t0.126\n",
        "Symptoms involving urinary system\t0.112\n",
        "General symptoms\t0.099\n",
        "Arthropathies and related disorders\t0.090\n",
        "Dorsopathies\t0.081\n",
        "Diseases of male genital organs\t0.080\n",
        "Range name na\t0.077\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.074\n",
        "----------------------------------------\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.101\n",
        "Anticholesteremic Agents\t0.100\n",
        "Platelet Aggregation Inhibitors\t0.097\n",
        "Fibrinolytic Agents\t0.096\n",
        "Hypolipidemic Agents\t0.095\n",
        "Antipyretics\t0.090\n",
        "Cyclooxygenase Inhibitors\t0.087\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.086\n",
        "Antihypertensive Agents\t0.085\n",
        "Vasodilator Agents\t0.083\n",
        "Angiotensin-Converting Enzyme Inhibitors\t0.080\n",
        "===== phenotype 27=================================================================\n",
        "proportion of pts: 0.11463704879\n",
        "lambda: 10170.7536676\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.135\n",
        "General symptoms\t0.122\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.114\n",
        "Range name na\t0.113\n",
        "Disorders of lipoid metabolism\t0.103\n",
        "Symptoms involving head and neck\t0.091\n",
        "Nutritional deficiencies\t0.085\n",
        "Disorders of the eye and adnexa\t0.082\n",
        "Other diseases of intestines and peritoneum\t0.079\n",
        "Symptoms involving urinary system\t0.076\n",
        "----------------------------------------\n",
        "Angiotensin-Converting Enzyme Inhibitors\t0.090\n",
        "Vitamins\t0.090\n",
        "Calcium Channel Blockers\t0.086\n",
        "Vasodilator Agents\t0.086\n",
        "Fibrinolytic Agents\t0.084\n",
        "Platelet Aggregation Inhibitors\t0.083\n",
        "Antipyretics\t0.082\n",
        "Antihypertensive Agents\t0.081\n",
        "Cardiotonic Agents\t0.081\n",
        "Bone Density Conservation Agents\t0.080\n",
        "Cyclooxygenase Inhibitors\t0.079\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.078\n",
        "===== phenotype 9=================================================================\n",
        "proportion of pts: 0.115430384768\n",
        "lambda: 10101.8850735\n",
        "----------------------------------------\n",
        "Diabetes\t0.186\n",
        "Disorders of lipoid metabolism\t0.127\n",
        "Hypertensive disease\t0.126\n",
        "Disorders of the eye and adnexa\t0.111\n",
        "Rheumatism, excluding the back\t0.109\n",
        "Organic sleep disorders\t0.088\n",
        "Range name na\t0.085\n",
        "Diseases of the ear and mastoid process\t0.084\n",
        "Symptoms involving skin and other integumentary tissue\t0.083\n",
        "----------------------------------------\n",
        "Hypoglycemic Agents\t0.109\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.099\n",
        "Antipyretics\t0.094\n",
        "Anticholesteremic Agents\t0.094\n",
        "Hypolipidemic Agents\t0.092\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.091\n",
        "Cyclooxygenase Inhibitors\t0.090\n",
        "Platelet Aggregation Inhibitors\t0.089\n",
        "Fibrinolytic Agents\t0.087\n",
        "Antihypertensive Agents\t0.081\n",
        "Anti-Inflammatory Agents\t0.072\n",
        "===== phenotype 20=================================================================\n",
        "proportion of pts: 0.11106703689\n",
        "lambda: 9740.17006232\n",
        "----------------------------------------\n",
        "Other diseases of skin and subcutaneous tissue\t0.157\n",
        "Hypertensive disease\t0.094\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\t0.091\n",
        "Malignant neoplasm of skin\t0.087\n",
        "Arthropathies and related disorders\t0.086\n",
        "Rheumatism, excluding the back\t0.085\n",
        "Neoplasm of uncertain behavior of other sites & tissues\t0.084\n",
        "Symptoms involving skin and other integumentary tissue\t0.083\n",
        "Dorsopathies\t0.081\n",
        "Other forms of heart disease\t0.077\n",
        "Infections of skin and subcutaneous tissue\t0.074\n",
        "----------------------------------------\n",
        "Antipyretics\t0.104\n",
        "Platelet Aggregation Inhibitors\t0.102\n",
        "Fibrinolytic Agents\t0.100\n",
        "Cyclooxygenase Inhibitors\t0.097\n",
        "Antihypertensive Agents\t0.097\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.096\n",
        "Vitamins\t0.087\n",
        "Anti-Arrhythmia Agents\t0.084\n",
        "Bone Density Conservation Agents\t0.079\n",
        "Vasodilator Agents\t0.078\n",
        "Diuretics\t0.076\n",
        "===== phenotype 46=================================================================\n",
        "proportion of pts: 0.123760412535\n",
        "lambda: 9560.99712745\n",
        "----------------------------------------\n",
        "Disorders of thyroid gland\t0.174\n",
        "Hypertensive disease\t0.150\n",
        "Disorders of lipoid metabolism\t0.143\n",
        "Organic sleep disorders\t0.120\n",
        "Dorsopathies\t0.087\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.086\n",
        "Other symptoms involving abdomen and pelvis\t0.085\n",
        "General symptoms\t0.080\n",
        "Diseases of esophagus, stomach, and duodenum\t0.075\n",
        "----------------------------------------\n",
        "Diuretics\t0.095\n",
        "Anti-Arrhythmia Agents\t0.094\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.091\n",
        "Anticholesteremic Agents\t0.088\n",
        "Antihypertensive Agents\t0.087\n",
        "Anti-Allergic Agents\t0.080\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.080\n",
        "Sodium Chloride Symporter Inhibitors\t0.080\n",
        "Cyclooxygenase Inhibitors\t0.079\n",
        "Calcium Channel Blockers\t0.079\n",
        "Antipyretics\t0.076\n",
        "Platelet Aggregation Inhibitors\t0.073\n",
        "===== phenotype 47=================================================================\n",
        "proportion of pts: 0.127727092424\n",
        "lambda: 9296.79470308\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\t0.154\n",
        "Hypertensive disease\t0.147\n",
        "Acute respiratory infections\t0.130\n",
        "Arthropathies and related disorders\t0.128\n",
        "Diabetes\t0.097\n",
        "Rheumatism, excluding the back\t0.090\n",
        "Other diseases of the upper respiratory tract\t0.085\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.085\n",
        "Range name na\t0.083\n",
        "----------------------------------------\n",
        "Cyclooxygenase Inhibitors\t0.120\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.119\n",
        "Antipyretics\t0.117\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.116\n",
        "Fibrinolytic Agents\t0.113\n",
        "Platelet Aggregation Inhibitors\t0.113\n",
        "Anticholesteremic Agents\t0.111\n",
        "Antihypertensive Agents\t0.102\n",
        "Diuretics\t0.089\n",
        "===== phenotype 34=================================================================\n",
        "proportion of pts: 0.111463704879\n",
        "lambda: 8965.02823872\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.126\n",
        "Range name na\t0.122\n",
        "Rheumatism, excluding the back\t0.107\n",
        "Diabetes\t0.105\n",
        "Disorders of lipoid metabolism\t0.099\n",
        "Other forms of heart disease\t0.097\n",
        "Arthropathies and related disorders\t0.092\n",
        "Disorders of the eye and adnexa\t0.090\n",
        "General symptoms\t0.087\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\t0.075\n",
        "----------------------------------------\n",
        "Diuretics\t0.141\n",
        "Calcium Channel Blockers\t0.126\n",
        "Sodium Potassium Chloride Symporter Inhibitors\t0.126\n",
        "Vasodilator Agents\t0.123\n",
        "Anti-Arrhythmia Agents\t0.120\n",
        "Sympatholytics\t0.105\n",
        "Anticoagulants\t0.092\n",
        "Rodenticides\t0.086\n",
        "Antihypertensive Agents\t0.082\n",
        "===== phenotype 21=================================================================\n",
        "proportion of pts: 0.103530345101\n",
        "lambda: 8757.62309733\n",
        "----------------------------------------\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\t0.119\n",
        "Arthropathies and related disorders\t0.115\n",
        "Rheumatism, excluding the back\t0.104\n",
        "Hypertensive disease\t0.103\n",
        "Range name na\t0.094\n",
        "Dorsopathies\t0.083\n",
        "Other diseases of urinary system\t0.081\n",
        "Symptoms involving urinary system\t0.080\n",
        "General symptoms\t0.078\n",
        "Diseases of esophagus, stomach, and duodenum\t0.072\n",
        "Disorders of the peripheral nervous system\t0.071\n",
        "----------------------------------------\n",
        "Calcium Channel Blockers\t0.128\n",
        "Anti-Arrhythmia Agents\t0.114\n",
        "Anti-Ulcer Agents\t0.114\n",
        "Anticonvulsants\t0.107\n",
        "Anti-Anxiety Agents\t0.105\n",
        "Analgesics\t0.103\n",
        "Antipyretics\t0.089\n",
        "Serotonin Uptake Inhibitors\t0.088\n",
        "Cyclooxygenase Inhibitors\t0.077\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.075\n",
        "===== phenotype 22=================================================================\n",
        "proportion of pts: 0.115827052757\n",
        "lambda: 8619.81740246\n",
        "----------------------------------------\n",
        "Other diseases of the upper respiratory tract\t0.172\n",
        "Hypertensive disease\t0.154\n",
        "Acute respiratory infections\t0.143\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.137\n",
        "Chronic obstructive pulmonary disease and allied conditions\t0.113\n",
        "Disorders of lipoid metabolism\t0.107\n",
        "Disorders of the eye and adnexa\t0.097\n",
        "Diseases of esophagus, stomach, and duodenum\t0.077\n",
        "----------------------------------------\n",
        "Anti-Inflammatory Agents\t0.120\n",
        "Anti-Allergic Agents\t0.117\n",
        "Bronchodilator Agents\t0.116\n",
        "Dermatologic Agents\t0.102\n",
        "Histamine H1 Antagonists, Non-Sedating\t0.099\n",
        "Glucocorticoids\t0.095\n",
        "Anti-Bacterial Agents\t0.092\n",
        "Antihypertensive Agents\t0.091\n",
        "Anti-Ulcer Agents\t0.088\n",
        "Proton Pump Inhibitors\t0.081\n",
        "===== phenotype 42=================================================================\n",
        "proportion of pts: 0.105910353035\n",
        "lambda: 8566.13784106\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.145\n",
        "General symptoms\t0.117\n",
        "Range name na\t0.105\n",
        "Disorders of lipoid metabolism\t0.101\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.100\n",
        "Arthropathies and related disorders\t0.095\n",
        "Rheumatism, excluding the back\t0.090\n",
        "Symptoms involving head and neck\t0.087\n",
        "Dorsopathies\t0.082\n",
        "Disorders of the eye and adnexa\t0.078\n",
        "----------------------------------------\n",
        "Hypnotics and Sedatives\t0.135\n",
        "Anticonvulsants\t0.135\n",
        "Anti-Anxiety Agents\t0.129\n",
        "Antiemetics\t0.128\n",
        "GABA Modulators\t0.123\n",
        "Histamine H1 Antagonists\t0.094\n",
        "Analgesics\t0.090\n",
        "Serotonin Uptake Inhibitors\t0.086\n",
        "Antidepressive Agents, Second-Generation\t0.081\n",
        "===== phenotype 2=================================================================\n",
        "proportion of pts: 0.113843712812\n",
        "lambda: 8354.70109205\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.157\n",
        "Disorders of lipoid metabolism\t0.142\n",
        "Other forms of heart disease\t0.136\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.102\n",
        "Symptoms involving skin and other integumentary tissue\t0.100\n",
        "Symptoms involving cardiovascular system\t0.097\n",
        "Range name na\t0.096\n",
        "Nonspecific findings on examination of blood\t0.086\n",
        "Ischemic heart disease\t0.084\n",
        "----------------------------------------\n",
        "Vasodilator Agents\t0.107\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.103\n",
        "Cyclooxygenase Inhibitors\t0.103\n",
        "Antihypertensive Agents\t0.102\n",
        "Anti-Arrhythmia Agents\t0.101\n",
        "Antipyretics\t0.101\n",
        "Diuretics\t0.098\n",
        "Fibrinolytic Agents\t0.097\n",
        "Platelet Aggregation Inhibitors\t0.096\n",
        "Calcium Channel Blockers\t0.093\n",
        "===== phenotype 48=================================================================\n",
        "proportion of pts: 0.105513685046\n",
        "lambda: 8262.34360185\n",
        "----------------------------------------\n",
        "Diseases of esophagus, stomach, and duodenum\t0.172\n",
        "Hypertensive disease\t0.129\n",
        "Arthropathies and related disorders\t0.121\n",
        "Disorders of lipoid metabolism\t0.110\n",
        "Rheumatism, excluding the back\t0.106\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.106\n",
        "General symptoms\t0.097\n",
        "Disorders of thyroid gland\t0.086\n",
        "Symptoms involving digestive system\t0.074\n",
        "----------------------------------------\n",
        "Proton Pump Inhibitors\t0.114\n",
        "Anti-Ulcer Agents\t0.111\n",
        "Vitamins\t0.098\n",
        "Cyclooxygenase Inhibitors\t0.091\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.089\n",
        "Fibrinolytic Agents\t0.087\n",
        "Platelet Aggregation Inhibitors\t0.087\n",
        "Bone Density Conservation Agents\t0.084\n",
        "Antipyretics\t0.084\n",
        "Antihypertensive Agents\t0.078\n",
        "Vasodilator Agents\t0.077\n",
        "===== phenotype 12=================================================================\n",
        "proportion of pts: 0.0987703292344\n",
        "lambda: 7760.02966973\n",
        "----------------------------------------\n",
        "Other forms of heart disease\t0.143\n",
        "Range name na\t0.136\n",
        "Hypertensive disease\t0.127\n",
        "Disorders of lipoid metabolism\t0.124\n",
        "Ischemic heart disease\t0.113\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.100\n",
        "Arthropathies and related disorders\t0.095\n",
        "Rheumatism, excluding the back\t0.082\n",
        "Dorsopathies\t0.081\n",
        "----------------------------------------\n",
        "Hypolipidemic Agents\t0.102\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.100\n",
        "Anticoagulants\t0.100\n",
        "Anti-Arrhythmia Agents\t0.099\n",
        "Anticholesteremic Agents\t0.094\n",
        "Sympatholytics\t0.093\n",
        "Rodenticides\t0.092\n",
        "Anti-Allergic Agents\t0.086\n",
        "Histamine H1 Antagonists, Non-Sedating\t0.082\n",
        "Platelet Aggregation Inhibitors\t0.077\n",
        "Fibrinolytic Agents\t0.076\n",
        "===== phenotype 28=================================================================\n",
        "proportion of pts: 0.0920269734232\n",
        "lambda: 7590.77220222\n",
        "----------------------------------------\n",
        "Disorders of lipoid metabolism\t0.139\n",
        "Ischemic heart disease\t0.126\n",
        "Hypertensive disease\t0.119\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.113\n",
        "Other diseases of skin and subcutaneous tissue\t0.093\n",
        "Chronic obstructive pulmonary disease and allied conditions\t0.091\n",
        "Range name na\t0.083\n",
        "General symptoms\t0.082\n",
        "Cerebrovascular disease\t0.079\n",
        "Arthropathies and related disorders\t0.077\n",
        "----------------------------------------\n",
        "Hypolipidemic Agents\t0.119\n",
        "Anticholesteremic Agents\t0.116\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.108\n",
        "Vasodilator Agents\t0.103\n",
        "Platelet Aggregation Inhibitors\t0.101\n",
        "Fibrinolytic Agents\t0.098\n",
        "Cyclooxygenase Inhibitors\t0.094\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.089\n",
        "Antipyretics\t0.089\n",
        "Explosive Agents\t0.083\n",
        "===== phenotype 39=================================================================\n",
        "proportion of pts: 0.119793732646\n",
        "lambda: 7454.76466836\n",
        "----------------------------------------\n",
        "Nutritional deficiencies\t0.159\n",
        "Hypertensive disease\t0.153\n",
        "Range name na\t0.128\n",
        "Disorders of lipoid metabolism\t0.113\n",
        "Disorders of the eye and adnexa\t0.103\n",
        "Arthropathies and related disorders\t0.101\n",
        "Anemias\t0.088\n",
        "General symptoms\t0.081\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\t0.074\n",
        "----------------------------------------\n",
        "Vitamins\t0.146\n",
        "Bone Density Conservation Agents\t0.136\n",
        "Vitamin B Complex\t0.129\n",
        "Antioxidants\t0.125\n",
        "Antihypertensive Agents\t0.105\n",
        "Antipyretics\t0.093\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.090\n",
        "Serotonin Uptake Inhibitors\t0.089\n",
        "Cyclooxygenase Inhibitors\t0.087\n",
        "===== phenotype 17=================================================================\n",
        "proportion of pts: 0.0904403014677\n",
        "lambda: 7386.30999248\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.144\n",
        "Gout\t0.136\n",
        "Disorders of lipoid metabolism\t0.127\n",
        "Range name na\t0.124\n",
        "Ischemic heart disease\t0.115\n",
        "Other forms of heart disease\t0.099\n",
        "Dorsopathies\t0.086\n",
        "Arthropathies and related disorders\t0.085\n",
        "Diabetes\t0.085\n",
        "----------------------------------------\n",
        "Gout Suppressants\t0.109\n",
        "Enzyme Inhibitors\t0.091\n",
        "Antimetabolites\t0.090\n",
        "Antipyretics\t0.084\n",
        "Adrenergic alpha-1 Receptor Antagonists\t0.084\n",
        "Vasodilator Agents\t0.083\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.081\n",
        "Cyclooxygenase Inhibitors\t0.079\n",
        "Free Radical Scavengers\t0.079\n",
        "Antihypertensive Agents\t0.074\n",
        "Fibrinolytic Agents\t0.074\n",
        "Platelet Aggregation Inhibitors\t0.072\n",
        "===== phenotype 25=================================================================\n",
        "proportion of pts: 0.115033716779\n",
        "lambda: 7082.86623024\n",
        "----------------------------------------\n",
        "Dorsopathies\t0.167\n",
        "Arthropathies and related disorders\t0.153\n",
        "Hypertensive disease\t0.139\n",
        "Rheumatism, excluding the back\t0.137\n",
        "Range name na\t0.119\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\t0.100\n",
        "Disorders of lipoid metabolism\t0.100\n",
        "General symptoms\t0.086\n",
        "----------------------------------------\n",
        "Anti-Inflammatory Agents\t0.137\n",
        "Calcium Channel Blockers\t0.126\n",
        "Glucocorticoids\t0.126\n",
        "Anti-Allergic Agents\t0.124\n",
        "Dermatologic Agents\t0.108\n",
        "Antihypertensive Agents\t0.105\n",
        "Bronchodilator Agents\t0.099\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.089\n",
        "Cyclooxygenase Inhibitors\t0.085\n",
        "===== phenotype 11=================================================================\n",
        "proportion of pts: 0.111860372868\n",
        "lambda: 6679.2444502\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.151\n",
        "Range name na\t0.151\n",
        "Rheumatism, excluding the back\t0.116\n",
        "Arthropathies and related disorders\t0.114\n",
        "General symptoms\t0.107\n",
        "Disorders of lipoid metabolism\t0.102\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.092\n",
        "Dorsopathies\t0.089\n",
        "Other forms of heart disease\t0.077\n",
        "----------------------------------------\n",
        "Analgesics, Opioid\t0.152\n",
        "Narcotics\t0.143\n",
        "Immunosuppressive Agents\t0.111\n",
        "Antimalarials\t0.109\n",
        "Anti-Infective Agents, Urinary\t0.107\n",
        "Enzyme Inhibitors\t0.104\n",
        "Antirheumatic Agents\t0.095\n",
        "Antifungal Agents\t0.094\n",
        "Anti-Infective Agents, Local\t0.087\n",
        "===== phenotype 44=================================================================\n",
        "proportion of pts: 0.10392701309\n",
        "lambda: 6438.04258222\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.126\n",
        "Disorders of lipoid metabolism\t0.115\n",
        "Other diseases of skin and subcutaneous tissue\t0.107\n",
        "Disorders of the eye and adnexa\t0.105\n",
        "Arthropathies and related disorders\t0.103\n",
        "Mycoses\t0.096\n",
        "Range name na\t0.093\n",
        "Ischemic heart disease\t0.090\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\t0.083\n",
        "Diabetes\t0.082\n",
        "----------------------------------------\n",
        "Angiotensin-Converting Enzyme Inhibitors\t0.138\n",
        "Cardiotonic Agents\t0.135\n",
        "Anticholesteremic Agents\t0.127\n",
        "Anti-Ulcer Agents\t0.124\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.121\n",
        "Antihypertensive Agents\t0.121\n",
        "Proton Pump Inhibitors\t0.118\n",
        "Diuretics\t0.116\n",
        "===== phenotype 24=================================================================\n",
        "proportion of pts: 0.0840936136454\n",
        "lambda: 6383.46427199\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.166\n",
        "Range name na\t0.137\n",
        "Disorders of lipoid metabolism\t0.119\n",
        "Arthropathies and related disorders\t0.118\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.110\n",
        "Rheumatism, excluding the back\t0.090\n",
        "General symptoms\t0.089\n",
        "Ischemic heart disease\t0.087\n",
        "Diabetes\t0.084\n",
        "----------------------------------------\n",
        "Adrenergic beta-1 Receptor Antagonists\t0.122\n",
        "Enzyme Inhibitors\t0.107\n",
        "Sympatholytics\t0.106\n",
        "Immunosuppressive Agents\t0.104\n",
        "Folic Acid Antagonists\t0.100\n",
        "Dermatologic Agents\t0.095\n",
        "Nucleic Acid Synthesis Inhibitors\t0.094\n",
        "Antimetabolites, Antineoplastic\t0.092\n",
        "Antirheumatic Agents\t0.090\n",
        "Abortifacient Agents, Nonsteroidal\t0.090\n",
        "===== phenotype 31=================================================================\n",
        "proportion of pts: 0.10035700119\n",
        "lambda: 6092.01055504\n",
        "----------------------------------------\n",
        "Diseases of arteries, arterioles, and capillaries\t0.125\n",
        "Symptoms involving cardiovascular system\t0.105\n",
        "Diseases of male genital organs\t0.097\n",
        "Other diseases of urinary system\t0.096\n",
        "Other symptoms involving abdomen and pelvis\t0.091\n",
        "Other forms of heart disease\t0.089\n",
        "Malignant neoplasm of male and female genital organs\t0.085\n",
        "Other diseases of intestines and peritoneum\t0.084\n",
        "Hypertensive disease\t0.082\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\t0.074\n",
        "Other and unspecified effects of external causes\t0.070\n",
        "----------------------------------------\n",
        "Anticholesteremic Agents\t0.109\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.106\n",
        "Antihypertensive Agents\t0.105\n",
        "Antipyretics\t0.103\n",
        "Platelet Aggregation Inhibitors\t0.100\n",
        "Cyclooxygenase Inhibitors\t0.099\n",
        "Fibrinolytic Agents\t0.097\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.095\n",
        "Vasodilator Agents\t0.093\n",
        "Anti-Arrhythmia Agents\t0.093\n",
        "===== phenotype 45=================================================================\n",
        "proportion of pts: 0.0936136453788\n",
        "lambda: 5905.58037738\n",
        "----------------------------------------\n",
        "Other diseases of skin and subcutaneous tissue\t0.146\n",
        "Hypertensive disease\t0.136\n",
        "Disorders of lipoid metabolism\t0.126\n",
        "Neoplasm of uncertain behavior of other sites & tissues\t0.111\n",
        "General symptoms\t0.105\n",
        "Diseases of esophagus, stomach, and duodenum\t0.103\n",
        "Range name na\t0.096\n",
        "Other inflammatory conditions of skin and subcutaneous tissue\t0.090\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.088\n",
        "----------------------------------------\n",
        "Anti-Ulcer Agents\t0.119\n",
        "Proton Pump Inhibitors\t0.117\n",
        "Anti-Allergic Agents\t0.113\n",
        "Anti-Inflammatory Agents\t0.102\n",
        "Antihypertensive Agents\t0.097\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.095\n",
        "Anticholesteremic Agents\t0.095\n",
        "Bronchodilator Agents\t0.092\n",
        "Histamine H1 Antagonists, Non-Sedating\t0.092\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.078\n",
        "===== phenotype 32=================================================================\n",
        "proportion of pts: 0.0916303054344\n",
        "lambda: 5820.02782057\n",
        "----------------------------------------\n",
        "Rheumatism, excluding the back\t0.131\n",
        "Hypertensive disease\t0.119\n",
        "Arthropathies and related disorders\t0.113\n",
        "Sprains and strains of joints and adjacent muscles\t0.105\n",
        "Dorsopathies\t0.103\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.089\n",
        "Disorders of lipoid metabolism\t0.089\n",
        "Diseases of oral cavity, salivary glands, and jaws\t0.088\n",
        "Range name na\t0.086\n",
        "Other diseases of skin and subcutaneous tissue\t0.075\n",
        "----------------------------------------\n",
        "Anti-Arrhythmia Agents\t0.124\n",
        "Anesthetics, Local\t0.099\n",
        "Antihypertensive Agents\t0.094\n",
        "Vasodilator Agents\t0.092\n",
        "Anti-Inflammatory Agents\t0.092\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.088\n",
        "Cyclooxygenase Inhibitors\t0.087\n",
        "Antipyretics\t0.087\n",
        "Fibrinolytic Agents\t0.079\n",
        "Anti-Allergic Agents\t0.079\n",
        "Platelet Aggregation Inhibitors\t0.079\n",
        "===== phenotype 19=================================================================\n",
        "proportion of pts: 0.0753669178897\n",
        "lambda: 5484.75256385\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.177\n",
        "Disorders of lipoid metabolism\t0.128\n",
        "Arthropathies and related disorders\t0.108\n",
        "Range name na\t0.104\n",
        "Diabetes\t0.103\n",
        "Disorders of thyroid gland\t0.103\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\t0.096\n",
        "Nutritional deficiencies\t0.091\n",
        "Rheumatism, excluding the back\t0.089\n",
        "----------------------------------------\n",
        "Dermatologic Agents\t0.121\n",
        "Anti-Allergic Agents\t0.103\n",
        "Bronchodilator Agents\t0.098\n",
        "Anti-Inflammatory Agents\t0.098\n",
        "Enzyme Inhibitors\t0.096\n",
        "Immunosuppressive Agents\t0.092\n",
        "Antirheumatic Agents\t0.084\n",
        "Folic Acid Antagonists\t0.078\n",
        "Abortifacient Agents, Nonsteroidal\t0.078\n",
        "Nucleic Acid Synthesis Inhibitors\t0.077\n",
        "Antimetabolites, Antineoplastic\t0.076\n",
        "===== phenotype 16=================================================================\n",
        "proportion of pts: 0.0916303054344\n",
        "lambda: 4987.87492682\n",
        "----------------------------------------\n",
        "Chronic obstructive pulmonary disease and allied conditions\t0.155\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.131\n",
        "Diabetes\t0.126\n",
        "Hypertensive disease\t0.117\n",
        "Disorders of lipoid metabolism\t0.113\n",
        "Ischemic heart disease\t0.098\n",
        "Other diseases of respiratory system\t0.098\n",
        "Range name na\t0.088\n",
        "Pneumonia and influenza\t0.073\n",
        "----------------------------------------\n",
        "Tocolytic Agents\t0.183\n",
        "Bronchodilator Agents\t0.168\n",
        "Adrenergic beta-2 Receptor Agonists\t0.156\n",
        "Vasodilator Agents\t0.137\n",
        "Antipyretics\t0.130\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.115\n",
        "Antihypertensive Agents\t0.111\n",
        "===== phenotype 8=================================================================\n",
        "proportion of pts: 0.0936136453788\n",
        "lambda: 4985.77500611\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.127\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.117\n",
        "Disorders of lipoid metabolism\t0.115\n",
        "Range name na\t0.109\n",
        "Diseases of esophagus, stomach, and duodenum\t0.105\n",
        "Diabetes\t0.097\n",
        "Ischemic heart disease\t0.091\n",
        "General symptoms\t0.086\n",
        "Other symptoms involving abdomen and pelvis\t0.078\n",
        "Dorsopathies\t0.074\n",
        "----------------------------------------\n",
        "Proton Pump Inhibitors\t0.223\n",
        "Anti-Ulcer Agents\t0.216\n",
        "Hypnotics and Sedatives\t0.174\n",
        "Anti-Anxiety Agents\t0.152\n",
        "GABA Modulators\t0.133\n",
        "Antipyretics\t0.102\n",
        "===== phenotype 7=================================================================\n",
        "proportion of pts: 0.0872669575565\n",
        "lambda: 4944.23224636\n",
        "----------------------------------------\n",
        "Range name na\t0.156\n",
        "Hypertensive disease\t0.150\n",
        "Osteopathies, chondropathies, and acquired musculoskeletal deformities\t0.117\n",
        "Disorders of lipoid metabolism\t0.115\n",
        "Disorders of thyroid gland\t0.103\n",
        "Malignant neoplasm of breast\t0.098\n",
        "Rheumatism, excluding the back\t0.090\n",
        "General symptoms\t0.088\n",
        "Arthropathies and related disorders\t0.083\n",
        "----------------------------------------\n",
        "Vitamins\t0.128\n",
        "Bone Density Conservation Agents\t0.121\n",
        "Angiotensin-Converting Enzyme Inhibitors\t0.110\n",
        "Antihypertensive Agents\t0.102\n",
        "Antipyretics\t0.096\n",
        "Hypnotics and Sedatives\t0.096\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.090\n",
        "Cyclooxygenase Inhibitors\t0.089\n",
        "Fibrinolytic Agents\t0.088\n",
        "Antineoplastic Agents, Hormonal\t0.079\n",
        "===== phenotype 37=================================================================\n",
        "proportion of pts: 0.109083696946\n",
        "lambda: 4918.83243177\n",
        "----------------------------------------\n",
        "Na\t0.173\n",
        "Hypertensive disease\t0.122\n",
        "Neurotic, personality, nonpsychotic disorders\t0.112\n",
        "Rheumatism, excluding the back\t0.102\n",
        "Drug dependence\t0.093\n",
        "Disorders of lipoid metabolism\t0.092\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.083\n",
        "Dorsopathies\t0.078\n",
        "Arthropathies and related disorders\t0.076\n",
        "General symptoms\t0.070\n",
        "----------------------------------------\n",
        "Antidepressive Agents, Second-Generation\t0.212\n",
        "Serotonin Uptake Inhibitors\t0.206\n",
        "Antipyretics\t0.152\n",
        "Antihypertensive Agents\t0.151\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.140\n",
        "Cyclooxygenase Inhibitors\t0.138\n",
        "===== phenotype 49=================================================================\n",
        "proportion of pts: 0.100753669179\n",
        "lambda: 4918.01340952\n",
        "----------------------------------------\n",
        "Other forms of heart disease\t0.133\n",
        "Hypertensive disease\t0.120\n",
        "Range name na\t0.111\n",
        "Symptoms involving skin and other integumentary tissue\t0.110\n",
        "General symptoms\t0.102\n",
        "Arthropathies and related disorders\t0.096\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.094\n",
        "Acute respiratory infections\t0.080\n",
        "Anemias\t0.078\n",
        "Diseases of the ear and mastoid process\t0.076\n",
        "----------------------------------------\n",
        "Anti-Inflammatory Agents\t0.193\n",
        "Diuretics\t0.184\n",
        "Anti-Allergic Agents\t0.172\n",
        "Sodium Potassium Chloride Symporter Inhibitors\t0.161\n",
        "Bronchodilator Agents\t0.154\n",
        "Antihypertensive Agents\t0.136\n",
        "===== phenotype 35=================================================================\n",
        "proportion of pts: 0.0948036493455\n",
        "lambda: 4916.34771888\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.141\n",
        "Arthropathies and related disorders\t0.115\n",
        "Diseases of esophagus, stomach, and duodenum\t0.114\n",
        "Rheumatism, excluding the back\t0.105\n",
        "Range name na\t0.099\n",
        "Disorders of lipoid metabolism\t0.093\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.089\n",
        "Other diseases of urinary system\t0.086\n",
        "Symptoms involving digestive system\t0.079\n",
        "Other disorders of female genital tract\t0.079\n",
        "----------------------------------------\n",
        "Proton Pump Inhibitors\t0.160\n",
        "Anti-Ulcer Agents\t0.146\n",
        "Anti-Allergic Agents\t0.146\n",
        "Anti-Inflammatory Agents\t0.140\n",
        "Bronchodilator Agents\t0.140\n",
        "Antihypertensive Agents\t0.097\n",
        "Adrenergic beta-2 Receptor Agonists\t0.091\n",
        "Estrogens\t0.082\n",
        "===== phenotype 38=================================================================\n",
        "proportion of pts: 0.10035700119\n",
        "lambda: 4913.56115742\n",
        "----------------------------------------\n",
        "Disorders of the peripheral nervous system\t0.147\n",
        "Diabetes\t0.121\n",
        "Hypertensive disease\t0.106\n",
        "Disorders of lipoid metabolism\t0.103\n",
        "Rheumatism, excluding the back\t0.096\n",
        "Nephritis, nephrotic syndrome, and nephrosis\t0.095\n",
        "Arthropathies and related disorders\t0.091\n",
        "General symptoms\t0.086\n",
        "Anemias\t0.079\n",
        "Range name na\t0.076\n",
        "----------------------------------------\n",
        "Hypoglycemic Agents\t0.216\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.178\n",
        "Anticholesteremic Agents\t0.176\n",
        "Anticonvulsants\t0.154\n",
        "Analgesics\t0.150\n",
        "Antihypertensive Agents\t0.127\n",
        "===== phenotype 43=================================================================\n",
        "proportion of pts: 0.0888536295121\n",
        "lambda: 4902.27590203\n",
        "----------------------------------------\n",
        "Disorders of the eye and adnexa\t0.156\n",
        "Acute respiratory infections\t0.140\n",
        "General symptoms\t0.126\n",
        "Range name na\t0.123\n",
        "Hypertensive disease\t0.111\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.100\n",
        "Other symptoms involving abdomen and pelvis\t0.085\n",
        "Infections of skin and subcutaneous tissue\t0.082\n",
        "Other diseases of intestines and peritoneum\t0.078\n",
        "----------------------------------------\n",
        "Cyclooxygenase Inhibitors\t0.111\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.109\n",
        "Anti-Inflammatory Agents\t0.105\n",
        "Antipyretics\t0.103\n",
        "Antihypertensive Agents\t0.103\n",
        "Platelet Aggregation Inhibitors\t0.097\n",
        "Diuretics\t0.097\n",
        "Vasodilator Agents\t0.096\n",
        "Fibrinolytic Agents\t0.094\n",
        "Dermatologic Agents\t0.086\n",
        "===== phenotype 18=================================================================\n",
        "proportion of pts: 0.0880602935343\n",
        "lambda: 4305.4470172\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.159\n",
        "Disorders of lipoid metabolism\t0.128\n",
        "Range name na\t0.118\n",
        "Disorders of the eye and adnexa\t0.108\n",
        "Diabetes\t0.105\n",
        "Other diseases of skin and subcutaneous tissue\t0.102\n",
        "Rheumatism, excluding the back\t0.102\n",
        "Disorders of the peripheral nervous system\t0.095\n",
        "General symptoms\t0.083\n",
        "----------------------------------------\n",
        "Excitatory Amino Acid Antagonists\t0.170\n",
        "Antiparkinson Agents\t0.169\n",
        "Anticonvulsants\t0.163\n",
        "Anti-Anxiety Agents\t0.160\n",
        "Serotonin Uptake Inhibitors\t0.134\n",
        "Analgesics\t0.127\n",
        "Antihypertensive Agents\t0.076\n",
        "===== phenotype 3=================================================================\n",
        "proportion of pts: 0.0975803252678\n",
        "lambda: 4128.40498172\n",
        "----------------------------------------\n",
        "Other diseases of intestines and peritoneum\t0.186\n",
        "Symptoms involving digestive system\t0.148\n",
        "Hypertensive disease\t0.117\n",
        "Range name na\t0.113\n",
        "Other symptoms involving abdomen and pelvis\t0.105\n",
        "Diseases of esophagus, stomach, and duodenum\t0.089\n",
        "Complications of surgical and medical care, not elsewhere classified\t0.084\n",
        "Other diseases of urinary system\t0.083\n",
        "Certain traumatic complications and unspecified injuries\t0.075\n",
        "----------------------------------------\n",
        "Analgesics, Opioid\t0.164\n",
        "Narcotics\t0.157\n",
        "Antihypertensive Agents\t0.153\n",
        "Antipyretics\t0.135\n",
        "Hypnotics and Sedatives\t0.134\n",
        "Anti-Anxiety Agents\t0.134\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.124\n",
        "===== phenotype 29=================================================================\n",
        "proportion of pts: 0.0884569615232\n",
        "lambda: 3917.3493932\n",
        "----------------------------------------\n",
        "Symptoms involving digestive system\t0.160\n",
        "Other symptoms involving abdomen and pelvis\t0.146\n",
        "Nonspecific findings on examination of blood\t0.100\n",
        "Liver\t0.098\n",
        "Anemias\t0.094\n",
        "Other diseases of urinary system\t0.086\n",
        "Dorsopathies\t0.085\n",
        "Hypertensive disease\t0.080\n",
        "Disorders of fluid, electrolyte, and acid-base balance\t0.080\n",
        "Symptoms involving skin and other integumentary tissue\t0.072\n",
        "----------------------------------------\n",
        "Anti-Ulcer Agents\t0.156\n",
        "Antihypertensive Agents\t0.150\n",
        "Anti-Arrhythmia Agents\t0.148\n",
        "Vasodilator Agents\t0.146\n",
        "Cyclooxygenase Inhibitors\t0.136\n",
        "Antipyretics\t0.134\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.131\n",
        "===== phenotype 40=================================================================\n",
        "proportion of pts: 0.0662435541452\n",
        "lambda: 3658.33095523\n",
        "----------------------------------------\n",
        "Miscellaneous diagnostic and therapeutic procedures\t0.268\n",
        "Operations on the cardiovascular system\t0.204\n",
        "Other diseases of respiratory system\t0.190\n",
        "Diseases of veins and lymphatics, and other diseases of circulatory system\t0.117\n",
        "Operations on the musculoskeletal system\t0.114\n",
        "Diseases of arteries, arterioles, and capillaries\t0.107\n",
        "----------------------------------------\n",
        "Antipyretics\t0.136\n",
        "Antihypertensive Agents\t0.135\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.130\n",
        "Cyclooxygenase Inhibitors\t0.128\n",
        "Fibrinolytic Agents\t0.123\n",
        "Platelet Aggregation Inhibitors\t0.123\n",
        "Anti-Arrhythmia Agents\t0.116\n",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors\t0.107\n",
        "===== phenotype 36=================================================================\n",
        "proportion of pts: 0.0900436334788\n",
        "lambda: 3539.018473\n",
        "----------------------------------------\n",
        "Other disorders of female genital tract\t0.135\n",
        "Range name na\t0.124\n",
        "Dorsopathies\t0.121\n",
        "Hypertensive disease\t0.115\n",
        "Rheumatism, excluding the back\t0.100\n",
        "Arthropathies and related disorders\t0.091\n",
        "Symptoms involving urinary system\t0.085\n",
        "General symptoms\t0.083\n",
        "Disorders of lipoid metabolism\t0.074\n",
        "Pain\t0.071\n",
        "----------------------------------------\n",
        "Analgesics, Non-Narcotic\t0.278\n",
        "Antihypertensive Agents\t0.153\n",
        "Antipyretics\t0.148\n",
        "Estrogens\t0.142\n",
        "Anti-Inflammatory Agents, Non-Steroidal\t0.139\n",
        "Cyclooxygenase Inhibitors\t0.139\n",
        "===== phenotype 15=================================================================\n",
        "proportion of pts: 0.0880602935343\n",
        "lambda: 2949.89593007\n",
        "----------------------------------------\n",
        "Dorsopathies\t0.129\n",
        "Range name na\t0.111\n",
        "Rheumatism, excluding the back\t0.107\n",
        "Hypertensive disease\t0.104\n",
        "Symptoms involving urinary system\t0.101\n",
        "Arthropathies and related disorders\t0.097\n",
        "Disorders of lipoid metabolism\t0.094\n",
        "Nonspecific findings on examination of blood\t0.092\n",
        "Organic sleep disorders\t0.091\n",
        "Other diseases of urinary system\t0.075\n",
        "----------------------------------------\n",
        "Anti-Ulcer Agents\t0.255\n",
        "Anti-Inflammatory Agents\t0.250\n",
        "Bronchodilator Agents\t0.248\n",
        "Anti-Allergic Agents\t0.247\n",
        "===== phenotype 1=================================================================\n",
        "proportion of pts: 0.0955969853233\n",
        "lambda: 2859.52512376\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.132\n",
        "Diabetes\t0.118\n",
        "Disorders of lipoid metabolism\t0.118\n",
        "Organic sleep disorders\t0.110\n",
        "Nonspecific findings on examination of blood\t0.106\n",
        "Disorders of the eye and adnexa\t0.099\n",
        "Range name na\t0.085\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.078\n",
        "Diseases of esophagus, stomach, and duodenum\t0.077\n",
        "Arthropathies and related disorders\t0.077\n",
        "----------------------------------------\n",
        "Calcium Channel Blockers\t0.308\n",
        "Vasodilator Agents\t0.264\n",
        "Analgesics\t0.257\n",
        "Antihypertensive Agents\t0.171\n",
        "===== phenotype 33=================================================================\n",
        "proportion of pts: 0.0955969853233\n",
        "lambda: 2762.15764191\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.131\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.123\n",
        "General symptoms\t0.121\n",
        "Other diseases of urinary system\t0.101\n",
        "Pneumonia and influenza\t0.093\n",
        "Other diseases of respiratory system\t0.092\n",
        "Other forms of heart disease\t0.089\n",
        "Acute respiratory infections\t0.086\n",
        "Symptoms involving urinary system\t0.084\n",
        "Other diseases of the upper respiratory tract\t0.078\n",
        "----------------------------------------\n",
        "Anti-Bacterial Agents\t0.345\n",
        "Anti-Allergic Agents\t0.256\n",
        "Bronchodilator Agents\t0.200\n",
        "Antihypertensive Agents\t0.199\n",
        "===== phenotype 30=================================================================\n",
        "proportion of pts: 0.0880602935343\n",
        "lambda: 2713.34016047\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.173\n",
        "Other forms of heart disease\t0.163\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.159\n",
        "Range name na\t0.141\n",
        "Disorders of the eye and adnexa\t0.133\n",
        "Disorders of lipoid metabolism\t0.127\n",
        "General symptoms\t0.104\n",
        "----------------------------------------\n",
        "Enzyme Inhibitors\t0.228\n",
        "Immunosuppressive Agents\t0.212\n",
        "Dermatologic Agents\t0.199\n",
        "Antimetabolites, Antineoplastic\t0.182\n",
        "Antirheumatic Agents\t0.179\n",
        "===== phenotype 14=================================================================\n",
        "proportion of pts: 0.0864736215787\n",
        "lambda: 2526.00247841\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.156\n",
        "Symptoms involving urinary system\t0.134\n",
        "Other diseases of urinary system\t0.131\n",
        "Range name na\t0.123\n",
        "Disorders of lipoid metabolism\t0.110\n",
        "Nephritis, nephrotic syndrome, and nephrosis\t0.097\n",
        "Anemias\t0.091\n",
        "Diseases of esophagus, stomach, and duodenum\t0.083\n",
        "Nonspecific findings on examination of blood\t0.077\n",
        "----------------------------------------\n",
        "Enzyme Inhibitors\t0.240\n",
        "Dermatologic Agents\t0.219\n",
        "Immunosuppressive Agents\t0.200\n",
        "Antirheumatic Agents\t0.176\n",
        "Antihypertensive Agents\t0.165\n",
        "===== phenotype 6=================================================================\n",
        "proportion of pts: 0.0761602538675\n",
        "lambda: 2411.19090565\n",
        "----------------------------------------\n",
        "Na\t0.128\n",
        "Hypertensive disease\t0.117\n",
        "Other symptoms involving abdomen and pelvis\t0.115\n",
        "Neurotic, personality, nonpsychotic disorders\t0.113\n",
        "Range name na\t0.106\n",
        "Diseases of esophagus, stomach, and duodenum\t0.098\n",
        "Organic sleep disorders\t0.094\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.080\n",
        "General symptoms\t0.077\n",
        "Other diseases of urinary system\t0.071\n",
        "----------------------------------------\n",
        "Serotonin Uptake Inhibitors\t0.292\n",
        "Antidepressive Agents, Second-Generation\t0.280\n",
        "Anti-Anxiety Agents\t0.228\n",
        "Antihypertensive Agents\t0.201\n",
        "===== phenotype 4=================================================================\n",
        "proportion of pts: 0.0805236017453\n",
        "lambda: 1308.47093397\n",
        "----------------------------------------\n",
        "Overweight, obesity and other hyperalimentation\t0.143\n",
        "Symptoms involving skin and other integumentary tissue\t0.127\n",
        "Dorsopathies\t0.108\n",
        "Acute respiratory infections\t0.098\n",
        "Hypertensive disease\t0.094\n",
        "Diabetes\t0.093\n",
        "Anemias\t0.088\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.086\n",
        "Organic sleep disorders\t0.083\n",
        "Disorders of lipoid metabolism\t0.080\n",
        "----------------------------------------\n",
        "Calcium Channel Blockers\t0.585\n",
        "Antihypertensive Agents\t0.415\n",
        "===== phenotype 26=================================================================\n",
        "proportion of pts: 0.0606902023007\n",
        "lambda: 814.986544388\n",
        "----------------------------------------\n",
        "Hypertensive disease\t0.156\n",
        "Range name na\t0.147\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.120\n",
        "Disorders of lipoid metabolism\t0.109\n",
        "Other forms of heart disease\t0.102\n",
        "Ischemic heart disease\t0.101\n",
        "Rheumatism, excluding the back\t0.097\n",
        "General symptoms\t0.096\n",
        "Other diseases of respiratory system\t0.072\n",
        "----------------------------------------\n",
        "Surface-Active Agents\t1.000\n",
        "===== phenotype 10=================================================================\n",
        "proportion of pts: 0.070606902023\n",
        "lambda: 670.236126258\n",
        "----------------------------------------\n",
        "Symptoms involving respiratory system and other chest symptoms\t0.131\n",
        "Anemias\t0.130\n",
        "Other diseases of respiratory system\t0.128\n",
        "Other forms of heart disease\t0.125\n",
        "Disorders of fluid, electrolyte, and acid-base balance\t0.104\n",
        "Hypertensive disease\t0.103\n",
        "Range name na\t0.102\n",
        "Pain\t0.094\n",
        "Symptoms involving cardiovascular system\t0.082\n",
        "----------------------------------------\n",
        "Anti-Anxiety Agents\t1.000\n",
        "===== phenotype 41=================================================================\n",
        "proportion of pts: 0.0\n",
        "lambda: 1.0\n",
        "----------------------------------------\n",
        "----------------------------------------\n",
        "===== phenotype 23=================================================================\n",
        "proportion of pts: 0.0\n",
        "lambda: 1.0\n",
        "----------------------------------------\n",
        "----------------------------------------\n"
       ]
      }
     ],
     "prompt_number": 170
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": []
    }
   ],
   "metadata": {}
  }
 ]
}